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SUMMARY
Mammalian reoviruses have been used as a model to study the control of host cell 
protein synthesis following infection. The reovirus genome is composed of 10 
segments of double stranded RNA each of which, with one exception, encodes a 
single protein. The three serotypes of the virus show marked differences in their 
effects on host cell protein synthesis following viral infection. Serotypes 2 and 3 
give pronounced inhibition and serotype 1 has little effect. Genetic studies using 
intertypic réassortants have mapped this property to the S4 gene of the virus which 
encodes the major outer capsid polypeptide o3. The S4 gene of serotypes 1 and 3 
have been sequenced and show 96 % homology at the amino acid level.
Full length cDNA clones of the S4 gene of serotypes 1 and 3 (S4-1 and S4-3) were 
used to develop in vitro and in vivo assay systems to study the mechanism 
underlying the differential effects on host cell protein synthesis of the corresponding 
o3 proteins. The ability of o3 to inhibit host cell protein synthesis was investigated 
in two in vitro translation systems: the rabbit reticulocyte lysate system and S-10 
cell extracts prepared from uninfected and type 1 and type 3 infected L-cells. o3 
had no effect on either the translation o f B-actin when used as a marker for 
eukaryotic protein synthesis, or endogenous protein synthesis in either of these 
systems.
In vivo assay systems made use of the HIVLTR/tat inducible reporter system to 
drive o3 expression. The effects of o3 on the expression of two reporter genes, 
chloramphenicol acetyltransferase (CAT) and B-galactosidase were investigated in 
transient in vivo assay systems. o3 expressed from S4-3 cDNA caused a significant 
stimulation of reporter gene expression. In contrast o3 from S4-1 cDNA had no 
affect on gene expression, suggesting a domain of S4-3 was responsible for this 
stimulation. In an attempt to domain map this property two hybrids were 
constructed, one containing the S' 800 base pairs of S4-1 and the 3' 400 base pairs 
of S4-3 (HY-1), and the other, HY-3, the converse of this. o3 synthesised from 
HY-1 stimulated reporter gene expression whereas that from HY-3 had no effect. 
o3 was readily detected in cells transiently expressing either the parental type 3 S4 
cDNA or the HY-1 hybrid by immunoprécipitation and immunofluorescence. By 
contrast only very small amounts of o i were detected when either the S4 cDNA 
from type 1 or the HY-3 were used. Pulse-chase experiments indicated that the o3 
from type 1 virus is less stable than the type 3 protein and that the domain 
responsible for this stability is in the 3' terminus of the S4 gene. This domain is 
also that shown by others to be responsible for the ability of o3 to bind dsRNA.
A model is proposed in which o3 is postulated as controlling host cell protein 
synthesis by inactivating the dsRNA kinase inhibitor (DAI), induced by foreign 
dsRNAs in the cell, which leads to inhibition of initiation of protein synthesis. In 
the infected cell o3 either exists free or is associated with protein /*lc on the outer 
capsid shell. The model proposes that unassociated o3 from the type 3 virus is 
stable and can bind to dsRNA structures produced during viral infection, thereby 
inactivating DAI and allowing expression o f  late viral proteins at the expense of 
cellular proteins. By contrast unassociated o3 from type 1 appears to be unstable 
and therefore may not be able to promote late viral protein synthesis as efficiently as 
type 3 virus can. This model also accounts for the differing abilities of the two 
serotypes to inhibit host cell protein synthesis.
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1.1 TYPES OF PATHOGENESIS
Viruses are often termed intracellular parasites as they utilise the cellular 
gene products for DNA and RNA replication, transcription, processing and 
transport of mRNA, protein synthesis and post-translational modification of 
polypeptides.
The events that occur when a virus infects an animal can be divided into 
two major stages:
A. Extracellular pathogenesis
B. Intracellular pathogenesis
A. Extracellular pathogenesis:
This can be used to refer to the steps that the virus takes from entering the 
host until it reaches and enters the target cell: that is, how the virus reaches and 
recognises a specific receptor on the surface of the target cell and then enters it.
B. Intracellular pathogenesis:
This can be used to refer to the steps that the virus takes in utilising the 
host cell systems for its own propagation and in so doing causing, in many cases, 
the eventual death of the target cell.
One important aspect of intracellular pathogenesis is the inhibition of host 
macromolecular synthesis, particularly protein synthesis, following viral 
infection. Before discussing how viruses exert their effects on the host cell 
translational apparatus, a basic understanding of eukaryotic protein synthesis is 
required.
1.2 EUKARYOTIC PROTEIN SYNTHESIS
Over the last twenty years there has been considerable work on the 
regulation of gene expression, both at the level of transcription and of 
translation. Studies concerning regulation at the translational level have largely 
been carried out in mammalian reticulocyte lysates. These are non-nucleated 
cells and hence translational control is the only method by which gene expression 
can be regulated. The information obtained from reticulocyte lysates forms the 
basis of our understanding of mammalian protein synthesis and will form the 
basis for this discussion.
1.2.1 Production of mRNA
mRNA is transcribed in the nucleus where it is also processed to ensure its 
stability. This processing involves the addition of a modified 5' cap structure 
and a 3' polyadenylated tail. Most eukaryotic transcripts are also spliced prior to 
export of the mature mRNA into the cytoplasm where it enters the translational 
process.
The presence of a 5' terminal 'cap' structure m7G(5')ppp(5')N is a 
common feature of eukaryotic mRNAs. The addition of the cap is an early 
transcriptional modification occurring at the 3' triphosphate ends of nascent 
nuclear pre-mRNAs. The reaction is catalysed by nuclear guanyl and 
methyltransferases, thus viruses that replicate exclusively in the cytoplasm must 
encode their own versions of these enzymes. The cap structure serves as a 
stabilising element on both pre-mRNAs in the nucleus (Green et al. , 1983), and 
mRNAs in the cytoplasm (Furuichi et al. , 1977).
In eukaryotic genes the protein coding sequence (consisting of a number of 
exons) is often interrupted by one or more intervening sequences (introns). The 
primary transcripts are therefore spliced to remove these introns and generate the
mature mRNA with an uninterrupted reading frame for translation (Rogers & 
Wall, 1980; Cech, 1983). The splicing mechanism plays a critical role in the 
regulation of gene expression (Krämer et a l., 1984). Many viral mRNAs also 
contain introns (Sharp, 1981).
mRNA is also modified at the 3' end by the addition of a long sequence (up 
to 200 nucleotides) o f polyadenylic acid. This poly A tail is thought to serve to 
stabilise mRNA (Kozak, 1983; Zeevi, 1982;). However this cannot be its 
exclusive role since other mRNAs lacking poly A are stable. For example, 
reovirus and histone mRNAs are non polyadenylated (McCrae & Woodland, 
1981; Adesnick & Darnell, 1972). Recently Munroe and Jacobson (1990) have 
reported that the poly A tail may have a role in enhancing initiation of 
translation.
1.2.2 Protein Synthesis
Mature mRNA enters the cytoplasm and the translation pathways. The 
translational process can be divided into three stages: initiation, elongation and 
termination (recently reviewed by Nygärd 1990).
1.2.2.1 Initiation
Initiation is one of the most highly regulated steps in translation and it too 
can be divided into 3 stages:
a) , formation of the 43S pre-initiation complex
b) . formation of the 48S initiation complex
c) . formation of the 80S initiation complex.
Each of these stages involves a number of initiation factors (elF’s), which
are listed in table 1.
Table 1: Eukaryotic initiation factors
FACTOR PUTATIVE FUNCTION
eIF2 Binding met-tRNA to the 
40S subunit
1GEF Nucleotide exchange 
factor
eIF3 Dissociation of 80S 
ribosomes
eIF4A ATP dependent unwinding 
of mRNA
eIF4B binding of mRNA to 40S 
subunit
eIF4C dissociation of 80S 
ribosomes
eIF4E cap recognition
eIF4F cap recognition and 
mRNA binding
eIF5 GTP dependent subunit 
joining
eIF6 dissociation of 80S 
ribosomes
1GEF= Guanine nucleotide exchange factor.
The first step in initiation is the dissociation of the 80S ribosome into its 
two subunits - 40S and 60S. The interaction of the initiation factors eIF-3 and 
eIF-4C with the 40 S subunit (Lutsch et al., 1986) and eIF-6 with the 60 S 
subunit (Raychaudhuri et al. , 1984) shift the equilibrium of the reaction towards 
dissociation of the subunits (figure 1).
The initiator tRNA, Met-tRNAf, forms a ternary complex with GTP and 
initiation factor eIF2. This binds to the 40S ribosome subunit, which is 
complexed with two initiation factors, eIF-3 and eIF-4C, to form a 43S pre­
initiation complex (Proud, 1986) (step A figure 1). The second step of initiation 
involves the binding of mRNA to the 43S complex to form the 48S initiation 
complex (step B figure 1). In eukaryotes this process involves several initiation 
factors, eIF-4B and eIF4F, and the hydrolysis of ATP. Initiation factor eIF-4F 
is a multi-subunit complex consisting of two initiation factors, eIF-4A and 
eIF4E, and a 220kDa protein (Rhoads, 1988). eIF-4E is a protein of about 25 
kDa (Rychlik et al., 1987), often referred to as CBP1 (cap binding protein 1), 
and in the eIF-4F complex it recognises the 5* cap structure on the mRNA 
(Shatlrin, 1985). eIF-4A and eIF-4B appear to unfold the mRNA secondary 
structure, in an ATP dependent process, providing a suitable site for the 
association of the 43S pre-initiation complex (Tahara et a l., 1983). eIF-4B also 
has an affinity for the codon AUG and may be responsible for identifying the 
initiation signal. It was recently proposed that the 43S pre-initiation complex 
associates with the cap structure on the mRNA-factor complex and scans the 
mRNA from the 5' end to locate the correct initiation codon (Kozak, 1989). The 
polypeptide p220 is required for many of the factor interactions.
Once the initiator signal is identified the programmed 40S particle is ready 
to associate with the 60S subunit to form the 80S ribosome (step C figure 1). 
This requires initiation factor eIF-5 and is accompanied by the hydrolysis of 
GTP. During the subunit joining the factors associated with the pre-initiation
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FIGURE 1: INITIATION OF EUKARYOTIC PROTEIN SYNTHESIS
This figure illustrates the major steps in the initiation of protein synthesis in 
eukaryotes.
A: met-tRNA binds to GTP and eIF-2 which associate with eIF-3 and eIF-4c to 
form the 43S pre-initiation complex.
B: mRNA binds to the 43S complex, in an ATP driven process involving initiation 
factors eIF-4F and eIF-4b. The mRNA scans the area for the initiation complex 
and moves to this site forming the 48S initiation complex.
C: Formation of the 80S initiation complex: eIF-5 allows the addition of the 60S 
ribosomal subunit to the complex, resulting in the release of all initiation factors.
*1 and *2 indicate major regulatory areas for control of protein synthesis.
KEY:
□  GTP
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#  eIF-2
^  elF-4c 
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ELO N GATION
complex are released from the ribosome and the 80S initiation complex is ready 
to enter the elongation cycle.
1.2.2.2 Elongation
The ribosome has two major sites for positioning of mRNA, the P or donor 
site and the A or acceptor site. At the end of the initiation process met-tRNAf is 
bound to the P site and its anticodon is base-paired at that site with the initiator 
codon AUG in the mRNA. Like initiation, the elongation process is also 
mediated by soluble cellular factors, which have been termed elongation factors 
EF1 and EF2. Elongation is a cyclic process which can be divided into 3 basic 
reaction steps:
1. The cognate aminoacyl-tRNAs are brought to the A site in a ternary 
complex with EF1 and GTP, in a process which involves the hydrolysis of GTP.
2. When the two ribosomal binding sites are filled a peptide bond is 
formed between the methionine residue and the incoming aminoacyl moiety. 
This reaction is catalysed by peptidyltransferase and results in the newly formed 
dipeptide occupying the A site, leaving the P site with a deacylated tRNA.
3. The A site is the decoding site for chain elongation and movement of 
the next codon involves elongation factor EF2 promoting the translocation of the 
elongated peptidyl t-RNA from the A site to the P site with the concomitant 
hydrolysis of GTP (Moldave, 1985).
1.2.2.3 Termination
Elongation continues until a termination codon is reached (UAA, UAG, 
UGA) and occupies the A site (Beaudet & Caskey, 1971). When this occurs a 
protein factor (release factor RF) binds to the A site in the presence of GTP and 
catalyses the termination reaction. This reaction involves the hydrolysis of the 
peptidyl tRNA ester bond, the hydrolysis of GTP and the release of the
completed polypeptide chain, the deacylated tRNA and the ribosome from 
mRNA. It also appears to be catalysed by peptidyltransferase.
1.2.3 Regulation of translation: Recycling of eIF-2b
At the end of initiation all the initiation factors are released from the 
initiation complex. The initiation factors enter the cellular pool and are ready for 
the next round of initiation. eIF-2 has a very strong affinity for, and forms a 
complex with, the GDP generated by the GTP -* GDP + Pi hydrolysis which is 
part of the initiation process. The cycle can only be completed once the GDP 
has been exchanged for GTP. This is a major regulatory point in eukaryotic 
protein synthesis.
The factor eIF-2B is responsible for the exchange of bound GDP for free 
GTP thereby regulating the reentry of eIF-2 into the active pool and allowing the 
initiation cycle to recommence (Safer, 1983). eIF2 is a trimer of 3 distinct 
subunits designated alpha, (38K), beta (35K) and gamma (55K). The alpha and 
beta subunits take part in guanine nucleotide binding and/or exchange mechanism 
and eIF-2 gamma binds met-tRNAf. This nucleotide binding regulates the rate 
and extent of met-tRNAf binding. Hydrolysis of GTP is required for the release 
o f eIF-2 and the other initiation factors from the 48S initiation complex upon 60S 
ribosomal joining.
The ability of the cell to recycle eIF-2 may be blocked as a means of 
protecting the cell against viral infection or deprivation of certain vitamins or 
minerals. This occurs by phosphorylation / dephosphorylation of eIF-2. The 
phosphorylation state of eIF-2a is elevated under a variety of physiological 
conditions such as interferon (IFN) treatment (Samuel, 1979a; 1979b; Pestka et 
al., 1987) and haemin deficiency (Farrell, 1977; Ochoa, 1983). In such cases 
activity of eIF-2 is inhibited by phosphorylation of the a subunit. For example, 
low concentrations of dsRNA activate a factor in reticulocytes in the presence of
haeme, termed the dsRNA activated inhibitor (DAI). This factor has also been 
found in nucleated cells as an inactive precursor which is induced by treatment 
with interferon and the presence of dsRNA (Ochoa, 1983). Once induced, DAI 
phosphorylates the a  subunit of the initiation factor eIF-2 thereby blocking 
initiation (Ochoa, 1983).
1.2.4 Interferon
Interferons (IFN) are a family of regulatory proteins affecting a number of 
biological processes in animal cells, including their ability to support infection 
with a range of RNA and DNA viruses, (Petska et al., 1987). 3 classes of 
IFNs, alpha, beta and gamma have been identified with a  and 8 IFNs being of 
greatest importance in virus infection.
Two interferon induced dsRNA dependent enzymes have been identified 
and play an important role in the regulation of viral and cellular macromolecular 
synthesis and mRNA degradation (Pestka et al. , 1987):
1. Protein kinase
2. 2 '-5 ' oligoadenylate synthetase.
1. Pl/eIF-2a Protein kinase-Phosphoprotein phosphatase protein 
(DAI)
As described above the phosphorylation state of eIF-2a is a key control 
point o f the initiation of translation. The phosphorylation state of two proteins, 
PI and eIF-2o, which is modulated by a protein kinase and a phosphoprotein 
phosphatase, is very sensitive to IFN. Increases in the level of phosphorylation 
of these proteins in IFN-treated cell systems is dependent on virus infection (Rice 
et al. , 1985a; Samuel et al. , 1984) or the addition of dsRNA (Gupta, 1979).
The protein kinase (DAI) is activated by viral gene expression in the case 
of some viruses such as reovirus (Samuel et al., 1984), vesicular stomatitis virus 
(VSV) (Sahni & Samuel, 1986) and encephalomyocarditis virus (EMCV) (Rice et
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al., 1985a), thus providing a cellular defence against viral infection. However 
other viruses such as adenovirus (Anderson & Fennie, 1987) and vaccinia virus 
(Whitaker-Dowling & Younger, 1984) have adapted ways to overcome this host 
cell defence system, which will be discussed in section 1.3.
2. The (2'-5') oligoadenylate synthetase-nuclease system.
Another enzyme system induced in response to IFN and dsRNA is the (2'- 
5') oligoadenylate synthetase-nuclease system. This is also a latent enzyme 
system that is induced by IFN and dsRNA. There are 3 enzymes that play an 
important role in this system:
a. 2,5-(A)n synthetase
b. endoribonuclease
c. phophodiesterase.
The 2 '5‘ oligoadenylate synthetase is induced by interferon and dsRNA 
hence polymerising ATP into a series of 2 ',5 '-linked oligomers. These 
oligomers, termed 2-5A, bind and activate a latent cellular endoribonuclease 
which cleaves mRNA and rRNA. A 2 '5 ' phosphodiesterase then degrades the 2- 
5A. This system is activated in EMCV- infected HeLa cells (Rice et al. , 1985a) 
and novel 2'5' oligoadenylates have also been found in IFN-treated vaccinia- 
virus infected cells (Rice et al., 1985b).
1.2.5 Summary
Protein synthesis is a highly regulated series of events. When a virus 
enters the cell it utilises the cell's facilities for translating its own proteins. 
Viruses have adapted various ways of promoting their own protein synthesis over 
that o f the host, in many cases resulting in the inhibition of host cell protein
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synthesis and the eventual death of the cell. These mechanisms will be discussed 
in the following sections.
1.3 VIRUS INDUCED CONTROL OF HOST CELL PROTEIN 
SYNTHESIS.
The efficient replication of a virus depends on its ability to harness the host 
cell macromolecular machinery at a variety of levels. Many viruses have 
evolved mechanisms which enable them to dominate various components of the 
host cell machinery: for example, the host cell translational apparatus. A wide 
variety of such mechanisms have been described including (recently reviewed by 
Schneider & Shenk, 1987):
1. Degradation of host cell mRNA e.g Herpes simplex virus (HSV).
2. Inactivation of translation factors e.g Poliovirus.
3. Production of factors specifically inhibiting cellular translation e.g 
Adenovirus.
4. Viral mRNAs that out-compete cellular mRNAs e.g VSV.
1.3.1 Inhibition of host cell protein synthesis by poliovirus
Poliovirus is a member of the picomaviradae, a group of viruses whose 
genome is composed of positive sense single stranded RNA. The viral genomic 
RNA is translated in one open reading frame into a polyprotein precursor that on 
subsequent proteolysis releases the final viral proteins (Rueckert & Wimmer, 
1984). The initial proteolysis of the polyprotein yields 3 precursors PI, P2 and 
P3 in a cleavage event mediated by two virus-encoded proteinases, polypeptides 
3C and 2A The primary proteolytic products then split into smaller protein 
products.
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An important feature of picomaviral mRNA is that it lacks the blocked 
methylated cap structure found in most mRNAs (Nomoto et al., 1976), and 
which under normal conditions is required for efficient translation (discussed in 
section 1). In place of the 5' cap structure picomaviruses have a pUp sequence 
(Hewlett, 1976).
Penham (1963) first reported that infection of cells with poliovirus causes a 
rapid and marked inhibition of cellular protein synthesis. It is also able to 
interfere with the translation of a variety of other viral mRNAs in co-infection 
experiments, for example, VSV (Ehrenfeld & Lund, 1977) and adenovirus 
(Bablanian & Russell, 1974), which in contrast to poliovirus have mRNA 
containing a 5' methylated cap structure similar to that of host cell mRNA. This 
observation led to the proposal that the difference between the 5* termini of 
polioviral and cellular mRNA could be a basis for the inhibition of host protein 
synthesis. This idea was further supported by Femandez-Munz and Darnell 
(1976), who concluded that host mRNA was not destroyed and remained 
functional after poliovirus infection. The central postulate of this hypothesis was 
that a mechanism existed in infected cells to translate viral uncapped mRNA in 
preference to host capped mRNA.
To investigate this hypothesis further Rose et al. (1978) used VSV mRNA 
in extracts derived from poliovirus infected and uninfected HeLa cells to study 
the mechanism of inhibition. They found that addition of eIF-4B (purified from 
rabbit reticulocytes) to the assays overcame the poliovirus-associated inhibition of 
VSV translation mentioned above. This suggested that eIF4B, which is required 
for the translation of capped mRNA, may be lost or inactivated by poliovirus. 
When this activity of eIF-4B was first observed it was termed the 'restoring 
factor'. Trachsel et a /.(1980) purified this 'factor' from poliovirus infected cells 
and found that the activity co-purified with a 24 kDa polypeptide that was 
identical to the cap binding protein (CBP1) originally described by Sonenberg et
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al. (1978). This observation led to a new hypothesis in which poliovirus 
infection resulted in the inactivation of the cap-dependent recognition of mRNA 
that occurs during initiation. When the 24 kDa protein was purified it was nearly 
always found in association with eIF-3 (Lee & Sonenberg, 1982). To further 
investigate the alterations of eIF-3 and associated proteins (such as CBP1) 
following virus infection in HeLa cells, polyclonal antibodies against rabbit 
reticulocyte elF-3 were used. A polypeptide of 220 kDa (p220) was found to 
disappear at 2.5 hours post infection (p220 is one of the components of the cap­
binding complex eIF-4F (section 1)). Its disappearance was associated with the 
appearance of several smaller proteins (Etchison et al. , 1982). The cleavage of 
this protein correlated with viral infection: the loss of p220 occurred at the same 
time as cellular protein synthesis began to decrease. The findings of Etchison 
and collaborators suggested that a viral product must mediate the cleavage of 
p220. Lee et al. (1985) showed that this product was not the well-defined viral 
protease protein 3C.
In an attempt to elucidate the nature of the viral product cleaving p220, 
Bernstein et al. (1985) generated a range of single codon insertion mutants using 
a full length cDNA clone of the virus (Racaniello & Baltimore, 1981). One of 
these mutants contained an extra amino acid in the P2 segment of the virus 
coding for protein 2A. When this was transfected into a variety of cell lines 
there was no rapid inhibition of host cell protein synthesis associated with 
wildtype virus infection, nor were significant levels of p220 cleavage proteins 
evident in the mutant infected cells, thus implying that protein 2A may have a 
role in the cleavage of p220. Using an in vitro translation assay system to study 
p220 cleavage by protein 2A, Krausslich et al. (1987) found that synthetic 
mRNA transcripts encoding the 2A region of the viral genome completely 
cleaved p220. To investigate this cleavage in vivo Sun and Baltimore (1989) 
determined that protein 2A, produced from a cDNA clone, in HeLa cells inhibits
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the translation of a wide range of reporter genes and it cleaved p220 into the 
products that were also found in poliovirus infected HeLa cells. The results of 
Krausslich et al. (1987) and Sun and Baltimore (1989) led to a model proposing 
that protein 2A activates a cellular protease which cleaves p220. Wyckoff et al. 
(1990) studied the ability of protein 2A expressed in E.Coli to induce p220 
cleavage and found that cleavage was incomplete, suggesting a cellular factor 
was also involved. HeLa cell extracts were fractionated by various methods and 
the capacity of each fraction to cleave p220 in the presence of protein 2A 
produced from E.Coli was analysed. eIF-3 was found to be required for protein 
2A to completely cleave p220 (Wyckoff et al. 1990).
Thus poliovirus inhibits host protein synthesis by production of a protease, 
protein 2A, that cleaves protein p220, a component of the eIF-4F initiation 
complex, in the presence of initiation factor eIF-3. (Recently reviewed by 
Sonenberg, 1987).
Other viruses controlling host shut-off by cleavage of the cellular protein 
p220 include foot and mouth disease virus (Devaney et al., 1988) and human 
rhinovirus 14. (Etchison & Fout, 1985).
1.3.2 Control of host cell macromolecular synthesis by VSV
VSV is a member of the rhabdoviridae, a group of viruses which contain 
negative sense single stranded RNA as their genome. The virion contains the 
enzymes necessary to translate the negative stranded RNA to positive stranded 
(messenger) RNA. The mRNA of this virus is synthesised by a virion associated 
transcriptase and mimics host cell RNA in having a 5’ cap structure and 3' 
polyadenylated tail. The viral genome has a leader sequence of 45 nucleotides 
and is transcribed into 5 monocistronic mRNAs, each encoding a specific 
protein, N, NS, M, G and L respectively. The genome is transcribed: 3'- 
Leader-N-NS-M-G-L-5' (Ball Sc White, 1976).
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Infection of a wide variety of animal cells with VSV results in inhibition of 
cellular DNA, RNA and protein synthesis and finally cell death. This discussion 
will focus on the control of cellular protein synthesis by the virus. VSV 
infection of mouse L-cells results in a visible reduction in the synthesis of 
cellular proteins within 5 hours of infection (M in is te r  & Wagner, 1976). This 
inhibition process requires transcription but not replication of the VSV genome 
as the virion itself is unable to shut off host transcription (Wek and Wagner 
1979).
Initial studies on the inhibition mechanisms in this case suggested that it 
occurred at the level of initiation. Thus Nuss et al. (1975) proposed that VSV 
mRNA initiated protein synthesis with greater efficiency than cellular mRNA, in 
so doing out-competing the host mRNA for the available ribosomes. Using cell 
free translation systems Lodish and Porter (1980; 1981) provided experimental 
support for this proposal. However several other groups have reported that a 
viral specified function is required for host shut-off. Stanners et al. (1977) 
termed this virus-specified product the P function and isolated and partially 
characterised a P ' mutant having a lower capacity to inhibit host protein synthesis 
than the wild type virus. Using temperature sensitive (t.s.) mutants Marvalidi et 
al. (1977) proposed that the N and NS gene products may be involved in this 
shut-off. Successive viral mRNA can be inhibited with increasing doses of U. V 
irradiation, the furthest from the 3' end of the viral genome being inactivated 
first. By comparing the relative doses of U.V irradiation required to cause 
inhibition of host protein synthesis, Marvalidi et al. (1978) confirmed that the 
viral N gene and possibly the NS gene (i.e. the two smallest gene products) were 
required for the inhibition of cellular protein synthesis in mouse L-cells. Support 
that only the 3' end of the viral genome was required was provided by 
Schnitzlein et al. (1983) who reported that 5’ Defective Interfering (DI) virus
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particles hod little effect on the capacity of the wild type virus to inhibit cellular 
protein synthesis.
In an attempt to dissect the molecular mechanisms of inhibition of protein 
synthesis by VSV Dunigan et al. (1983) used cell-free extracts from U.V 
irradiated virus. They found that the U.V inactivation curve consisted of two 
phases, suggesting that two viral transcription products were involved in 
inhibition of cellular protein synthesis. One of these products was 373 
nucleotides and the other was 42 nucleotides. U.V inactivation of the larger 
transcription product resulted in a 40% decrease in the capacity of the virus to 
shut off host protein synthesis. The smaller product was the same size as the 
leader RNA which had previously been shown to inhibit cellular RNA synthesis 
(McGowan & Wanger, 1981). To further study the role of the leader RNA in 
host shut-off, Dunigan et al. (1986) examined the relationship between the extent 
of shut-off and accumulation o f  leader mRNA in cells infected by wild type VSV 
and different mutants. These mutants were defective in either their ability to 
shut-off RNA and protein synthesis or in replication. From these studies 
Dunigan et al. (1986) confirmed that two VSV transcription products of the VSV 
genome were required to cause inhibition.
In summary, two VSV transcription products, possibly the leader RNA and 
the N protein, are required to inhibit host protein synthesis. This inhibition 
occurs at the level of initiation. However, to date there is no conclusive 
evidence to indicate at which stage this inhibition occurs (reviewed by Wagner, 
1987).
1.3.3 Control of protein synthesis by adenovirus
Adenoviruses are a group of double stranded DNA containing viruses. 
Adenovirus mRNA has all the major characteristics of host mRNA and they have
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been widely used as models for studying the splicing process in eukaryotes 
(Grabowski et al. 1984).
Host cell protein synthesis in adenovirus infected cells is depressed at late 
times in infection. Babich et al. (1983) showed that host mRNA from infected 
cells could still be translated in in vitro translating systems, suggesting that 
inhibition of protein synthesis may occur at the level of initiation of protein 
synthesis of pre-existing cellular mRNA.
Adenovirus infection results in the production of a range of small virion- 
associated RNAs of about 160 nucleotides in length (VA RNAI (VAI) and VA 
RNAII). VAI is synthesised in large amounts at late times in infection when it is 
the dominant RNA species in the cytoplasm. This occurs at a time comparable to 
the commencement of host shut-off. To investigate the functions of VAI, 
Thimmappaya et a/. (1982) generated a range of mutations in the VAI region of 
the adenovirus 5 genome. One o f these mutants, d!331, was defective in VAI. 
This mutant has been widely investigated and forms the current understanding of 
the control of protein synthesis by adenovirus. dl331 does not grow well 
compared to the wild type virus, suggesting that VAI is required for efficient 
translation of viral mRNA at late times post infection. Thimmappaya et al. 
(1982) suggested that VAI could have a role in the initiation of translation of 
viral mRNAs by counteracting a cellular antiviral response at late times after 
infection.
Reichel et al. (1985) showed that translational activity could be restored to 
cell free extracts derived from dl331 infected cells by the addition of purified 
eIF-2 and eIF-2B from reticulocytes lysates. This finding led to the proposal that 
the virus may cause inhibition by interfering with initiation at the level of eIF-2 
recycling (discussed in section 1.2.3). The Pi/eIF-2a kinase (DAI) was found to 
be activated in dl331 infected but not in wild type infected cells (Schneider et 
al., 1985; Siekierka et al., 1985). This led to the proposal that VAI directly
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inhibits the expression of DAI. VAI has extensive double stranded character 
(Akusjârvi et a l., 1980) and it is conceivable that the action of VAI is such that it 
increases ds RNA concentrations in infected cells to levels that prevent DAI 
activation. In dl331 infected cells such levels of RNA would not be present, 
therefore DAI would be activated by other ds RNAs produced during viral 
infection thus preventing the continuation of protein synthesis. Subsequently to 
this hypothesis Kitajewsld et al. (1986) showed that this could not be the case as 
VAI could not activate the kinase and therefore did not act as a simple dsRNA. 
O'Malley et al. (1986) confirmed that the protein kinase responsible for 
phosphorylation of eIF-2a in dl331 infected cells was DAI. From the results of 
their experiments they proposed that in vivo VAI counteracts the activation of 
DAI by dsRNA which is generated by late viral transcription. This proposal was 
further supported by Maran and Mathews (1988) who demonstrated that the 
dsRNA responsible for DAI activation in dl331 infected cells was derived from 
transcription off both strands of the viral genome.
Katze et al. (1987) used monoclonal antibodies (Laurent et al., 1985) to 
gain a greater insight into the role o f DAI and VAI in the regulation o f protein 
synthesis in adenovirus infected cells. Levels of DAI were found to be similar in 
dl33 l and wild-type infected cells and these in turn were the same as those found 
in uninfected cells. However during infection with the dl331 the protein kinase 
became highly autophosphorylated and hence, highly inactivated. Katze et al. 
(1987) showed that VAI (absent in dl331 infected cells) prevented this 
autophosphorylation in vitro by directly complexing with the eIF-2a protein 
kinase, DAI, thereby inactivating it and allowing the translation of late viral 
proteins. This hypothesis was further supported by Galabru et al. (1989) and by 
O'Malley et al. (1989) who demonstrated that adenovirus 2 did not inhibit host 
protein synthesis in cell lines deficient in DAI kinase activity.
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In summary, adenovirus appears to control host cell protein synthesis by 
the synthesis of VAI, a small virion associated RNA, which complexes with 
DAI, an antiviral cellular response system, thereby inactivating the kinase and 
allowing the translation of late viral mRNA at the expense of cellular mRNA.
Other viruses that have evolved mechanisms of combating cellular antiviral 
defence systems by phosphorylation o f eIF-2o include Epstein Barr virus (Clarke 
et al. , 1990), mengovirus (De Stefano, 1990), HIV (Edery et al. (1989); 
Gunnery et al. , 1990) and influenza virus (Katze et al. , 1986).
1.3.4 Control of host cell protein synthesis by influenza virus
Influenza virus is an enveloped RNA virus. The genome consists of eight 
discrete segments of negative single-stranded RNA. Each segment encodes a 
single protein except for the two smallest RNA segments, each of which encode 
two individual proteins. In contrast to other RNA viruses transcription of the 
virion RNA occurs in the nucleus and utilises capped RNA primers 10 -13 
nucleotides long, which are cleaved from newly synthesised cellular transcripts to 
initiate viral RNA transcription (Herz et al., 1981).
Influenza virus effectively inhibits host cell protein synthesis during 
infection (Lazarowitz, 1971; Skehel, 1972). This event most likely involves a 
mechanism blocking the translation o f host mRNAs before and after initiation. 
Initial reports by Inglis (1982) suggested that inhibition was caused by virus- 
induced degradation of host cell mRNAs in the cytoplasm. By co-infecting cells 
with adeno and influenza virus, Katze and Krug (1984) determined that influenza 
viral mRNAs could overcome the blocks adenovirus exerted against the host cell 
mRNA. The viral mRNAs were also efficiently exported from the nucleus and 
translated. Katze and Krug (1984) concluded that influenza virus established its
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own mechanism for transport and translation of viral mRNA by utilising 
influenza virus-specific nuclear transport and translation systems.
Katze and Krug (1984) demonstrated a reduction in the appearance of 
newly processed mRNA in the cytoplasm 1-2 hours post infection. This event 
was thought to be a consequence of cleavage of the 5' cap of the newly formed 
cellular transcripts by the influenza viral cap dependent endonuclease. However 
there was no significant degradation of cytoplasmic mRNA. The cellular mRNA 
present in the cell, when inhibition of host protein synthesis was observed, was 
functional in in vitro translation systems, further indicating a system for selective 
translation of viral mRNA rather that cellular mRNA degradation as the 
mechanism responsible for host shut-off.
When cells infected with the adenovirus mutant dl331 (discussed in section 
1.2.3) were superinfected with influenza, only influenza viral proteins were 
synthesised (Katze & Krug, 1984). Katze et al. (1986) showed that this selective 
translation resulted from a partial suppression by influenza virus of the DAI 
kinase activity, which is expressed after dl331  infection. Thus the influenza 
virus gene product acts against dsRNA activation of the eIF-2cr kinase. Katze et 
al. (1986) proposed that a viral gene product suppressed the dsRNA-dependent 
eIF-2a kinase (DAI) which was induced by IFN in response to viral infection. 
Further to these studies Lee et al. (1990) purified and partially characterised a 
DAI repressor factor from influenza infected cells. This inhibitor was found to 
be a cellular not a viral protein. Lee et al. (1990) propose that the repressor of 
DAI acts in a similar way to adenovirus VAI, by directly interacting with the 
kinase, thereby irreversibly inactivating it.
1.3.5 Inhibition of host protein synthesis by HSV
Another mechanism for controlling host protein synthesis is illustrated by 
HSV. When HSV infects a variety of tissue culture cells there is a marked
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suppression of host protein synthesis (Roizman et al., 1965). Nishioka and 
Silverstein (1977) determined that the mechanism of this suppression involved 
degradation of the cellular mRNA present in the cell prior to infection. Shut-off 
of host cell protein synthesis by HSV is mediated by a viral gene product termed 
the virion host shut-off factor (vhs) (Read & Frenkel, 1983). This product plays 
a role in the degradation of mRNA possibly by activating a pre-existing cellular 
RNAase that degrades cellular and early viral mRNAs thus allowing translation 
of the late viral mRNA (Strom & Frenkel, 1987). The host shut-off function 
may be part of a mechanism that the virus has evolved to regulate the expression 
of its own genes (Kwong & Frenkel, 1987; 1988; 1989).
Vaccinia virus also controls host shut-off by mRNA degradation (Rice & 
Roberts, 1983). However the mechanism o f vaccinia virus host shut-off is 
thought to involve the interferon 2-5A system discussed in section 1.2.4 (Pacha 
& Condit, 1985; Whitaker-Dowling & Younger, 1984).
1.3.6 Summary
The preceding sections have outlined a variety of the mechanisms viruses 
have evolved to ensure their survival in the host cell. Some of these mechanisms 
are well understood, such as that of poliovirus. However, there is still a degree 
of controversy concerning the mechanisms by which other viruses such as 
influenza and VSV take control of the host cell translational machinery. 
Reovirus has also adapted ways to control host protein synthesis and the proposed 
mechanisms are discussed in section 1.5.
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FIGURE 2: STRUCTURE OF THE REO VIRUS PARTICLE
(Illustrated by P. Battaglino, from Schiff & Fields, 1989)
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1.4 REOVIRUSES
1.4.1 Structure and physicochemical properties of reovirus
Mammalian reoviruses are the type members of the orthoreovirus genus of 
the virus family reoviridae. The virus particle is approximately 75 nm in 
diameter. Unlike many other viruses they do not have a lipid envelope, but do 
possess a double capsid shell (figure 2). Each shell consists of subunits or 
capsomers arranged in icosohedral symmetry (Rhim et al. , 1961). The outer 
shell is composed of three proteins, a3, file and a l .  It is readily removed by 
digestion with proteases such as chymotrypsin and trypsin resulting in single 
shelled viral cores (Joklik, 1972). The core has the unique structural feature of 
12 prominent icosohedrally located projections or spikes which are thought to be 
pentameric aggregates of the lambda 2 protein (Ralph et al., 1980). These 
spikes are hollow, providing a means of access to and exit from the interior of 
the particle (Luftig et al. , 1972). The virus core also contains the enzymes 
necessary to transcribe the 10 viral genes into capped mRNA. These enzymes 
include:
1. ds -* ss RNA transcriptase (Shatkin & Sipe, 1968)
2. 5’ Terminal guanyltransferase (Furuichi et a l., 1975)
3. 5' Terminal methylase (Furuichi & Shatkin, 1976)
In the 1960s Gomatos and collaborators demonstrated that the viral genome 
was composed of 10 segments of double stranded RNA falling into three size 
classes, large (L), medium (M) and small (S). The individual segments can be 
readily resolved by polyacrylamide gel electrophoresis (Shatkin et al., 1968) 
which reveals that there are three L gene segments (L1-L3 molecular weight 2.3-
2.5 x 106), three M gene segments (M1-M3 molecular weight 1.5-1.6 x 106)
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and four S gene segments (S1-S4 molecular weight 0.6-0.9 x 10**). The 10 
segments are present in equimolar amounts in the virion.
mRNA is synthesised in the core and is extruded through the 12 projections 
or spikes located at the vertices of the core structure (Gillies et al., 1971) into the 
cytoplasm where it enters the translation process. The mRNA encodes the viral 
proteins which also fall into 3 size classes: in order o f decreasing size these are: 
lamda, mu and sigma.
1.4.2 Replication cycle of reovirus
The entry of reovirus into the host cell involves specific interaction of the 
al protein on the outer capsid shell with receptor molecules on the cell surface 
(Lee et al., 1981). Initially Co et al. (1985a; 1985b) proposed that the reovirus 
receptor closely resembled the 6-adrenergic receptor. However, this proposal 
was discredited by Choi et al. (1988), and Paul et al. (1989) provided evidence 
that sialic acid-bearing glycoproteins were a major receptor component on both 
mouse L-cells and human erythrocytes for reovirus binding, thus proposing that 
al recognition of such receptors triggered a series of events leading to 
internalisation of the virion. Virions are taken into the cell by receptor mediated 
endocytosis forming phagocytic vacuoles (Silverstein & Dales, 1968) which 
migrate towards the centre of the cell and fuse with lysosomes.
Studies using ISVPs, generated by chymotrypsin digestion (Borsa et al., 
1973a; Borsa et al., 1973b; Borsa et al., 1979), as described in section 1.4.1, 
have shown that they directly penetrate L-cells without appearing in lysosomes 
(Borsa et al., 1979). These particles are fully infectious once inside the cell 
(Borsa et al., 1973a) suggesting that a second pathway for reovirus entry into 
target cells may exist.
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Reoviruses have evolved a unique mechanism for uncoating of reovirus 
particles (Dales, 1973). This occurs within the lysosomes and involves 
proteolytic digestion of the outer capsid by lysosmal hydrolases (Chang & 
Zweerink, 1971; Silverstein et al., 1972) resulting in the removal of <r3 and 
cleavage of n \ to file. This process requires a low pH and is an essential step in 
the infectious cycle (Canning & Fields, 1983; Sturzenbecker et al., 1987). The 
genome is left intact within the inner capsid, termed the parental subviral particle 
(SVP) or core. These particles are released from the lysosome into the 
cytoplasm. The viral enzymes are only activated once the parental virion is 
uncoated (Silverstein et al., 1972; Chang & Zweerink, 1971). Thus when the 
parental SVPs are released into the cytoplasm they are ready to transcribe the 
genome dsRNA into viral mRNA. Several studies suggest that a conformational 
change is important in producing transcriptionally active particles. This may 
involve a conformational change that prevents genomic RNA cross-linking with 
protein (Morgan & Zweerink, 1975). This event may be induced by large 
monovalent cations that facilitate full activation of the transcriptase following 
proteolytic digestion (Nagai et al., 1984).
The transcriptase reaction is fully conservative. Both RNA strands of the 
parental dsRNA remain in the SVP and neither strand appears among the 
transcription products (Levin et al., 1970; Schonberg et al., 1971). The minus 
strand of each of the 10 parental RNA segments is transcribed into mRNA 
(Joklik, 1970; Skehel & Joklik, 1969) producing full length, complete copies of 
each gene segment. The viral enzymes guanyl transferase and methylase are 
activated at the same time as the transcriptase, adding a 5' cap structure to the 
early transcription products (Furuichi et al., 1975a; 1975b). However these 
transcripts do not contain a modified 3' end, that is, they have no poly A tail.
'Early' transcription occurs within the cores and produces capped mRNA 
(Chang & Zweerink, 1971; Silverstein et al., 1972). These serve as mRNA
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Table 2: Transcription and translation frequency of Reovirus genes
Gene Protein
LI 3
L2 2
L3 1
Ml m2
M2 Ml
M3 mNS
SI ol
S2 o2
S3 oNS
S4 o3
Adapted from
Relative
translation
frequency
0.6
3
2
0.6
20
10
1
4 
6 
14
Relative
transcription
frequency
1
1
1
3
6
10
10
10
20
20
Joklik (1981).
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templates for protein synthesis and as templates for minus strand synthesis 
(Furuichi et a l., 1975a). Transcription of early reovirus mRNAs appears to be 
regulated in vivo. The plus strand of the LI, M3, S3 and S4 genes appear before 
other early capped mRNAs (Nonoyama et al., 1974) and have been referred to as 
pre-earl y mRNA (Zarbl & Mill ward, 1983). The remaining six dsRNA 
segments appear to require synthesis of viral proteins but not viral replication to 
be transcribed (Drayna & Fields, 1982; Spandidos & Graham, 1976). By 6 
hours post infection all 10 dsRNA segments are transcribed (Nonoyama et al., 
1974). However, the number of copies varies (table 2, adapted from Joklik, 
1981). These findings suggested that the viral transcriptase can only transcribe 
LI, M3, S3 and S4 until a viral protein product is synthesised in sufficient 
amounts to allow full transcription to occur. A second model for this regulation 
proposes that a host cell repressor protein interacts with the uncoated virus 
particle and in so doing prevents transcription of the six 'late' genes. A protein 
encoded by one or more of the 'early' genes may depress this factor thus 
allowing transcription of the late genes (Nonoyama et al., 1974; Zarbl & 
Millward, 1983). Further evidence for this process was reported by Spandidos 
and Graham (1976), who showed that the 'early ' genes were the only ones 
transcribed by avian reoviruses in non-permissive L-cells indicating that the avain 
reovirus polypeptides were incapable of inactivating the L-cell repressor.
The processes described to date occur within the parental SVPs. Zweerink 
and collaborators (1972; 1974) proposed that dsRNA replicated within nascent 
progeny SVPs, which form when the 10 segments of plus sense ssRNA in the 
cytoplasm associate with viral proteins to form a virion-like particle. In these 
particles minus strand RNA is synthesised using capped plus strand RNA as a 
template (Acs et al., 1971; Sakuma & Watanabe, 1972). Once the 
complementary minus strand is synthesised it remains associated with the plus 
strand (Sakuma & Watanabe, 1972). In this way 10 unique dsRNA segments
28
FIGURE 3: DIAGRAM OF THE REOVIRUS REPLICATION CYCLE
(Illustrated by P.Battaglino, from Schiff Sc Fields, 1989)
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assemble in each nascent particle. However, the mechanism by which this 
occurs remains unknown. The progeny dsRNA are formed within the nascent 
SVP and remain there (Acs et al., 1971). Free minus strand ssRNA and free 
dsRNA are never found in infected cells. Once dsRNA synthesis is complete the 
progeny SVPs undergo structural rearrangements that lead to the formation of 
particles resembling cores, and they become RNAase resistant and mRNAs 
encoding viral proteins Gate mRNAs) are synthesised. These particles have 
latent mRNA capping enzymes, thus producing mRNA with uncapped 5' ends 
(Skup et al., 1981) which synthesise further viral proteins. Mature virions are 
formed by the assembly of the structural polypeptides, <rl, o3 and file  to form 
the outer capsid shell. The mature virions also contain adenine-rich short 
oligonucleotides which constitute 15-20 % of the total RNA (Bellamy & Joklik, 
1967). These are abortive transcripts formed after the inactivation of the 
transcriptase during the last stages of maturation (Zaibl et al. 1980a; 1980b). 
Finally, the mature virions are released by cell lysis via steps that to date remain 
undefined. The replication cycle is outlined in figure 3.
After viral infection commences there is a gradual decrease in host-cell 
protein synthesis and an increase in viral protein synthesis (Ensminger & Tamm, 
1969; Gomatos & Tamm, 1963). The proposed mechanisms by which the virus 
controls host protein synthesis will be discussed in section 1.5.
1.4.3. Biochemical and biological characteristics of reovirus
Three serotypes of mammalian reoviruses have been defined using 
haemagglutination inhibition and antibody neutralisation tests (Fields, 1982). 
These serotypes are commonly termed Types 1, 2 and 3 with the prototype 
strains being Lang, Jones and Dealing respectively.
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Serological studies have indicated that reoviruses are ubiquitous in their 
distribution among mammals. In man infection generally occurs in childhood 
and by the age of sixteen 50-80% of the population have antibodies to the virus 
(Sharpe & Fields, 1985). The importance of infection in man is difficult to 
ascertain due to its ubiquity and the common absence of symptoms associated 
with infection. In contrast to man, mice are highly susceptible to reovirus 
induced disease and have been widely used as models to  study various aspects of 
viral pathogenesis.
1.4.3.1 Gene-protein assignment
Mixed infections of reovirus in tissue culture cells result in reassortment of 
gene segments at high frequency to yield recombinant viruses of different 
genotypes which can be used in viral gene-function studies.
A range of t.s. mutants of the type 3 virus were initially generated by 
chemical mutagenesis (Fields Sc Joldik, 1969). Such mutants bearing a lesion in 
one of the genome segments were widely used in early studies of reovirus 
genetics. Genetic analysis of mixed infection between pairs of t.s. mutants 
revealed that certain mutant pairs yielded a high proportion of t.s. + 
recombinants, that is, they showed wild type activity, while others produced no 
detectable t.s. + mutants. This suggested that recombination was 'all or none', 
that is, recombination of the reovirus genome occurred through a mechanism of 
genome segment reassortment rather than true intermolecular recombination 
(Fields, 1971). However, proof that recombination occurred by reassortment 
required markers for the genome segments or gene products, so that the parental 
genes in the reassorted progeny virus could be identified.
These markers were identified when it was demonstrated that there was a
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difference in electrophoretic migration among the genome segments of the three 
serotypes (Ramig et al., 1977). For example the SI gene of type 3 migrates less 
rapidly on PAGE than the SI gene of type 1.
The parental origin of each genome segment in a recombinant could, in 
most cases, be easily determined by electrophoretic analysis of potential 
recombinants and this was used to demonstrate that the mechanism of 
recombination in reoviruses was in fact reassortment (Sharpe e t al., 1978).
Ramig et al. (1978) also used this type of recombinant analysis to map 
many of the t.s. lesions originally isolated by Fields and Joklik in the earlier 
genetic studies. Crosses were made between the t.s. mutants o f  serotype 3 and 
wildtype type 1. Screening of recombinants from such crosses identified the 
genome segment bearing the t.s. lesion since it was always replaced by the 
corresponding wild type gene segment. Similar experiments using wild type 
viruses showed that reassortment occurred at such a high frequency that it was 
not difficult to isolate monoreassortants (i.e. a progeny virus containing 9 
segments from 1 serotype and 1 from the other). Such monoreassortants were 
used to assign specific polypeptides to the reassorted gene segment; this would be 
the only polypeptide having the same mobility as the parent contributing the 
single gene segment. This analysis was used to assign the polypeptides of the n 
and a classes to specific gene segments (Mustoe et al., 1978). However there is 
little heterogeneity among the lamda polypeptides of the various serotypes so this 
method was unable to elucidate the protein assignment of these genes. Using a 
biochemical approach of in vitro translation of the denatured individual genome 
segments McCrae and Joklik (1978) made similar assignments for all 10 gene 
segments (figure 4). It has since been shown that the SI gene is polycistronic, 
encoding proteins a\ and pl4 (Ernst & Shatkin, 1985; Jacobs & Samuel, 1985).
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1.4.3.2 Reoviruses as models for study ins pathogenesis
Mammalian reoviruses have been developed as a model for dissecting the 
molecular mechanisms of pathogenesis. Several unique properties of the virus 
have made this possible. These may be briefly summarized as follows:
a. Each serotype has unique pathogenic properties:
Although structurally quite similar, the three virus serotypes interact with 
their hosts to give very distinct patterns of disease (reviewed by Fields, 1982).
For example:
Intracerebral inoculation of less than 10 pfu of serotype 3 into neo-natal 
mice causes infection of the neurones (Margolis et al., 1971) and results in a 100 
% lethal encephalitis. If the mice are infected by the same route with serotype 1 
an acute ependymitis occurs as the virus infects the ependymal cells (Kilham & 
Margolis, 1969). However when serotype 3 is given orally even at doses of 10 7 
pfu of purified virus it is avirulent due to the apparent inability of the virus to 
escape from the intestinal tract. In contrast, reovirus serotype 1 multiplies in the 
intestine, later spreading to the brain where it produces a benign ependymitis, 
similar to that which develops after intracerebral injection (Rubin & Fields, 
1980).
b. High frequency gene reassortment facilitates th e  Isolation of virus 
recombinants with predetermined gene constellations:
Study of the biological properties of monoreassortants has proven to be a 
very useful technique for mapping the reovirus genome. Reoviruses have been 
widely used as a tool for studying the molecular mechanisms of pathogenesis by
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assigning specific functions to specific genes. For example, in the pathogenic 
studies described above the difference in tissue tropism of the tw o serotypes was 
found to be a function of the SI gene which encodes the ol protein. Type 3 al 
was shown to specifically interact with neuronal receptors and type 1 al with 
ependymal receptors (Weiner & Fields, 1977; Lee et al., 1981). The ability of 
the virus to survive in the intestine was found to be a function o f the M2 gene 
(Rubin & Fields, 1980; Hrdy et al. 1981; Drayna & Fields, 1982). This 
difference is due to the susceptibility of the proteins to chymotrypsin: type 1 p i 
is not cleaved by the enteric enzymes but type 3 /*1 is. Similarly type 1 and 3 al 
proteins are differentially susceptible to trypsin and chymotrypsin (Yeung et al., 
1989), which may be related to the receptor activity of the virus in the intestinal 
tract.
The three serotypes of the virus also exhibit differences in their ability to 
control host cell macromolecular synthesis. Using monoreassortants, as 
discussed above, the genes responsible for the control of host cell DNA and 
protein synthesis have been identified (Sharpe & Fields, 1981, Sharpe & Fields, 
1982). These will be discussed in the following section.
1.5 Control of host cell macromolecular synthesis by mammalian 
reo virus
Infection of monolayer cultures of mouse L-cells with reovirus type 3 
results in a depression in host cell DNA and protein synthesis (Gomatos & 
Tamm, 1963). In contrast to these findings, infection of the same cell lines with 
type 1 reovirus has little or no effect on host DNA or protein synthesis (Sharpe 
& Fields, 1981; Munemitsu & Samuel, 1984).
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The inhibition of host DNA synthesis begins 8-10 hours post infection with 
reovirus type 3, prior to the onset of cytopathic effects (Cox & Shaw, 1974). 
This inhibition occurs without any detectable degradation of cellular DNA or 
alteration in the activity of either DNA polymerase or any of the other enzymes 
involved in DNA replication (Ensminger & Tamm, 1969a; 1969b). However, it 
does result in a blockade of multifocal initiation of new chain DNA synthesis by 
replication units, resulting in the accumulation of cells in the G 1 phase (Hand et 
al., 1971; 1974). The difference between types 1 and 3 in this property allowed 
Sharpe and Fields (1981) to use réassortants in mapping it to the SI gene which 
encodes the <rl and alS proteins (Ernst & Shatkin, 1985). Thus inhibition of 
DNA synthesis is dependent on the presence of the proteins derived from the SI 
gene of the type 3 virus. The mechanism for this effect may include a direct 
receptor-mediated effect on a) DNA synthesis after virus binding or b) intra­
cellular effects on a 1 or <rlS proteins, or c) SI transcripts on synthetic 
machinery. Indeed, Gaulton and Greene (1989) concluded that the inhibition 
occurs through a direct receptor-triggered event that involves microaggregation 
but not intracellular processing of receptor molecules. The virus binds to a 
membrane protein and induces the inhibition of cellular DNA synthesis by either 
normal or aberrant signalling through this molecule. Further to these studies 
Fajardo and Shatkin (1990) studied the effect of the two type 3 SI protein 
products in transfected mammalian cells on host DNA synthesis. They found 
expression of the proteins together or individually did not cause inhibition to the 
same extent as the whole virus. This suggested that other viral factors were 
required to interact with <rl or alS to elicit the full inhibitory effect observed in 
type 3 infected cells.
1.5.1 Inhibition of host cell DNA synthesis
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1.5.2 Inhibition of host cell protein synthesis by mammalian reovirus
Initial studies on the effects of reovirus type 3 on host cell protein synthesis 
produced conflicting results. When monolayer cultures of L-cells were infected 
with the virus for up to 16 hours no inhibition of cellular protein synthesis was 
observed (Gomatas & Tamm, 1963). In contrast, inhibition was observed in 
suspension cultures at 10 hours post infection and beyond (Kudo & Graham, 
1965). The difference in these observations was assigned to cell damage 
occurring in the suspension cultures (Ensminger & Tamm, 1969a), because at 
times when the inhibition was noticed the cells were no longer able to exclude 
trypan blue. However, in both of these studies total protein synthesis rather that 
host-specific protein synthesis was measured. Investigation o f host-specific 
protein synthesis showed that inhibition occurred 3-6 hours earlier than inhibition 
of total protein synthesis in suspension cultures of L-cells, (Zweerink & Joklik, 
1970), the time of onset of inhibition correlating with the start o f viral mRNA 
synthesis. This led to an initial hypothesis for the mechanism of host shut-off 
which suggested that the host and viral mRNAs were involved in direct 
competition for some component of the protein synthesising machinery.
In recent years several alternative mechanisms for host shut-off by 
mammalian reovirus have been proposed.
1.5.2.1 mRNA competition
Throughout the infectious cycle the level of synthesis of individual viral 
polypeptides varies widely. Joklik (1974) proposed that this regulation partly 
occurred at the level of translation. In vitro translation studies revealed that the 
in vitro translation efficiency of a particular mRNA correlated closely with the
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amount of the corresponding protein produced in vivo (Levin & Samuel, 1980). 
S4 and M2 mRNAs were found to be translated at the highest frequency and their 
proteins o3 and /ilc were present in the largest amounts in the infected cell. By 
contrast other mRNAs, such as SI and Ml mRNAs were poorly translated and 
their proteins <rl and fi2 were expressed in low amounts in the infected cell. The 
relative translational efficiencies of the viral mRNAs differ by as much as 100 
fold (Gaillard & Joklik, 1985). The efficiency of expression of cDNAs of the 
reovirus SI and S4 genes in animal cells was found to differ at the level of 
translation (Atwater et al. (1987). This discrepancy was resolved by Roner et al. 
(1989). Placing the 5' upstream sequence of the S4 gene in the same position in 
SI resulted in a significant increase in the efficiency of SI mRNA translation. 
Kozak (1981) determined that the nature of the sequence around the initiation 
sequence is important in determining the rate of translation. This suggested that 
the 5‘ upstream sequence of the S4 gene contains sequences enabling it to 
compete more efficiently for the translation apparatus.
Thach and colleagues suggested that such competition may play a role in 
regulating the translation of host and reovirus mRNA in infected cells (Walden et 
al., 1981; Brendler et al., 1981a; 1981b). Walden et al. (1981) concluded that 
major viral mRNAs such as S4, encoding o3, are poor initiators o f translation 
relative to host mRNAs and this was possibly due to low affinity for an initiation 
component which discriminated between viral and host mRNA. Viral mRNA 
concentrations were found to be unusually high at maximal times of viral protein 
synthesis, suggesting that translation of viral mRNA was forced by mass action. 
On the basis of these results Thach and collaborators proposed a model whereby 
mRNA competes for a limiting message-discriminatory initiation factor in order 
to be translated. They also suggested that competition between mRNAs might be 
important in regulating the rate in initiation. This discriminatory factor was 
thought to be associated with the 40S ribosomal subunit (Ray et al., 1983).
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1.5.2.2 CAP independent translation
To investigate the mechanism by which the virus takes over host cell 
protein synthesis Skup and Millward (1980a; 1980b) studied changes in the 
methylation pattern of the viral mRNA during the process of viral infection. 
Using efficient cell-free protein synthesising systems derived from L-cells (Skup 
& Millward, 1977), comparisons were made between the ability o f extracts 
prepared from uninfected and type 3 infected mouse L-cells to translate 
exogenously added reovirus mRNA in vitro (Skup & Millward, 1980a). 
Translation of uncapped viral mRNA was found to be highly efficient in extracts 
from infected cells. In contrast, capped reovirus mRNA or globin mRNA were 
efficiently translated in extracts from uninfected cells but not in infected cell 
extracts. From such observations Skup and Millward (1980a) proposed that the 
host cell translational machinery became modified as a result of viral infection 
such that it preferentially translated uncapped mRNA at late times in infection, 
possibly by a mechanism similar to that seen in poliovirus infected cells 
(Schneider St Shenk, 1987).
Further support for this hypothesis was obtained when Skup and Millward 
(1980b) studied the enzymatic activities associated with progeny SVPs isolated 
from L-cells at late times post infection when viral protein synthesis is at its 
maximum. They showed that the mRNA capping enzymes (guanyl transferase 
and RNA methylase) were not expressed in the progeny SVPs, that is, the 
capping enzymes were masked or latent. Thus the progeny SVPs synthesise 
uncapped mRNA. Analysis of the mRNA synthesised indicated that the 5' end 
was monophosphorylated having the structure pGpC. Skup et al. (1981) were 
also able to demonstrate that uncapped reovirus mRNA associated with 
polyribosomes at late times post infection. Therefore at late times in infection 
uncapped reovirus mRNA is apparently preferentially translated in comparison to
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host capped mRNA, resulting in viral takeover and depression o f host protein 
synthesis. In support of this hypothesis translation of reovirus uncapped mRNA 
synthesised in vitro in cell free extracts from infected L-cells was found to be 
insensitive to inhibition by a monoclonal antibody directed against the cap 
binding protein (CBP) (Sonenberg et al., 1981).
However, other studies using the mouse cell line SCI reported that during 
infection translation of reovirus type 3 mRNA remains cap dependent (Detjen et 
al., 1982). Extracts made from uninfected and reovirus infected cell extracts 
were able to translate capped and uncapped globin mRNA with the same 
efficiency. These workers also obtained similar results in mouse L-cells with the 
exception that the shut-off of host translation was far greater in L-cells than in 
SC-1 cells. These results supported the work of Walden et al. (1981) suggesting 
that the regulation of protein synthesis in infected cells did not occur by a switch 
of cap dependent to cap independent translation.
To investigate the inconsistency of these results direct competition 
experiments between L-cell mRNA and late reovirus mRNA were carried out 
(Liemeux, 1984). The results indicated that late reovirus mRNAs did not 
compete with L-cell mRNA for a limiting component on the host translational 
apparatus in infected cell lysates, rather the virus induced an alteration in the cap 
dependent translational apparatus of L-cells. However the absence of the 5' cap 
structure could not be the only factor responsible for this switch because 
poliovirus mRNA was unable to be translated as efficiently in S-10 extracts 
prepared from reovirus infected cell extracts made at late times post infection as 
it was in uninfected cell extracts of L-cells.
The experiments by Liemeux et al. (1984) support the hypothesis that in 
extracts from infected cells certain initiation factors stimulating the translation of 
viral mRNA are more active, or are present in greater amounts, than are 
initiation factors required for the translation of host cell mRNA. Indeed,
40
FIGURE 5: GENE REASSORTMENT
Reassortants containing the S4 gene segment of type 2 and the other 9 gene 
segments of type 3 (Rec2) caused inhibition of host protein synthesis to the same 
extent as wild type type 2 (Sharpe and Fields, 1982).
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Liemeux et al. (1984) showed that this stimulatory factor could be a viral 
product: a factor in infected L-cells specifically stimulated the translation of 
uncapped reovirus mRNA.
These results suggest that at late times in infection host cell protein 
synthesis is depressed as a result of the virus producing a factor to favour 
translation of its own mRNA.
1.5.3 Identification of the protein responsible for inhibition of protein 
synthesis
The mechanisms of reovirus control o f  host protein synthesis discussed 
above have involved study of type 3 reovirus. Other workers have investigated 
the ability of type 1 and type 2 to inhibit host protein synthesis.
Type 2 reovirus has also been reported to inhibit both DNA and protein 
synthesis in RA (human amnion) cells but had little effect on RNA synthesis 
(Loh & Soergel, 1965). Sharpe and Fields (1982) reported that reovirus type 2 
inhibits protein synthesis in L-cell monolayers more rapidly and efficiently than 
type 3 virus. Using monoreassortants it was found that recombinant viruses 
required only the S4 gene to come from type 2 virus to be able to inhibit protein 
synthesis to the same extent as type 2 wild type. From these results they 
concluded that the S4 gene or at least its protein product, <t3, is responsible for 
the shut-off of host cell protein synthesis (figure 5).
Further studies on the effects of the different serotypes were carried out by 
Munemitsu and Samuel (1984) who found that serotypes 1 and 3 differed 
significantly in their rates of multiplication and their effects on cellular protein 
synthesis. They found that at late times o f infection there was a decrease in the 
overall rate of protein synthesis as noticed by others but not in the case of type 1 
infected cells. Therefore there is a hierarchy of the ability of the virus to do this: 
type 2 >  type 3 > type 1.
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This property of reovirus has allowed it to be used as a model to study the 
molecular aspects of this important intracelluar pathogenic event in more detail.
1.5.3.1 Other properties of a3
Several other properties have been assigned to <r3:
A. It has a role in establishing persistence.
B. It has a role in binding ds RNA.
C. It is a zinc binding protein.
A. Role In establishing persistence
Persistent infections of reovirus can be established by infecting L-cells with 
reovirus stocks that have been serially passaged at a high multiplicity of infection 
(Ahmed & Graham, 1977). Such viral stocks contain many types of mutants 
(deletion mutants, growth attenuated mutants and temperature sensitive mutants) 
(Ahmed & Fields, 1981). These stocks are referred to as defective interfering 
viral stocks (DI).
To investigate the mechanism of establishing persistence Ahmed and Fields 
(1982) co-infected cells with wild type 2 virus and DI stocks of type 3 which had 
established persistent infections. Analysis of the resulting persistently infected 
cell lines and the reassortant viruses showed they contained the S4 gene from the 
DI virus. As the S4 gene is responsible for inhibition of host cell protein 
synthesis a symbiotic cell-virus relationship leading to a persistent infection can 
only be established if the S4 gene of the type 2 virus is excluded from the lytic 
virus by selecting the S4 segment from the defective virus.
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FIGURE 6: PROTEIN SEQUENCE OF TYPE 3 ff3 SHOWING AMINO ACID 
CHANGES IN TYPE 1 o3
........................R ..................................................................................................................
*
MEVCLPHGHQWDLINNAFEGRVSIYSAQEGWDKTISAQPDMMVCGGAW
CMHCLGWGSLQRKLKHLPHHRCNQQIRHQDYVDVQFAADRVTAHWKRGML
..................A ...................E ....................................... W.........................................................
* *  *
S FVAQMH EMMNDVS PDDLVRT EGGS LVELNRLQVDNSNFRSIH S SWTDPLQ
.......................................................... V.................................. R ....................
* *
WDDLTVKLDQYWTALNLMIDSSDLIPNFMMRDPSHAFNGVKLEGDARQTQ
FSRTFDFRSSLEWGVMVYDYSELEHDPSKGRAYRKELVTPARDFGHFGLSH
..........................................................................................................................D S ...................
**
Y SRATTPILGKMP AVF SGMLTG N CKM Y P F IKGT AKLKTVRK L  V EA VNHAWG
..............................................D ......................................................S . T .............. D .............* * * *
VEKIRY ALGPGGKTGWYKRTNQQAPIVLTPAALTMFPDTIKFGDLN YPVMIG
DPMILG
... = positions of amino acid identity 
• = amino acid differences
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B. Binding of double stranded RNA
Huisman and Joklik (1976) showed that o3 binds strongly to ds RNA. This 
property of the protein could be involved in the control of host protein synthesis 
by binding to double stranded regions of rRNA, tRNA or mRNA (Sharpe & 
Field, 1982).
C. Zinc binding
o3 has also been shown to be a zinc metalloprotein. (Schiff & Fields, 
1988). This may influence the ability of o3 to bind dsRNA and may be 
important for its proposed effects on regulating viral and host cell transcription 
and translation.
1.5.3.2 Sequence of the S4 gene
The S4 genes of type 3 (Giantini et al., 1984) and type 1 (Atwater et al., 
1986) have been fully sequenced. The overall sequence homology between 
serotype 1 and 3 S4 gene is 94 % at the nucleotide level. The 2 genes are the 
same length (1,196 nucleotides) and the positions of the initiation AUG codon 
(nucleotides 33-35) and termination UAA codon (nucleotides 1128-1130) are 
conserved. There is a slightly greater homology in the S' and 3' untranslated 
sequences showing 97 % homology at the nucleotide level. The predicted <j3 
coding sequences, of 365 amino acids, display 96 % homology at the amino acid 
level. These differences are not clustered but are scattered throughout the gene 
(figure 6).
Despite the similarity of the S4 type 1 and S4 type 3 genes their ability to 
inhibit host cells protein synthesis varies:
Type 1 does not inhibit protein synthesis at late times in infection
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Type 3 does inhibit protein synthesis at late times in infection.
1.6 Aims of the project
The preceding sections have discussed the hypothesis to account for the 
general mechanism by which reovirus exerts control on host cell protein 
synthesis. However, precise details of the molecular mechanism involved in the 
inhibition and the exact role of the S4 gene remain undefined.
The aims of this project were first to obtain full length cDNA clones of the 
S4 gene of serotypes 1 and 3. Then to use these cDNAs in developing an in 
vitro assay system to try and localise the region of the S4 gene responsible for 
the inhibition of translation of a eukaryotic protein. Thirdly, to develop an in 
vivo assay system again using the S4 cDNAs to gain a greater insight into the 
role of the S4 gene in causing the inhibition of host cell protein synthesis.
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2.1 MATERIALS
The materials used in this study are listed in Table 3.
Table 3: Reagents used in this study.
REAGENT SUPPLIER
1.Tissue culture
All Tissue culture media GIBCO/BRL
Amino acids SIGMA
Antibiotics SIGMA
Crystal violet BDH
Foetal calf serum GIBCO/BRL
NaHC03 BDH
New-Born calf serum GIBCO/BRL
8-Propiolactone SIGMA
2. Gel Systems
Acrylamide 
Agarose Type 2 
Ammonium persulphate 
Bromophenol blue 
Ethidium Bromide 
Fuji film
FISONS
SIGMA
BIORAD
SIGMA
SIGMA
FUJI
PHOTO LTD.
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Gel tanks NEW
Glycine
LX24 X ray developer
BRUNSWICK
FISONS
EASTMAN
FX40 X ray fixer
KODAK
COMPANY
N’N-methylene bis acrylamide BIORAD
PPO BDH
Sodium dodecyl sulphate BIORAD
Temed BIORAD
Tris Base BDH
Xylene cyanol FF BDH
3. DNA Techniques
lkb DNA ladder BRL
Agar
AMV Reverse transcriptase
DIFCO LABS 
LIFE SCIENCES
Bacto-Tryptone
INC
DIFCO LABS
Chloramphenicol SIGMA
Calf Intestinal Phosphatase BCL
Dithiothreitol SIGMA
Klenow 1 DNA polymerase PHARMACIA
EDTA BDH
Electroporation cuvettes BIORAD
Ethanol HAYMAN LTD
Glycerol BDH
IPTG SIGMA
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FISONSKCl
LiCl BDH
Lysozyme SIGMA
MgCl2 FISONS
Mouse liver t-RNA Roger Jenkins
NaCl FISONS
Nucleotide triphosphates SIGMA
HYBOND Nylon filters AMERSHAM
Phenol FISONS
Restriction enzyme buffers BRL
Restriction enzymes BRL
RNA Ligase BRL
RNAase A BRL
Salmon Sperm DNA SIGMA
Sodium Acetate BDH
Sucrose BDH
T4 DNA ligase BCL
Triton BDH
X-gal NBL ENZYMES 
LTD
Yeast extract OXOID
Yeast t-RNA SIGMA
4. Radioactive chemicals
32P-dGTP AMERSHAM
32P-rCTP "
3^S-Methionine "
3H-Uridine -
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3H-Uridine 5'Triphosphate
5. In vitro Transcription
lOx T7 transcription buffer STRATAGENE
Ammonium Acetate BDH
m7G(5')ppp(5’)Gm (CAP) PHARMACIA
RNA guard ™ PHARMACIA
RNAase free DNAase BRL
T7 RNA polymerase STRATAGENE
6. Protein techniques
BIORAD Protein assay kit BIORAD
CAS amino acids DIFCO
Creatine Phosphate SIGMA
Creatine Phosphokinase SIGMA
EGTA FISONS
FITC-GAR SIGMA
Haemin BDH
Hepes SIGMA
Mnase PHARMACIA
NET-290 Acetyl co-enzyme A NEN
RESEARCH
PRODUCTS
NP40 SIGMA
ONPG SIGMA
Optiphase scintillation fluid LKB
Protein A Sepharose SIGMA
Sodium deoxycholate BDH
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BDH
FSA
RHONE
POULENC
2.1.2 Cells and virus
8-mercaptoelhanol 
Trichloroacetic acid 
Toluene
Mouse L-cells were obtained from M.A.McCrae.
COS-1 and HeLa cells were obtained from K.Leppard.
Reovirus serotypes 1,2 and 3 were obtained from M.A.McCrae.
2.1.3. Bacterial strains
The bacterial strains MC1061 and JM103 used in this study were obtained 
from lab stocks from M.A.McCrae.
2.1.4: Media, Buffers and Solutions used in this study
The media , buffers and solutions used in this study are listed below.
1. Tissue culture:
M et-free G-MEM
2 x GMEM without Leu, Val, Met , NaHCOg 500 ml
Leucine (200 mM) 10 ml
Valine (200 mM) 10 ml
Glutamine (200 mM) 10 ml
NaHC03 (5 % w/v) 20 ml
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Antibiotics (100/ig/ml) 1 ml
Distilled water to 1 litre
Phosphate-Buffered saline (PBS)
Potassium Chloride 0.2 g
Sodium Chloride 8.18 g
Potassium dihydrogen orthophosphate 0.2 g
di-sodium hydrogen orthophosphate 1.15 g
Distilled water 1 litre
Crystal violet
7.5 % crystal violet in ethanol
Formal saline
PBS 350 ml
formaldehyde 150 ml
Overlay agar
2 x GMEM 50 ml
FCS 2 ml
Noble agar (1.8 %) 50 ml
Resuspension Buffer
Tris-HCl pH 8 50 mM
NaCl 10 mM
8- mercaptoethanol 1.5 mM
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2. Gel systems
10 x T.B.E. Buffer pH 8
Tris base 108 g/litre
EDTA 9.5 g/litre
Borie acid 55 g/litre
5 x Loading buffer
Glycerol 50 %
Bromophenol blue 0.01 %
Xylene cyanol FF 0.01 %
T.B.E 1 X
10 x alkali gel buffer 
NaOH 0.3 M
EDTA 20 mM
10 x alkali loading buffer 
NaOH 0.3 M
EDTA 20 mM
Glycerol 50 %
Bromocresol green 0.01 %
10 x MOPS buffer pH 7
MOPS 0.2 M
NaAc 50 mM
EDTA 10 mM
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Tris base 
SDS
Distilled water to
4 x stacking buffer pH 6.8
Tris Base 
SDS
Distilled water to
10 % SDS Polyacrylamide gel
Acrylamide-bis (30:0.8)
4 x separating buffer
4 x stacking buffer 
Glycerol 
100mg/ml APS 
TEMED
Distilled water to
5 x Cracking buffer
SDS
8- mercaptoethanol 
glycerol
Gel stacking buffer 
Bromophenol blue
4 x separating buffer pH 8.8
36.3 g
0.8 g
200 ml
12.1 g 
0.8 g
200 ml
10 % 5 %
Gel Stacker
8.3 ml 2 ml
6.25 ml -
- 3 ml
2.5 -
0.2 ml 3 ml
12.5 nl 15
8 ml 4 ml
10 %
2.5 *  
50 %
1 x
0.01 %
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3. DNA Techniques
10 x CIP buffer
Tris-HCl pH 9 0.5 M
MgCl2 10 mM
ZnCl2 1 mM
Spermidine 10 mM
L-Broth
Bactotryptone 10 g
NaCl 5g
Yeast Extract 5g
Distilled water to 1 litre
L-Agar
Bactotryptone 10 g
NaCl 5 g
Yeast Extract 5 g
Agar 15 g
Distilled water to 1 litre
Ligation buffer
2M Tris-HCl pH 7.5 6.7 m1
1M MgCl2 M
1M DTT 0.5/xl
100 mM A TP 2 Mi
H2O 9.3 m1
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10 x Klenow Polymerase I buffer
Tris-HCl pH 7.5 0.5 M
MgS04 0.1 M
DTT 1 mM
BSA 100 /ig/ml
T.N.E. Buffer 
NaCl 0.2 M
Tris-HCl pH 7.5 50 mM
EDTA 1 mM
20X SSC
NaCl 3 M
Sodium citrate 0.3 M
100 x Denhardts solution
BSA 2 g
Ficoll 2 g
PVPP 2 g
Distilled water to 1 litre
Prehybridisation mix
50 x Denhardts 4 ml
20 x SSC 6 ml
SDS
tRNA
Spermidine
10 %
Distilled water to 20 ml
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5. In vitro Transcription
10 x T7 RNA polymerase buffer
Tris-HCl pH 7.5 400 mM
MgCl2 60 mM
Spermidine 20 mM
NaCl 100 mM
6. Protein Techniques
10 x Hepes buffered saline (HBS buffer)
NaCl 4.09 g
Hepes 2.97 g
Na2HP04 0.1 g
Distilled water to 50 ml
CAT lysis bufTer
Tris HCl pH 7.9 0.25 M
DTT 5 mM
Glycerol 10 %
NP40 0.2 *
2 x Immunoprécipitation buffer 3 (1P3)
Tris-HCl pH 8 400 mM
NaCl 200 mM
EDTA 2 mM
NP40 2 %
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Deoxycholate
SDS
2 %
0.2  %
Immunoprécipitation butter 2: IP2
IP3 +  20 mg/ml BSA
immunoprécipitation butter 1: IPI
Tri*-HCI pH 8 
NaCl 
EDTA 
NP40
20 mM 
100 mM 
1 mM 
1 %
5 9
2.2 METHODS
2.2. CELL CULTURE AND VIRUS PROPAGATION.
2.2.1. CeU culture:
Mouse L-cells were maintained in suspension culture in a sterile flat 
bottomed flask at 37°C in Jokliks modified minimal essential medium (MEMS) 
supplemented with 5 % foetal calf serum, glutamine and 100 ng/m\ 
penicillin/streptomycin. The cell density was maintained at 5x10s - lxlO6 
cells/ml by splitting the culture 1:2 every 24 hours (McCrae 1985).
HeLa and COS-1 cells were maintained in 90 mm plastic tissue culture 
dishes in Dulbecco's modified Eagles medium (DMEM) supplemented with 10 
% new-born calf serum and 10 % foetal calf serum respectively. Cells were split 
1 : 10 every 4 days.
2.2.2. Preparation of virus inocula:
Confluent monolayers of L-cells were infected at a m.o.i of no greater than 
0.1. Virus growth was allowed to proceed for 2-4 days until complete c.p.e. 
was observed. The contents of each flask were harvested and stored at -70°C 
until used.
2.2.3. Viral infectivity assay
Serial ten fold dilutions of the virus were prepared in PBS and were 
inoculated onto 12 or 24 well tissue culture dishes. Following one hour of
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adsorption at 37°C the cells were overlaid with 1 x agar +  1 x Glasgow's 
modified minimal Eagles medium (GMEM) supplemented with 2 % FCS and 
incubated at 37°C for 4-5 days. The cells were fixed for 4 hours with formal 
saline, the overlay was removed and monolayers stained with crystal violet for 2- 
3 minutes. Excess stain was washed off and clear plaques counted.
2.2.4. Labelling of viral proteins
Confluent L-cell monolayers in 12 well dishes were infected at a m.o.i of 
10. Infection was allowed to proceed for 12-15 hours before removing the 
medium, washing the cells in 1 x methionine-free (met-free) GMEMS and 
overlaying with met-free GMEMS and 2 % dialysed FCS for 1-2 hours. After 
this the medium was removed and replaced with 100 ¿d of ^S-m et (500 /xCi/ml 
in PBS), and incubated for 20 minutes at 37°C. Cells were harvested in 300 /*! 
of 10 mM Tris-HCl pH 8.5 by scraping the monolayers with rubber policemen.
2.2.5. Large scale growth of virus
Virus was routinely grown up in 4 litre batches of suspension L-cells. 
Prior to culture infection the cells were transferred from the 37°C water bath to 
34°C as reovirus is cytotoxic to cells at 37°C. Cells were infected at an m.o.i. 
of 0.1 and virus growth allowed to proceed for 36 - 42 hours before transferring 
the culture to 4°C to allow the cells to settle out for at least 24 hours.
2.2.6. Virus purification
The settled viral and cellular debris were concentrated by centrifugation at 
2000 rpm, 4°C, for 20 minutes in a bench centrifuge, resuspended in
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sis
F IG U R E  7: CsC I G R A D IE N T P U R IF IC A TIO N  OF R EO VIR U S
Reovirus was purified by isolation on CsCI gradients
1.2-1.4) as described in the text The virus was harvested 
side puncture and washed in 10mM Tris pH 8 to reomve 
traces of CsCI.
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resuspension buffer and homogenised with 1/4 volume o f Arcton 113 
(trifluoroethane) 4-5 times using a Virtis 123 homogeniser. The aqueous phases 
were pooled together and finally the aqueous phase was back extracted with 
Arcton. Virus was concentrated by centrifugation at 100,000 g for 1 hour at 4°C 
in a M.S.E centrifuge (3 x 70 rotor). The pellet was resuspended in 50 mM Tris 
pH 8 and loaded onto a preformed CsCl2 gradient of p l.2-1 .4  which was 
centrifuged at 100,000 g at 4°C for 2 hours in a M.S.E. centrifuge (3 x 70 
rotor). The p i.36 band was collected by side puncture, concentrated by 
centrifugation and resuspended in 50 mM Tris-HCl pH 8. (McCrae 1985). 
Figure 7 shows a typical virus gradient profile.
2.2.7. Extraction of genomic RNA from purified virus
The viral suspension (1 mg/ml) was made 1 % with respect to SDS and 
extracted 3 times with 50 mM Tris-HCl pH 8 saturated phenol. Residual phenol 
was removed by extracting 4 times with di-ethyl-ether and RNA collected by 
ethanol precipitation in the presence of 0.15 M LiCl. The concentration of the 
RNA was calculated on the basis o f optical density at 260 nm.
2.3. GENERAL DNA TECHNIQUES
2.3.1. DNA precipitation
DNA was precipitated from aqueous solution on the addition of salt and 
ethanol. The salt routinely used was Lithium chloride. This was diluted from a 
10 M stock to 0.15 M in the solution containing the DNA, prior to addition of 
100 % ethanol and precipitation of the DNA (Sambrook et ai. , 1989). The DNA
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pellet was dried under vacuum and resuspended in T.E. buffer (10 mM Tris-HCl 
pH 8, 1 mM EDTA).
2.3.2. Phenol/Ether extraction
Proteins were removed from solutions containing DNA or RNA prior to 
ethanol precipitation with phenol saturated with 50 mM Tris-HCl pH 8. The 
DNA solution was made up to 100/tl with water and an equal volume of phenol 
was added. After mixing, the phases were separated by brief microfugation. 
The upper aqueous layer was removed and extracted with an equal volume of di­
ethyl-ether. The upper ether phase was removed and the lower aqueous phase 
was ethanol precipitated.
2.3.3. Restriction endonuclease digestion of DNA
Plasmid DNA (10 ng) was digested with the appropriate enzymes in a final 
volume of 20 /tl containing 2 /il of the appropriate 10 x enzyme buffer and 
restriction enzyme. Generally 4 Units of enzyme was used per sample and the 
digestion carried out by incubating overnight at 37°C or the optimal temperature 
for enzyme activity as recommended by the supplier.
2.3.4: Large Scale Plasmid Preparation
A 10 ml culture containing the relevant plasmid DNA was grown overnight 
at 37°C. This was diluted into 1 litre of L-Broth and grown at 37°C until the 
OD 590 reached 0.6, chloramphenicol was added to a final concentration of 150 
/ig/ml and the plasmid DNA amplified by overnight incubation at 37°C. Cells 
were harvested, lysed and plasmid DNA isolated as described by Sambrook et 
al., (1989). DNA was ethanol precipitated and the OD 260 used to calculate the 
amount of DNA recovered.
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2.3.5: Agarose gel electrophoresis of DNA
Two types of agarose gel electrophoresis were employed depending on the 
nature of the DNA under investigation.
a. Neutral gels
b. Alkaline gels
a. Neutral gels:
1-1.5 g of agarose/100 ml of sterile Distilled water (SDW) was dissolved in 
a microwave and allowed to cool to 48°C. To this 10 mis of 10 x T.B.E. and 10 
/zl of ethidium bromide (10 mg/ml) were added.
The gels were cast, allowed to set and were placed in 1 x TBE. 20 pi of 
DNA sample was mixed with 5 pi of 5 x Loading buffer and loaded into the 
wells. Most gels were run at 250 mA for 1-3 hours or until the lower dye front 
reached the bottom of the gel.
lkb Ladder (BRL) was routinely used as a marker for agarose gels. Gels 
were photographed under ultraviolet light using Polaroid 667 positive film.
b. Alkaline agarose gels
These gels were typically run for examining the products of c-DNA 
synthesis.
To every 90 ml of molten agar 10 ml of 10 x alkali gel buffer was added. 
The gels were placed in 1 x alkali gel buffer and DNA samples were mixed with 
10 x alkali gel loading buffer.
2.3.6. DNA isolation from agarose gels
DNA was isolated by two methods depending on the nature of the 
fragment.
6 5
a. Electroelution
This method was typically used for the isolation of radioactive c-DNA 
products as described by Sambrook et al., (1989). The c-DNA band was located 
by autoradiography and the gel piece excised using a scalpel.
b. Direct elution of DNA from the gel
Non-radioactive DNA fragments to be isolated were visualised and a slit 
cut in front of the relevant band. A piece of 3 mm Whatman filter paper backed 
with dialysis tubing was placed in the slit. Most of the buffer was removed from 
the gel tank, such that buffer was only touching the top of the gel. The gel was 
run for 5 minutes at a maximum of 150 mA. The filter paper was transferred to 
a small eppendorf with a hole in the bottom and placed in a large eppendorf. 
The liquid was removed by microfuging for 10 minutes, followed by addition of 
150 nl o f T.N.E buffer to the filter paper and further microfugation to elute the 
DNA. The elutants were pooled and the process repeated 2-3 times, 
phenol/ether extracted and ethanol precipitated (Dretzen et al., 1981).
2.3.7. Dephosphorylation of vector DNA
To remove the terminal 5' phosphate groups from linearised vector DNA, 
it was treated with calf intestinal phosphatase (CIP). The reaction mix consisted 
of <1 pg of digested vector DNA, 1 x CIP buffer and 1 Unit of CIP 
(Sambrook et al. , 1989)
2.3.« Blunt ending of DNA
a. Klenow rilling
5' overhangs of digested DNA (e.g. BamHl, EcoRI) were removed when 
required by Klenow filling the DNA. The reaction was allowed to proceed for 3
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hours at 15°C and contained the relevant DNA, 20 mM dNTPs, 2 Units of 
Klenow DNA polymerase 1 and 1 x Klenow poi 1 buffer (Sambrook et al., 
1989)
b. SI nuclease
3‘ underhangs of digested DNA (e.g. PstI) were removed when required 
by SI nuclease as described by Sambrook et al., (1989).
2.3.9. Ligation of DNA
DNA fragments were ligated with phosphatased vector DNA using a molar 
excess of insert to plasmid of 10:1. Ligation was allowed to proceed at 15°C 
overnight using 100 ng of vector DNA, and the relevant amount of insert DNA, 
2 Units of DNA ligase and 1 Unit of RNA ligase in ligation buffer (Sambrook et 
al., 1989).
2.3.10. Transformation
Ligated DNA samples were transformed into either competent E. Coli cells 
strain MC1061 (recA+ ) or JM103 (recA"), depending on the vector used.
Competent cells were generated by diluting an overnight culture 1 in 100 in 
L-Broth and incubating with agitation until the OD 590 reached 0.4-0.6.
Initially transformations were performed using the calcium chloride 
technique (Sambrook et al., 1989). However, more recently they were 
performed by electroporation.
Each 20 ml of competent cells was washed twice in SDW. Cells were 
resuspended in half the initial volume of cold 10 % glycerol and respun at 2K for 
10 minutes, 4°C in a bench centrifuge. They were then resuspended in 200 -
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300 n\ 10 % glycerol and either used directly or stored at -70°C until required. 
Cells were stored in such a way for up to 6 months.
For transformation, the ligation mix was ethanol precipitated to remove all 
traces of salt and the dried pellet resuspended in 10 pi of SDW. 40 p\ of 
competent cells were added to the DNA and the mix transferred to an 
electroporation cuvette. The cells were pulsed in a BIORAD gene pulser at:
Capacitance 25/iFD
Pulse controller 2000
Voltage 2.5K
A time pulse of 4.5 - 5 seconds resulted in a 'good pulse'.
The mix was transferred to 700 /¿I of L-broth and incubated at 37°C for 30 
minutes before plating onto 1.5 % L-agar containing 100 /*g/ml ampicillin or 10 
fig/ml tetracycline depending on the plasmid under investigation. The plates 
were incubated overnight at 37 °C. When JM103 / Bluescribe was the
vector/bacteria combination used the transformation mixture was plated onto 
selective plates containing 100 ngfrri ampicillin, 40 fig/rri X-gal and 5 mM 
IPTG. Potential recombinants were identified by the white colony colour 
compared to the blue colour of vector only containing colonies.
2.3.11. Screening for potential recombinants
a. Minipreparation of plasmid DNA
20 - 30 colonies were normally picked from transformed plates per 
ligation. The transformed E.coli colonies were cultured in 10 mis L-broth 
overnight and plasmid DNA was prepared from these cultures by the alkaline 
lysis method as described by Sambrook et al., (1989).
DNA inserts were detected by restriction enzyme digestion and analysed by
agarose gel electrophoresis.
b. Screening for DNA by hybridisation techniques
In some cases it was necessary to screen large numbers o f  colonies for the 
insert DNA. In such cases 200 - 400 colonies were picked onto an L-agar plate 
containing the relevant antibiotic and incubated at 37°C overnight. The colony 
hybridisation method of Grunstein and Hog ness (1975) was used. Colonies were 
overlaid with a nylon filter for 3 minutes instead of the traditional nitrocellulose 
filter. After lysing and fixing the colonies, the DNA was firmly bound to the 
filter by exposing to U.V illumination for 3 minutes. The filter was then placed 
in a plastic bag containing prehybridisation mix, sealed and incubated at 68°C 
for at least 1 hour.
The filter was then hybridised with a radioactive probe overnight at 68°C.
Non-hybridised radioactivity was removed by 4 washes in 2 x SSC and 0.5 
% SDS for 20 - 30 minutes. The filter was dried and exposed to 
autoradiography. Colonies containing the insert could be detected and further 
checked for insert and orientation by mini-plasmid preparations, restriction 
enzyme digestion and agarose gel electrophoresis.
c. Preparation of radioactive probe
Probes were generally prepared by Nick translation using <1 pg of the 
relevant insert DNA in a reaction mix of 1 x Poll buffer, containing 1 pi of 
DNAase (1 mg/ml diluted 1:10000), 1 Unit of Klenow 1 polymerase and 100 
pCi of a 32P dGTP (Sambrook et al., 1989). The reaction was incubated at 
15°C for 3 hours and stopped by the addition of 30 pi of 2 x column buffer and 
140 pi of 1 x column buffer.
Labelled DNA was separated from unincorporated radioactivity by running 
a Sephadex G50 column, equilibrated with 1 x column buffer. Twenty fractions 
(10 drops) were collected and counted by Cerenkov radiation in a LKB 1219 
Rack-beta scintillation counter. The incorporated peak was pooled and the DNA
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FIGURE 8: S EQ U EN CE OF TH E PRIMERS USED 
FOR cDNA SYNTHESIS OF T H E  S 4  GENE
5’ end primer for the S4 gene
Hindi 11
Nru1 Xba1 Eco47111
5 'TC G C G A A G C TTC G A G A G C G C TA TTTTTG C C  
3' CGATAAAAACGG
3' end primer for lhe S4 gene 
C TTC A TTC A TC TC  3'
G A A G TA A G TA G A G A C G TC G A C C TA G G C C T 5’
Pst1 Pvu11 BamH1
ethanol precipitated, resuspended in a suitable volume (300 /xl), boiled for 10 
minutes and quench cooled prior to use in hybridisation.
2.3.12. Autoradiography
Filters or gels bearing a 32P radioactive isotope were exposed at room 
temperature or at -70°C using a Lightening-plus intensifying screen to Fuji X-ray 
film, for times varying between several hours and several weeks depending on 
the amount of isotope present.
2.4. c-DNA CLONING OF THE S4 GENE
2.4.1. Preparation of oligonucleotides
With the sequence available for the S4 gene of serotypes 1 and 3, 
oligonucleotides were specifically synthesised for the 5’ and 3' ends of the gene 
(figure 8). These were used as primers for reverse transcription (Kurtz & 
Nicodemus, 1981) of the S4 gene. The important features of the oligos are 
discussed in section 4.2.
2.4.2. Purification of oligonucleotides
Oligonucleotides were resuspended in SDW and loaded onto a 20 % 
vertical acrylamide gel (20 % acrylamide, 42 % urea, 1 x T.B.E) and run in 1 x 
T.B.E. buffer. The oligos were excised from the gel and isolated by shaking 
overnight in 5 ml of elution buffer (10 mM MgAc, 500 mM NH4AC, 0.1 % 
SDS, ImM EDTA) and run through a Sephadex G25 column overlaid with 
DEAE Sephacel anion exchanger. The column was equilibrated with 50 mM 
NH4HCO3 and the oligo eluted with 1 M NaCl/50 mM NH4HCO3. 10 drop 
fractions were collected, the OD 260 measured, the peak of absorbance pooled
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and freeze dried. The oligo was resuspended in SDW and its concentration 
determined from the OD 260
2.4.3. Preparation of the RNA template
10 ng of ds viral RNA was precipitated and resuspended in 30 ¿*1 of 1 mM 
EDTA. The solution was made 90 % with respect to DMSO and incubated at 
45°C for 20 minutes, (thus lowering the t.m. o f the RNA) followed by rapid 
precipitation of the RNA to denature the RNA.
2.4.4. c-DNA synthesis
c-DNA was synthesised following the basic method developed by McCrae 
and N^Corquodale (1982).
As the primers were specific for the S4 gene, total single stranded viral 
RNA was used as the template for the reaction. The amount of oligo required 
for each reaction was calculated on the basis of using a 100 - 1000 x excess of 
the oligo over the calculated amount of S4 gene.
The RNA was diluted up to 40 /¿I in SDW and an equal volume of 5 mM 
Methyl mecuric hydroxide was added. The mixture was incubated at 20 °C for 3 
minutes. To this, 120 pi of reverse transcription reaction mix was added.
The reaction mix consisted of the following:
Tris-HCl pH 8.3 75 mM
MgCl2
dATP
180 mM
1.5 mM
dCTP 1.5 mM
dTTP 1.5 mM
dGTP 0.75 mM
DTT 15 mM
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Oligos 
a  32P dGTP 
Reverse transcriptase
c.a. 100/ig/ml
SDWto
50 pCi 
30 Units 
120 /¿I
The reaction was allowed to proceed for 5 minutes at room temperature, 
42°C for 60 minutes and finally 46°C for 10 minutes. Un-incorporated 
radioactivity was separated through a Sephadex G-50 column as described in 
section 2.3.11.
The overhanging end of the c-DNA, generated by the oligonucleotides, 
were filled using Klenow I polymerase and the c-DNA isolated on a denaturing 
alkaline gel followed by electroelution.
The cloning vector pAT153 was digested with Pst 1 and poly G tailed 
while the c-DNA was poly C tailed as described by N^Crae and McCorquodale 
(1982), vector and cDNA were hybridised and transformed into competent 
MC1061 cells.
As the ampicillin resistant region of the plasmid was destroyed by Pst 1 
digestion potential clones were initially screened for tetracycline resistance. 
Potential positives (i.e. those ampicillin sensitive) were further screened directly 
by mini-plasmid preparations or if there were large numbers of potential 
positives by Grunstein hybridisation, using a S4 cDNA probe, followed by mini­
plasmid preparations and agarose gel electrophoresis of any potentially positive 
colonies.
2.5. IN  VITRO TRANSCRIPTION
Using the techniques described in section 2.3 full length S4 c-DNA of 
types 1 and 3 (S4-1 and S4-3) were subcloned into the vector Bluescribe such
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that the 5' end o f the gene was adjacent to the T7 promoter, thus allowing in 
vitro transcription analysis using T7 RNA polymerase.
2.5.1. Linearisation of plasmid template
The T7 plasmid was linearised downstream of the coding sequence by 
digestion with PstI (S4-3) and BamHI (S4-1), to produce as authentic sized 
transcripts as possible. Generally 50 ng of DNA was digested and complete 
linearisation was confirmed by agarose gel electrophoresis. The linearised DNA 
was phenol extracted, precipitated and resuspended in SDW to a concentration of 
1 mg/ml.
2.5.2. Preparation of radioactive in vitro transcripts
Transcripts containing a  32P-r CTP were produced for size analysis of the 
T7 run off transcripts.
The reaction was made up at room temperature and incubated at 37 °C for 1 
hour. The final reaction mixture contained the following:
Reagent Final
cone
Plasmid DNA 2 ng
rUTP, rATP.r GTP 500
RNAsin 1 U/#il
BSA 125 U/Ml
DTT 10 mM
Transcription buffer 1 X
32P rCTP 5 0 MCi
T7 RNA polymerase 10 U
The final volume routinely used was 50 pi.
2.5.3. Size analysis of T7 transcripts
T7 transcripts were analysed by electrophoresis on 1.5 % agarose gels 
containing 6 % formaldehyde in 1 x MOPS buffer pH 7. The T7 transcripts 
were denatured in 20 pi of denaturing solution (500 pi DIF, 100 pi 10 x MOPS 
buffer, 150 pi formaldehyde), at 60°C for 15 minutes and quench cooled on dry 
ice. The samples were mixed with 2 pi of loading buffer and gels were run at 
250 mA for 3 hours, fixed in 10 % glycine, dried under vacuum below 60°C to 
avoid melting of the agarose, and then autoradiographed to detect the labelled 
transcripts.
2.5.4. Synthesis of unlabelled and capped transcripts
For in vitro translation analysis capped RNA transcripts were produced. 
To enable calculation of the amount of RNA produced 10 pCi of ^H- rUTP was 
incorporated into the reaction. This was vacuum dried to remove ethanol and 
resuspended in 25 pi SDW. The final reaction mix contained the following:
Reagent final
cone
rATP, rUTP 1 mM
rCTP
rGTP 0.5 mM
Transcription 1 X
buffer
DTT 2 mM
RNAsin 0.4 U
DNA 5 it g
75
CAP O.S mM
0.5 UT7 RNA Polymerase
The final reaction volume was routinely 50 pi.
The reaction was incubated at 37°C for 30 minutes prior to the addition of
1.5 pi 10 mM rGTP and incubation continued for 1 hour at 37°C.
In each in vitro transcription reaction the DNA template was removed by 
digestion with 2 Units of RNAase free DNAase and incubated for 15 minutes at 
37°C prior to precipitation using 0.7 M NH4AC to separate the RNA transcripts 
from rNTPs. This RNA was directly used in in vitro translation reactions.
2.5.5. Calculation of the amount of T7 transcript produced
The dried mRNA pellet was resuspended in 50 p i of SDW. 2 pi of this 
was precipitated in 1 ml of 10 % TCA and incubated on ice for 15 minutes. The 
precipitate was collected on 2.5 cm Whatman N o .l filter discs by passing 
through a suction funnel, washed twice with 5 % TCA, twice with ethanol, 
allowed to dry and counted in 'OPTIPHASE' scintillation fluid on a LKB 1212 
scintillation counter. The amount of mRNA produced per reaction could then be 
calculated.
For example:
The cpm produced from the in vitro transcription reactions ranged from 2 x 
103 cpm - 3.5 x lO^cpm. The amount of mRNA produced per reaction was 
calculated as follows:
1. The concentration of cold UTP added = 10 mM
In 50 pi have 25 nmoles of cold UTP.
2. Given that 1 pCi of 3H labelled UTP =  2.54 x 10^ cpm
7 6
The amount of UTP as TCA precipitatable RNA can be calculated: 
TCA ppt. counts
No. of counts in 10 /¿Ci 3H UTP x amount of cold UTP
3. For example: If 2.8 x 103 cpm were precipitated then:
[2.8 x 103 x 25] x 25
2.54 x 10^ =  nmoles of UTP
= 0.63 nmoles of UTP.
4. The average molecular weight of a ribonucleotide = 360
The amount of RNA produced 
=  [0.68 x 360 x 4] ng of RNA 
-  979 ng
5. The efficiency of counting of the scintillation counter:
From 1 /¿Ci of 3H UTP expect 2.54 x 106 cpm 
When 1 /¿Ci was counted it gave 2.2 x 10^ cpm.
The efficiency of counting = 9 %
Therefore the total amount of RNA produced was 10 /¿g.
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2.6 IN  VITRO TRANSLATION
2.6.1. The rabbit reticulocyte lysate system
2.6.1.1. Preparation of lysate
The rabbit reticulocyte lysate used in this study was prepared as described 
by Hunt et al. (1972) by M.A. N^Crae. Aliquots o f the lysate were removed 
from liquid N2 prior to micrococcal nuclease (Mnase) treatment to remove 
endogenous mRNA (Pelham & Jackson, 1976).
To 2 ml of lysate were added:
Creatine Kinase (5 mg/ml) 20 pi
Haemin (1 mM) 80 pi
CaCl2 (100 mM) 20 pi
Mnase (1 mg/ml) 30 pi
The reaction was incubated at 20°C for 12.5 minutes followed by the 
addition of 10 pi of 0.5 M EGTA, to chelate the calcium ions. The treated 
lysate was aliquoted into suitable sizes and stored in liquid N2 until required.
2.6.1.2. In vitro translation
m-RNA from in vitro transcription reactions was resuspended to a 
concentration of approximately 0.6 mg/ml. Generally 1 - 2 pi of mRNA was 
used per reaction.
The components of the reaction are listed below:
20 x Energy mix: di-Potassium-ATP 20 mM
Na-GTP 4 mM
Tris pH 7.5 0.2 M
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This was aliquoted and stored at -20°C. When required 145 mg of di-Tris 
creatine phosphate and 2 mg of creatine phosphokinase were added to each 2 mis 
of energy mix.
The reaction mix consisted of the following:
reaction incubated at 30°C for 1 hour.
The reaction volume routinely used was 25 pi.
2.6.2. In vitro translation in S-10 cell extracts
2.6.2.1. Preparation of S-10 cell extracts
S-10 cell extracts were prepared from 1 litre of Type 1 infected, Type 3 
infected and uninfected mouse L-cells. The cells were infected at 10 pfu/cell for 
16 hours at 34°C and S-10 extracts were prepared as described by Skup and 
Mill ward (1977). 1 ml aliquots were stored in liquid N2 until required.
Reagent Final
cone.
Tris pH 7.5 0.625 mM
amino acids 100 nM
Energy mix x
KC1 30 mM
0.5 mM
tRNA 45 ng/fil
Lastly 12.5 pi of lysate and 50 pCi of 35S-met were added and the
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Endogenous mRNA was removed by treating 1 ml aliquots with 75 Units Mnase 
and 1 mM CaCl2 at room temperature for 10 minutes. The calcium ions were 
chelated by the addition of 1.2 mM 2’-deoxythymidine-3\5'-diphosphate. The 
Mnase treated extracts were aliquoted and stored in liquid N2 until required.
2.6.2.2. In  vitro translation
mRNA from in vitro transcriptions was resuspended to a concentration of 1 
mg/ml. Generally 1 y.g of mRNA was used per reaction. The components of 
the reaction mix are listed below:
5 x Master Mix:
Reagent Final
cone
Hepes 50 mM
KAc 600 mM
MgAc 2.5 mM
Spermidine 250 mM
DTT 5 mM
GTP 2.5 mM
amino acids 100 mM
CPKase 2 mg/ml
To each reaction were added: 10 /xl Nuclease treated extract 
5 0 11 Ci 35S-met 
4 n\ 5 x master mix 
6 mRNA + H2O
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The reaction was allowed to proceed at 30°C for 2 hours.
2.7. Measurement of incorporation of radioactivity
For in vitro translation analysis, 2.S /tl aliquots were applied to 2.S cm 
Whatman No.l filter discs at various times throughout the reaction, and 
precipitated in 5 % cold TCA for at least 10 minutes. The filter discs were 
boiled for 10 minutes in 5 % TCA / 3 % CAS amino acids, followed by 2 
washes in ethanol and 2 washes in ether, air dried and the amount of ^S-m et 
incorporated into protein determined by scintillation counting in 'OPTIPHASE' 
scintillation fluid.
2.8. Analysis of protein products
Protein products were analysed on 10 % vertical polyacrylamide gels using 
the Laemmli discontinuous buffer system (Laemmli, 1970). Electrophoresis was 
continued at 40 mA for 3 hours and gels were treated with PPO (2,5 
Diphenyloxozole) and DMSO to allow fluorography and dried onto Whatman 
No.l filter paper under vacuum for 1 hour at 60 °C, prior to autoradiography.
2.9. TRANSFECTION OF DNA INTO MAMMALIAN CELLS
2.9.1. Electroporation
Mouse L-cells were taken from suspension culture, concentrated by 
centrifugation at 2 K, 4°C for 10 minutes in a bench centrifuge and resuspended 
to 107 cells/ml in cold PBS. 0.8 mis of cells were mixed with 1 - 10 ng of DNA 
and the mix electroporated at 0.5 Volts, resulting in a time constant of 0.7 - 0.8 
seconds. The samples were incubated on ice for 10 minutes and added to 60 mm
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tissue culture dishes containing 5 mis of medium and 10 % FCS. Cells were 
harvested in 1 ml of cold PBS 48 hours post transfection.
2.9.2. Calcium phosphate transfection
L-cells, HeLa and COS-1 cells were used in transfection assays.
5x l05 cells were plated onto 60 mm tissue culture dishes and left to form a 
monolayer by incubating overnight at 37°C. 3 hours prior to transfection the 
cells were fed with fresh medium containing 10 % serum. For each transfection 
the following mix was made up:
50 fil of 2x HBS was added to this mixture and a DNA precipitate allowed 
to form by standing for 15 minutes at room temperature. 900 pi of media 
containing 10 % serum was then added. The cells were overlaid with the 
transfection mixture, incubated at 37°C for 3 hours, with occasional rocking to 
ensure the DNA was taken up by the cells, and then glycerol shocked for 1 
minute with 15 % glycerol in 1 x HBS, washed twice in PBS and overlaid with 
media +  10 % serum. The cells were harvested in 1 ml of cold PBS 48 hours 
post transfection The cells were pelleted in a microfuge for 10 minutes and the 
pellets stored at -20°C until required.
2.10 ANALYSIS OF REPORTER GENE EXPRESSION
2.10.1. Preparation of cell lysates
sssDNA 1 mg/ ml 
1.25 M CaCl2 
T.E. buffer to
Relevant DNA 10 Mg 
1 Ml 
10 Ml 
50 Ml
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The cell pellets (from section 2.7) were resuspended in 150 fi\ of cold CAT 
lysis buffer incubated on ice for 10 minutes and sonicated in a sonication bath for 
4 x 15 second bursts. The nuclei were removed by microfugation for 10 minutes 
at 4#C.
2.10.2. Determination of the amount of protein in the lysate
The amount of protein used in each reaction was standardised using the 
BIORAD protein assay kit. 1 /¿I of the cell lysate was diluted into 1 ml of a 1:5 
dilution o f  the BIORAD assay kit. The amount of protein in each sample was 
determined by the OD 595 and a standard amount of protein was used per set of 
assays.
2.10.3. Chloramphenicol acetyl transferase (CAT) assays
CAT assays were performed by the two fluor diffusion assay as described 
by Neuman et al. (1987).
The cell extracts were made up to 50 /xl with 100 mM Tris-HCl buffer pH
7.5 and heated at 70°C for 15 minutes to destroy background activity. The 
reaction mix consisted of:
10 mM Chloramphenicol 50 m1
1 M Tris-HCl buffer pH 7.5 25 mI
3H-acetyl co-enzyme A 0.1 MCi
Distilled H2O 124 mI
The reaction mix was mixed with the heat treated cell extract, placed in a 5 
ml scintillation vial and overlaid with non aqueous scintillation fluid (Toluene + 
0.5 % PPO). The reactions were incubated at room temperature (Eastman,
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1987) in a scintillation counter with the samples being counted every 1 5 - 3 0  
minutes for 1 minute, depending on the number of samples under investigation.
2.10.4. B-galactosidase assays
8-galactosidase assays were performed as described by Sambrook et al. 
(1989).
Cell extracts containing equal amounts of protein were combined with the 
following reagents.
100 x Magnesium buffer 3 Ml
ONPG 66 m1
Sodium Phosphate buffer to
a final volume of 300 m1
The reaction was incubated at 37°C for 15 minutes until a yellow colour 
appeared and the reaction stopped by the addition of 0.5 ml 1 M Na2CC>3. The 
amount of enzyme activity was determined spectrophotometrically at 410 nm.
2.11. PRODUCTION OF POLYCLONAL ANTISERUM AGAINST 
<r3
2.11.1 Inactivation of reovirus
Antiserum was raised against reovirus type 3 in a New Zealand white 
rabbit. However, reovirus is highly virulent to mice and to avoid infection of 
mice in the animal house it had to be inactivated prior to use. To do this 1 mg of 
virus was made up to 1 ml in 50 mM Tris-HCl pH 7.5. To this 10 /d of a 1:10 
dilution of B-propriolactone was added.. The mixture was left at 4 °C overnight. 
The following day it was dialysed against several changes of prechilled (4°C)
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PBS. The virus was checked for inactivity by plaque assay prior to infection of 
the animal.
2.11.2 Production of polyclonal antisera
The animal was subcutaneously injected with 0.5 mg CsCl gradient 
purified, 8-propiolactone inactivated virus, emulsified in complete Freund's 
adjuvant. Two subsequent boosts , 0.3 mg each, were given in incomplete 
Freund's adjuvant and the animal was bled 10 days post injection. The activity 
of the antiserum was checked by plaque reduction assay as described by Offit et 
al. (1984).
2.12 DETECTION O F a3 IN TRANSFECTED CELLS
2.12.1. Immunoprécipitation
2.12.1.1. Labelling of cells with 35S-met
60 mm tissue culture dishes of transfected cells were labelled for 3 hours at 
48 hours post transfection with 100 pCi o f  -*5S-met per dish in met-free 
GMEMS. The cells were harvested in 300 pi of 10 mM Tris-HCl pH 8.5 and 
subjected to 3 x freeze thawing followed by 4 x 20 second bursts o f sonication in 
a sonication bath. The cell debris was removed by microfugation for 10 minutes 
at 4°C and the amount of labelled protein in each sample was determined by 
TCA precipitation and equal amounts were used for immunoprécipitation.
2.12.1.2. Immunoprécipitation
Samples were made up to 100 pi with 2 x immunoprécipitation buffer 3 
(IP3), 10 pi of neat serum was added and the mix incubated for 1 hour at 4°C
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with gentle agitation. The sample was then added to pre-swollen protein A 
sepharose (5mg in 100 pi of IP3) and incubated for 1 hour as above. The 
supernatant was removed by microfugation for 1 minute and non specifically 
bound molecules were removed from the beads by sequential washes in IP2, IP2 
+  1M NaCl, twice in 1 x IP3 and finally IP1.
The sample was made up to 30 pi with 50 mM Tris-HCl buffer pH 8 and 
10 pi of cracking buffer was added prior to boiling the samples for 3 minutes. 
The immunoprecipitated products were analysed on a 10 % polyacrylamide gel 
as described in section 2.8.
2.12.2. Immunofluorescence
For immunofluorescence, transfections were performed in 12 well tissue 
culture dishes. 1 coverslip was placed in each well prior to plating out the cells. 
It was important to keep the cells as subconfluent as possible. 48 hours post 
transfection the cells were formaldehyde fixed. This involved washing the 
monolayers 4 x in PBS, followed by incubating in 3.7 % formaldehyde at room 
temperature for 5 minutes. The cells were then incubated in 3.7 % 
formaldehyde +  0 . 1 % Triton X 100 for 5 minutes and finally in 1 % BSA in 
PBS for 10 minutes. The fixed monolayers were washed twice with PBS prior to 
incubation with 20 pi of antisera diluted 1:50 for 1 hour at 37°C. The 
monolayers were washed twice with PBS and were overlaid with 20 pi of 
fluorescent conjugate (FITCGAR) diluted 1:40, followed by incubation at 37°C 
for a further hour in the dark. The monolayers were thoroughly rinsed in PBS to 
remove any non bound conjugate, mounted onto slides in 10 % glycerol in PBS 
and viewed under the immunofluorescent microscope.
As a control for immunofluorescence cells were infected with reovirus type 
3 at 0.1 m.o.i for 16 hours prior to fixing the cells as described above.
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INHIBITION OF HOST CELL PROTEIN SYNTHESIS BY
MAMMALIAN REO VIRUS TYPES 1 AND 3
3.1 Introduction
As mentioned in section 1.6 the overall aim of this project was to gain a 
greater insight into the mechanism underlying the differential effects that types 1 and 
3 reovirus have on the inhibition of host cell protein synthesis. These effects were 
first reported by Sharpe and Fields (1982), who showed that the different abilities of 
type 2 and type 3 to inhibit host cell protein synthesis was a property of the S4 gene. 
Subsequently Munemitsu and Samuel (1984) demonstrated that type 1 and type 3 
also inhibit host cell protein synthesis to differing extents. The type 1 phenotype 
does not inhibit protein synthesis at late times in infection whereas type 3 does. 
Before starting work on the role of the S4 gene in this shut-off it seemed necessary 
to confirm that the results published by others held true under the conditions 
employed in our laboratory. That is, could it be demonstrated that reovirus type 3 
inhibits host cell protein synthesis to a greater degree than does type 1?
3.2 Rationale
Mouse L-cells were seeded into 12 well tissue culture dishes (5x10^ 
cells/dish). The cells were infected at 10 pfu/cell with type 1, type 2 or type 3 
reovirus. Mock-infected cells were used as a control. 3, 10, 20, 23 and 30 hours 
post infection, cells were pulse labelled with -^S-met for 30 minutes as described in 
materials and methods, and harvested by lysing the cells on the plates as described 
by Munemitsu and Samuel (1984). The recovery of cells was estimated by 
measuring the total amount of protein present in each sample using the Biorad 
protein assay lrit. The amount of ^S-m et incorporated into a standard number of 
cell equivalents was determined by TCA precipitation. Equivalent amounts of 
labelled protein were also analysed on 10 % acrylamide gels.
3.3 Results
Figure 9 shows that in type 1 infected cells total protein synthesis continues at 
approximately the same rate as mock infected cells even at late times in infection. 
However, in type 3 and type 2 infected cells inhibition of protein synthesis 
commences 20 hours post infection. When equal amounts of labelled protein were 
analysed on a 10% polyacrylamide gel it was evident that the r~tes of viral protein 
synthesis differed between the serotypes (figure 10). As can be seen in figure 10 
viral protein synthesis commences between 5 and 15 hours post infection by which 
time all the viral proteins are being synthesised ( tracks A - D 15 hours). In type 3 
infected cells viral protein synthesis reaches maximal levels at 15 hours post 
infection (track D 15 hours), by contrast in type 1 infected cells the maximal level of 
viral protein synthesis is not reached until at least 25 hours post infection (track B 25 
hours). At late times in infection (20 hours + ) inhibition of host protein synthesis is 
evident in type 2 and type 3 infected tracks (tracks C and D, 20 and 25 hours post 
infection). For example, the intensity of the actin band in type 2 and type 3 infected 
cells clearly decreases from 20 hours onwards when compared to that of type 1 and 
un-infected tracks (A - D, 20 and 25 hours).
3.4 Conclusion
The results from this experiment confirm the findings of Munemitsu and 
Samuel (1984), namely that type 3 reovirus inhibits host protein synthesis to a 
greater degree than type 1 reovirus. The results also show that the level of type 3 
reovirus synthesis reaches a maximum earlier in infection that does type 1.
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Mouse L-cells were infected at 10 pfu/cell of type 1, type 2 and type 3 reovirus and 
mock infected cells were used as a control. At 5, 10, 15, 20, 25 and 30 hours post 
infection the cells were pulse labelled with 35S-met as described in Methods. The 
amount of 35S-met incorporated into a standard number of cell equivalents was 
determined by TCA precipitation as described in section 3.2.
FIGURE 9: PROTEIN SYNTHESIS IN TYPE 1, 2 AND 3 INFECTED AND
MOCK INFECTED L-CELLS.
Mock infected cells
Type 1 infected cells
—
Type 2 infected cells
..o ...
Type 3 infected cells
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A = CONTROL 
B =  TYPE 1 INFECTED 
C =  TYPE 2 INFECTED 
D = TYPE 3 INFECTED
FIGURE 10: PROFILE OF PROTEIN SYNTHESIS IN REOVIRUS TYPE 1, 2
AND 3 INFECTED L-CELLS AT VARIOUS TIMES POST INFECTION.
Equal amounts of labelled protein from 5, 15, 20 and 25 hour time points were 
analysed on a 10 % polyacrylamide gel which was fluorographed as described in 
Materials and Methods.
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4.1 Introduction
To investigate the role of the S4 gene in the shut-off of host protein synthesis 
by mammalian reovirus it was first necessary to obtain full length c-DNA clones of 
the S4 gene from both type 1 and 3 virus (S4-1 and S4-3). The sequence of the two 
S4 genes was available (Atwater et al., 1986) and allowed for the construction of 
oligonucleotides specific to the 5' and 3' ends of the S4 genes (figure 8, Materials 
and Methods). These were used to specifically prime S4 c-DNA synthesis using 
total viral dsRNA as a template.
The oligonucleotides contain unique restriction enzyme sites overhanging the 
ends of the gene, the sites used being chosen on the basis that they did not occur 
within the gene, but were present in the M13 polylinker. This was done in order 
that the full length cDNA generated would have a set of unique restriction enzyme 
sites at either end to allow for easy manipulation of the cloned gene into other 
vectors. The restriction enzyme sites Eco47UI and Pstl were constructed to allow 
precise cutting at the S' and 3’ ends of the genes, such that an exact sized S4 c-DNA 
could be isolated if necessary. S4-1 cDNA contains an internal Pstl site, however 
Pstl was the only restriction enzyme sequence that could be constructed to cut 
precisely at the 3’ end of the gene. Due to the high homology at the 5' and 3' ends 
of the S4-1 and S4-3 genes the same 5' and 3' oligonucleotides were used in cDNA 
synthesis (figure 8).
4.2 c-DNA cloning of the S4 gene
The cloning strategy initially used is outlined in figure 11 and the methods 
employed are described in Materials and Methods.
The cDNA was cloned into the Pstl site of pAT153. pAT153 is resistant to 
ampicillin and tetracycline. Pstl lies within the ampicillin resistance region of the
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FIGURE 11: CLONING STRATEGY
Full length cDNA was synthesised according to the basic reaction described by 
McCrae and McCorquodale (1982) and described in Methods. 
dsRNA was denatured and the resulting ssRNA hybridised with the primers 
illustrated in figure 8.
Two RNA/cDNA hybrids were produced by reverse transcription and the RNA 
removed by alkaline hydrolysis. The complementary cDNA strands were 
hybridised and the overhanging ends produced by the primers filled in by Klenow I 
polymerase as described in Methods.
The full length cDNA was isolated from a 1.5 % alkaline agarose gel. It was C- 
tailed and the cloning vector pAT153 was digested with Pst I, and G-tailed. cDNA 
and vector DNA were hybridised together and transformed into the E. coli strain 
MC1061. Full length inserts were identified by antibiotic screening, mini-plasmid 
preparations and restriction enzyme analysis (figure 12).
* Point of PCR where the cDNA was amplified by McCrae (personnel 
communication, 1987).
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plasmid, therefore potential cDNA clones were identified by screening for ampicillin 
sensitivity. Any ampicillin sensitive colonies were screened for the S4 gene by mini­
plasmid preparations and restriction enzyme analysis. However initial attempts using 
the strategy outlined in figure 11 failed to isolate any full length cDNA clones. One 
possibility for this was that insufficient cDNA was being made from the dsRNA 
template as only faint cDNA bands were isolated from alkaline agarose gels. The 
polymerase chain reaction (PCR) was used to directly amplify the initial cDNA 
product. This procedure increased the amount of cDNA produced at least 50 fold. 
The cDNA was amplified and successfully cloned into the PstI site of the cloning 
vector pAT153 by McCrae (personnel communication, 1987) using the strategy 
outlined in figure 11. The resulting colonies were screened for the S4 gene by 
digestion with Hindlll and BamHl (present in the oligonucleotides at the S' and 3' 
ends of the gene respectively) which released a 1.2 kb insert of S4-1 and S4-3 genes 
(figure 12). Further enzyme digests also agreed with the predicted enzyme analysis 
obtained from the sequence of the genes. Single digestion with Hindlll (in the 5' 
oligo) and BamHl (in the 3' oligo) also orientated the S4 inserts.
4.3 Initial subcloning of the S4 gene
In order to use the S4 genes for investigations they had to be transferred from 
the pAT153 vector to a more versatile vector suitable for producing mRNA 
transcripts in vitro, and for manipulation to other vectors for in vivo experiments. 
The Bluescribe vector which contains the T3 and T7 RNA polymerase promoters in 
the coding region of the LacZ gene, at either end of the M13 polylinker, met these 
requirements. Recombinants were readily selected in the host strain, JM103, on L- 
amp plates containing IPTG and X-gal as colonies carrying a viral insert were white 
compared to the blue colonies obtained when only the vector plasmid was present.
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FIGURE 12: IDENTIFICATION OF FULL LENGTH cDNA CLONES
M l = pBr322 digested with Hinfl 
A = S4-1 digested with PstI 
B = S4-1 digested with Hindlll/BamHl 
C = S4-3 digested with PstI 
D -  S4-3 digested with Hindlll/BamHl 
M2 = pBr322 digested with AccI
Full length cDNA inserts in pAT153 were identified by Hindlll/BamHl digestion, 
releasing a 1.2 Kb insert (tracks B and D). The digest shown in track A is only a 
partial digest, however the relevant bands can be clearly seen. The bands released 
by PstI digestion are slightly larger than those predicted for S4-1 and S4-3 due to 
the presence of the G and C tails added to the cDNA and vector during the cloning 
procedure. PstI digestion of S4-3 released full length S4-3 (1.2 Kb), track C, 
however S4-1 contains an internal PstI at postion 489 resulting in two bands, 700 bp 
and 489 bp, track A. This site was used to distinguish S4-1 and S4-3.
The plasmids are also represented and the position of the restriction enzymes used 
identified.
A: S4-1 in pAT153
H i n d i I I
B: S4-3 in pAT 153
H i n d i l l
The two S4 genes were subcloned into the Bluescribe polylinker in such a way 
that the 5' end of the gene was adjacent to the promoter for T7 RNA polymerase (T7 
promoter), to allow for synthesis of S4 mRNA in vitro using T7 RNA polymerase. 
The subcloning procedure is outlined in figure 13. The ligated DNA was 
transformed into JM103 and grown on L-amp plates containing X-gal and 1PTG. 
Potential positives i.e white colonies, were picked and screened for S4 inserts by 
mini-plasmid preparations and restriction enzyme analysis. Full length S4 inserts 
were identified and orientated by Hindlll digestion (figure 14).
4.4 Analysis of reagents for in vitro experiments
In vitro experiments aimed at determining the role of the S4 gene in inhibiting 
the translation of a eukaryotic protein will be discussed in the following chapters. 
For this work a eukaryotic gene, of approximately the same size as the S4 gene was 
required as a control in the transcription and translation studies. The 8-Actin gene 
fitted these requirements and a clone of it ('1'78-ACT) (obtained from K.Leppard, 
1988), in Bluescribe was used in this work.
4.4.1 Synthesis of T7 transcripts
To synthesise full length mRNA transcripts of the S4 and B-actin genes in vitro 
using T7 RNA polymerase, the genes were first linearised at the 3‘ end by digestion 
with PstI (S4-3), BamHl (S4-1) and Hindlll (B-actin).
The size of the mRNAs produced were analysed by the synthesis of high 
specific activity mRNA transcripts, which allowed detection of the transcription 
products by autoradiography, as described in Materials and Methods. Figure 15(a) 
shows that the S4-1 and S4-3 mRNA produced were full length (1.2 Kb) and the 
T7B-ACT produced B-actin mRNA (1.8 Kb) of the size predicted for a full length 
transcript (figure 15(b)).
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FIGURE 13: SUBCLONING OF THE S4 GENE(S) INTO BLUESCRIBE.
The Bluescribe vector was prepared by first digesting with EcoRJ. The liberated 
ends were blunted using Klenow DNA polymerase I. The blunt ended DNA was 
digested with BamHl and the S' phosphate groups removed using Calf Intestinal 
Phosphatase (CIP) as described in Methods.
The S4 insert(s) was released from pAT153 by NruI/BamHI digestion. These 
enzyme sites are present in the oligos (figure 8) at the S' and 3' ends of the gene 
respectively. The insert was isolated on and excised from a 1 % agarose gel as 
described in Methods. The vector and insert DNA mixture were ligated, 
transformed into JM103 and grown on L-amp plates containing X-gal and IPTG. 
Potential positives i.e. white colonies, were picked and screened for S4 inserts by 
mini-plasmid preparations and restriction enzyme analysis (figure 14}
The position of the T7 promoter (T7) is indicated in the diagram. The S4 gene was 
inserted down stream of this to allow for the synthesis of S4 mRNA using T7 RNA 
polymerase.
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t r a n s f o r m
Hindlll BamH1
S4 in Bluescribe
A =  S4-1 
B =  S4-3
M =  BRL 1Kb ladder
S4 inserts in Bluescribe were identified by Hindlll,SphI and H indi digestion and 
were size analysed on a 1 % agarose gel.
Hindlll and Sphl were used to orientate the inserts. SphI cuts at position 184 in 
both S4-1 and S4-3 and in the Bluescribe polylinker at the 3' end of the gene, 
releasing a 1 Kb insert. Hindlll cuts at the S' and 3' ends of the gene releasing a
1.2 Kb full length S4-1 and S4-3 insert.
H indi was used to identify the two genes, as it cuts S4-1 once at position 857 and 
S4-3 twice at position 437 and 857 and in the polylinker at the 3' end of the gene 
resulting in one band of 350 bp for S4-1 and two bands o f 350bp and 400 bp for
S4-3.
The diagram beneath the photograph represents the bands released by the digests. 
The enzymes used did not cut elsewhere in the vector.
T7 =  T7 promoter
FIGURE 14: IDENTIFICATION OF THE S4 GENE(S) IN BLUESCRIBE.
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FIGURE 15: ANALYSIS OF mRNA TRANSCRIPTS
A. SIZE ANALYSIS OF S4-1 AND S4-3 mRNA
A = S4-1 mRNA transcript 1.2 kb 
B =  S4-3 mRNA transcript 1.2 kb 
C = Reovirus M2 mRNA transcript 2.2 kb 
D = Reovirus SI mRNA transcript 1.4 kb
B. SIZE ANALYSIS OF B-ACTIN mRNA
A =  Radioactively labelled pBr322 digested with AccI 
B =  S4-3 mRNA transcript 1.2 kb 
C =  B-actin mRNA transcript 1.8 kb
mRNA was produced by in vitro transcription using T7 RNA polymerase as 
described in Methods. The transcripts were size analysed on 1.5 % agarose gels 
containing 6 % formaldehyde in 1 x MOPS buffer pH 7 as described in Methods. 
The radioactively labelled DNA marker was prepared by incorporating 50 nCi of 
o32P dGTP into a Klenow 1 DNA polymerase reaction as described in Methods.

Stocks of 1 unlabelled ' capped mRNA transcripts were prepared for in vitro 
translation analysis as described in Materials and Methods.
4.5 Summary
Full length cDNA clones of S4-1 and S4-3 in the vector pAT153 were made 
available for this work. These were transferred to the more versatile Bluescribe 
vector such that mRNA sense transcripts could be produced in vitro using T7 RNA 
polymerase. 6-actin was chosen as a control eukaryotic cell gene for the in vitro 
translation studies to be discussed in the following chapters. The fi-actin gene was 
also available in a clone from which mRNA transcripts could be produced in vitro 
using T7 RNA polymerase. The transcripts produced in vitro were all of the size 
predicted for full length mRNAs (S4-1 and S4-3 1.2 Kb and B-actin 1.8 Kb). 10 ng 
of 5' capped mRNA was routinely produced for in vitro translation assay systems. 
The systems in which this mRNA was used were:
1. The rabbit reticulocyte lysate system
2. S-10 cell free in vitro translation system
The development of these systems and the experiments carried out will be 
discussed in the following chapters.
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Introduction
The mRNA produced in Chapter 4 was used in several in vitro translation 
systems. The effect o f <r3 produced in vitro on the translation of eukaryotic proteins 
was investigated, in an attempt to gain a greater insight into the underlying 
differences the two serotypes have on the inhibition of host protein synthesis. The 
use of the rabbit reticulocyte lysate system will be discussed in chapter 5 and the use 
of the translation capacity of cell free extracts prepared from reovirus infected and 
uninfected L-cells in chapter 6. However there are many limitations to in vitro 
experiments and to ascertain if the effects observed in the in vitro systems hold true 
for events that occur in infected cells the development of an in vivo assay system also 
using S4 cDNA will be discussed in chapters 7, 8 and 9.
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5.1 Introduction
The rabbit reticulocyte lysate in vitro translation system is a very efficient 
eukaryotic cell free protein synthesising system. Endogenous mRNA can be 
destroyed by pre-treatment of the lysate with micrococcal nuclease (Mnase) allowing 
the specific translation of exogenously added mRNA (Pelham & Jackson, 1976). 
This system was used to study the effect o3, synthesised in vitro from T7 mRNA 
transcripts, had on the in vitro translation of 8-actin mRNA.
5.2 Optimisation of the in vitro translation system
Endogenous mRNA was removed by treatment of the lysate with Mnase and in 
vitro translation reactions were performed as outlined in methods. The activity of 
the reticulocyte lysate system is sensitive to Mg2 +  , K+ and mRNA concentrations. 
To optimise these parameters S4 mRNA was translated at varying concentrations of 
K +  while keeping the Mg2+ concentration constant. The optimum level of K+ 
ions was found to be 90 mM (Figure 16(a)). To optimise the Mg2+ concentration, 
the K+ concentration was kept constant at 90 mM and Mg2"*" concentration varied. 
Figure 16(b) shows that optimum incorporation of ■55S-met into protein was achieved 
at 1 mM Mg2 + .
Using these optimal salt conditions the ability of the system to translate various 
concentrations of mRNA was investigated. Figure 17(a) shows that optimal 
translation was achieved at 40 ng//xl after which the system becomes saturated for 
mRNA. Finally the ability of the system to translate equivalent amounts of capped 
and uncapped mRNA was studied. Figure 17(b) shows that capped mRNA is 
translated slightly more efficiently than uncapped mRNA, as reported for the 
reticulocyte system (Dasso & Jackson, 1989).
10 5
In vitro translations were carried out at Mg2 +  and S4 mRNA concentrations of I 
mM and 40 ng//zl respectively. The K+  concentration was varied over the range 76 
mM to 120 mM. The results are expressed as the amount of ^S-m et incorporated 
into protein at the 60 minute time point of the reaction, determined by TCA 
precipitation as described in Methods.
END = endogenous
FIGURE 16a: OPTIMISATION OF RETICULOCYTE LYSATE FOR [K+]
FIGURE 16b: OPTIMISATION OF RETICULOCYTE LYSATE FOR [Mg2 + ]
The K+ and S4 mRNA concentrations were maintained at 90 mM and 40 ng/pl 
respectively. The Mg2 +  concentration was varied over the range 0.5 mM to 10 
mM.
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FIGURE 17a: OPTIMISATION OF mRNA CONCENTRATION
The Mg^+ and K+  concentrations were maintained at 1 mM and 90 mM 
respectively. The S4 mRNA concentration was varied in the range of 20 ng/^1 to 
80 ng/pl.
-Q---- endogenous
20ng//il
—* — 40ng//il
- O " 80ng//jl
FIGURE 17b: TRANSLATION OF CAPPED AND UNCAPPED mRNA
Capped and uncapped S4 and actin mRNA were translated at the optimal conditions 
described in figure 16.
- B - S4-3 capped mRNA
- A - S4-3 uncappped mRNA
Actin capped mRNA
Actin uncapped mRNA
endogenous
1 0 7
40,000
A
B
Act =  8-actin
o3.3 A = type 3 o3 from S4-3 BS
a3.3 B = type 3 o3 from HPA-3 (see figure 32)
03.1 A =  type 1 o3 from S4-1 BS
03.1 B = type 1 o3 from HPA-1 (see figure 32)
M = Type 3 infected cell lysate
S4-1, S4-3 and B-actin mRNAs were translated in reticulocyte lysates as described 
in Methods. The translation products were fractionated on a 10 % polyacrylamide 
gel run at 40 mA for 3 hours and fluorographed as described in Methods.
The translation efficiencies of both S4-1 and S4-3 mRNA were the same (data not 
shown).
FIGURE 18: SIZE ANALYSIS OF IN VITRO TRANSLATION PRODUCTS.

Thus the optimal conditions determined for the reticulocyte lysate and those 
used in the following experiments were 90 mM for K"*", 1 mM for Mg^+ , and 40 
ng/^tl for mRNA .
5.3 Size analysis of in vitro translation products
The size of the translation products produced from the in vitro synthesised S4 
mRNA and B-actin mRNA were analysed on 10 % polyacrylamide gels. Figure 18 
shows that in vitro transcription produces functional mRNA which is translated to 
authentic sized o3 and B-actin proteins in the rabbit reticulocyte lysate system.
5.4 The efTect of type 3 o3 on the translation of a eukaryotic protein.
5.4.1 Rationale
To investigate the effect of type 3 o3 on the translation of a eukaryotic protein 
the experimental rationale outlined in figure 19 was developed. It involves the use 
of two in vitro translation systems: A and B. The strategy was to investigate the 
effect of the translation products synthesised in A on the in vitro translation of 
mRNA in B. In A a comparatively large amount of type 3 a3 was synthesised. As a 
negative control in vitro translation was carried out without the addition of mRNA to 
the system (i.e. endogenous). At the end of the reaction the remaining mRNA and 
tRNA in the system were removed by Mnase treatment so they would not interfere 
with the in vitro translation capacity of system B. Increasing amounts of o3 or 
endogenous from system A were added to system B containing B-actin or S4 mRNA. 
The activity of each reaction in system B was determined by TCA precipitation of 5 
n\ aliquots of each reaction at 15 minute time intervals. Equal volumes of each of 
the reaction mixes were analysed on 10 % polyacrylamide gels.
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FIGURE 19: RATIONALE FOR IN VITRO ASSAY SYSTEM
S Y S TEM  A
S4 mRNA Endogenous
i
Mnase treat o3 Control
S YSTEM  B  Actin
mRNA
+/-o3
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A
ANALYSIS O F  PROTEIN PRODUCTS
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5.4.2 Results
Figure 20 shows that there was a gradual decrease in the extent of -^S-met 
incorporation with addition of increasing amounts of o3 or endogenous from A to the 
translation of 8-actin or S4-3 in in vitro translation B. There was little difference in 
the amount of stimulation of S4-3 translation between the addition of equal volumes 
of <r3 or endogenous samples from A. However a slight decrease in the translation 
of B-actin was observed on the addition of ct3 to B compared to the addition of 
endogenous, suggesting that o3 may have a slight inhibitory effect on B-Actin 
translation.
To further analyse the effects of <r3 on B-actin translation equal volumes of the 
samples from B were fractionated on 10 % polyacrylamide gels. Figure 21 shows 
that o3 from A was being carried through to the second reaction. However, there 
was no obvious difference in the intensity of the B-actin bands produced in those 
where o3 was added when compared to those in which negative control was added. 
This suggested that in this system o3 has no direct effect on B-actin translation.
One possible explanation for the apparent inhibition evident in figure 20, was 
that addition of increasing amounts of A to B might lead to changes in salt 
concentration. To investigate this possibility, following Mnase treatment of A it was 
dialysed overnight against 10 mM Tris pH 7.5 before being added to the second 
translation reactions. Unfortunately both o3 and endogenous reactions derived 
dialysates prevented the synthesis of both o3 and B-actin in the second translation 
assay (data not shown).
5.5 Summary
The rabbit reticulocyte lysate system was used to examine the effect of type 3 
o3 on the translation of cellular and viral mRNA. Full length o3 and B-actin
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A =  Actin mRNA +  o3 from system A 
B =  Actin mRNA + endogenous from system A 
C =  S4-3 mRNA +  o3 from system A 
D =  S4-3 mRNA + endogenous from system A
The effect of type 3 o3 produced in system A on the translation of actin or S4 
mRNA in system B was examined as described in section 3.1.4.1. /n vitro 
translations were carried out as described in Methods.
The results are expressed as the fold increase in stimulation of ^S -m et 
incorporation between 0 and 60 minutes of translation.
FIGURE 20: THE EFFECT OF TYPE 3 a3 ON THE TRANSLATION OF
ACTIN AND S4-3 mRNA.
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FIGURE 21: THE EFFECT OF TYPE 3 »3 ON THE TRANSLATION OF
ACTIN AND S4 mRNA.
Equal volumes of the reactions from system B were analysed on 10 % 
polyacrylamide gels, run at 40 mA for 3 hours and fluorographed as described in 
Methods.
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proteins were produced by the system. However, the in vUm translation assay 
system developed to investigate the effect of type 3 «3 on translation of B-actin 
provided no further insight into how this protein may act in inhibition of host cell 
protein synthesis in infected cells.
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TRANSLATION OF S4 AND B-ACTIN mRNA IN UNINFECTED AND 
INFECTED S-10 L-CELL EXTRACTS.
6.1 Introduction
Cell-free extracts prepared from mock infected and viral infected cells have 
been widely used to study the factors involved in viral control of host protein 
synthesis. For example, Jen and Thach (1982) used lysates prepared from 
encephalomyocarditis virus-infected (EMCV) L-cells to investigate the ability to 
translate capped mRNAs. Many of the experiments used to determine the 
mechanism by which poliovirus inhibits host cell protein synthesis were determined 
by comparison of cellular and viral mRNA translation in extracts prepared from 
poliovirus-infected and uninfected HeLa cells. Skup and Millward (1977) reported 
that mRNA could be efficiently translated in cell-free extracts prepared from mock- 
infected or reovirus infected L-cells. We developed this system to examine the 
ability of cell free extracts prepared from type 1 infected , type 3 infected and 
uninfected L-cells to translate viral and 8-actin mRNA prepared by in vitro 
transcription.
The objective of these experiments was to determine if the different extracts 
varied in their translational potential, that is, do type 3 infected cell extracts translate 
6-actin mRNA with the same efficiency as those from type 1 infected and uninfected 
cells?
6.2 Optimisation of in vitro translation derived from infected and 
uninfected L-cells
6.2.1 Mnase treatment
The amount of endogenous mRNA removed by Mnase treatment and the ability 
of exogenous mRNA to restore the translational ability of the extract was examined 
at Mnase treatments of 5 and 10 minutes.
116
A = Non Mnase treated extract
B = 10 minute Mnase treated extract +  50 ng/pl S4 mRNA 
C = 10 minute Mnase treated extract endogenous.
D =  5 minute Mnase treated extract +  50 ng//zl S4 mRNA 
E = 5 minute Mnase treated extract endogenous
The S-10 cell extracts were treated with Mnase for 5 or 10 minutes as described in 
Methods. In vitro translations were carried out using 50 ng//xl of S4 mRNA, 1 mM 
Mg2+ and 10 mM K+ as described in Methods.
The results are expressed as the total amount of 35S-met incorporated into each 
sample at the 90 minute time point of the reaction.
FIGURE 22: TIME COURSE FOR Mnase TREATMENT OF S-10 CELL
EXTRACTS.
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The results are shown in figure 22. As expected highest incorporation was 
seen in the non Mnase treated samples. Treatment of the extract for 5 minutes with 
Mnase reduced the endogenous activity to approximately one half its original activity 
and Mnase treatment for 10 minutes to one quarter. Despite the fact that the full 
activity of the extract was restored on addition of 50 ng//*l of S4 mRNA to the 5 
minute Mnase treated extract, the actual fold stimulation seen compared to the 
endogenous control was only 1.5. The level of stimulation was slightly greater in 
the extract that had been treated for 10 minutes, even though the original activity 
given by the extract was not fully restored As a result of this experiment 10 minute 
treatment of Mnase was chosen for further studies.
6.2.1.2 K + and Mg2-*- optimisation
The system was optimised for Mg2+  and K+ concentrations (figure 23). The 
optimum concentration of Mg2+  was found to be 0.5 mM and for K+  10 mM.
6.2.1.3 mRNA optimisation
The capacity of the system to translate varying amounts of S4 mRNA was 
investigated using final concentrations of 50 ng//d, 100 ng//xl, 200 ng/¿d and 300 
ng/pl. Analysis on 10 % polyacrylamide gels of the <r3 produced at these different 
levels of mRNA showed that there was no change in the amount synthesised (figure 
24).
Therefore the optimum conditions for translation in S-10 extracts were: Mnase 
treatment of 10 minutes, 0.5 mM Mg2 + , 10 mM K+ and 50 ng/jtl mRNA. These 
conditions were used in subsequent experiments.
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K+ and mRNA concentrations were maintained at 10 mM and 50 ng//xl 
respectively. Mg2 +  titration was over the range from 0.125 to 5 mM.
FIGURE 23a: OPTIMISATION OF S-10 EXTRACTS FOR Mg2 +
FIGURE 23b: OPTIMISATION OF S-10 EXTRACTS FOR K+
Mg2+  and mRNA concentrations were maintained at 0.5 mM and 50 ng//*l 
respectively. K+  titration was over the range 5 mM to 20 mM.
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FIGURE 24: mRNA OPTIMISATION OF S-10 CELL EXTRACTS
A B c D E F G
A = Endogenous control 
B -  50 ng/Ml of S4-3 mRNA 
C = 100 ng/pl of S4-3 mRNA 
D = 200 ng/fil of S4-1 mRNA 
E =  300 ng//<l of S4-1 mRNA 
F = Mock-infected cell lysate 
G =  Type 3 infected cell lysate
Increasing amounts of S4 mRNA were translated as described in Methods. The 
amount of o3 produced was analysed on a 10 % polyacrylamide gel as described in 
Materials and Methods.
6.3 Capacity of each of the extracts to translate viral and cellular mRNA
The ability of the S-10 extracts prepared from uninfected, type 1 and type 3 
infected L-cells to translate mRNA of viral and cellular origin (S4 and B-actin 
respectively) was investigated. The effect of type 1 and 3 <r3 on the translation of 
endogenous mRNA remaining in the extracts after Mnase treatment was also 
examined. In vitro translations were carried out as described in Materials and 
Methods. The activity of each extract was qualitatively analysed on a 10 % 
polyacrylamide gel (figure 25). As can be seen from figure 25 cellular and viral 
mRNAs were translated in extracts prior to Mnase treatment (tracks A-C end - 
Mnase) compared to the endogenous proteins translated in Mnase treated extracts 
(tracks A-B +  Mnase). It is evident that the total translation activity is less in the 
type 3 extracts (track B end -Mnase) than in type 1 infected and uninfected extracts 
(tracks A and C end -Mnase). In fact, the type 3 extract did not even translate 
exogenously added S4 mRNA efficiently (tracks B S4-1 and S4-3). B-actin mRNA 
was not efficiently translated in any of the extracts (tracks A-C ACT). However, 
type 1 and 3 o3 of the predicted size were synthesised in both uninfected and type 1 
infected extracts (tracks A and C S4-1 and S4-3). Expression of type 3 <r3 in either 
of these extracts did not have any effect on the expression of the remaining 
endogenous proteins when compared to the endogenous tracks or those expressing 
type 1 o3.
The presence of the high molecular weight protein products in extracts 
translating S4-3 mRNA was further investigated (figure 25 tracks A-C S4-3). The 
stock of S4-3 DNA which had been used in the previous experiments had been 
linearised with PstI prior to in vitro transcription. Pst I digestion produces a 3’ 
protruding end, which may cause non-specific initiation of RNA transcripts of the 
DNA template resulting in the synthesis of high molecular weight proteins. When
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FIGURE 25: TRANSLATION PRODUCTS SYNTHESISED IN S-10 CELL 
EXTRACTS
A = Mock infected extract 
B =  Type 3 infected extract 
C =  Type 1 infected extract
S-10 In vitro translations were carried out as described in Methods and equal 
volumes of each sample were analysed on a 10 % polyacrylamide gel.
For an explanation of the high molecular weight protein present in the S4-3 tracks 
see figure 26.
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BANDING OF S4-3.
FIGURE 26: IDENTIFICATION OF THE REASON FOR MULTIPLE
A B C  D E  F G  H
A = SA-HBamHI Type 1 extract 
B = S4-1 /BamHI Type 3 extract 
C = S4-31 BamHI Type 1 extract 
D = S4-31 BamHI Type 3 extract 
E = S4-3/PstI Type 1 extract 
F =  S4-3/PstI Type 3 extract 
G =  S4-3/PstI (SI nuclease treated) Type 1 extract 
H =  S4-3/PstI (SI nuclease treated) Type 3 extract
S4-3 DNA was linearised with PstI, BamHI and the 3' protruding end produced by 
PstI digestion was removed by S 1 nuclease as described in Materials and Methods. 
S4-3 mRNA was produced from each of the above DNA templates and o3 
expression analysed in S-10 cell extracts as previously described.
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S4-3 was linearised with BamHI or the 3' PstI end was removed by SI nuclease 
digestion this problem of multiple banding disappeared (figure 26).
6.4 Summary
S-10 extracts prepared from type 1 infected and uninfected L-cells translated 
viral and cellular mRNA with the same capacity. However, extracts prepared from 
type 3 infected cells did not translate viral or cellular mRNA efficiently. Type 3 a3 
did not have any effect on the ability of type 1 infected or uninfected extracts to 
translate endogenous mRNA that had not been removed by Mnase treatment. These 
results further suggested that in vitro <r3 has no effect on the translation of eukaryotic 
mRNAs. The results presented in this chapter did not provide any further insight 
into the different abilities of reovirus types 1 and 3 to inhibit host protein synthesis.
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FIGURE 27: RATIONALE OF IN VIVO 
EXPERIMENTS
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7.1 Rationale
The rationale of the experiments discussed in the following chapters is outlined 
in figure 27.
To investigate the effect of o3 on host cell protein synthesis in vivo, a system 
involving an easily assayable reporter gene as a marker for eukaryotic protein 
synthesis was developed. The rationale of these experiments was to have <r3 under 
the control of an inducible promoter, to allow for the analysis of reporter gene 
expression in the presence or absence of <r3 expression.
That is: does type 3 a3 inhibit reporter gene expression more than type 1 <r3?
7.2 Introduction
The development of an in vivo assay system for monitoring the effect of o3 on 
host protein synthesis required an easily assayable reporter gene to act as a marker 
for host protein synthesis. Several genes have been used as reporters including 
chloramphenicol acetyltransferase (CAT) (Gorman et al., 1982a; 1982b), bacterial 
B-galactosidase (B-gal) (An et at., 1982), and secreted alkaline phosphatase (SEAP) 
(Berger et al., 1988; Yoon et al., 1988). In each case the enzyme activity of the 
reporter can be easily assayed in cell lysates and at least in the case of CAT and B- 
gal background levels are low in eukaryotic cells. The use of an inducible promoter 
to control the level of S4 transcription would allow reporter gene expression to be 
monitored in the presence or absence of o3 expression. To ensure that every cell 
received equal amounts of both genes the S4 gene was initially linked onto the 
plasmid containing the reporter gene.
Several inducible promoter systems are available in eukaryotes including the 
mouse mammary tumour virus promoter which is regulated by steroid hormones (eg 
Lee et al., 1984; Beato, 1989), and the HIV-LTR which is fro/w-activated by the
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HIV tat protein. Sun and Baltimore (1989) used this latter system to investigate the 
role of poliovirus protein 2A in the inhibition of host protein synthesis. They found 
that in co-transfection experiments performed in HeLa cells, CAT reporter gene 
expression was inhibited when protein 2A was activated by tat induction of the HIV- 
LTR, thus suggesting protein 2A has a role in regulating the inhibition of host 
protein synthesis.
7.2.1 Regulation of the HIV-LTR
The HIV-LTR operates as a promoter in a variety of animal and human cell 
lines. This has been largely determined by using the CAT gene linked to the HIV- 
LTR, as a reporter gene for HIV driven gene expression (eg Sodoroski et al., 1984). 
Initiation of transcription from the LTR relies on certain binding sites for cellular 
and viral transcription factors in the LTR. Transcription of the LTR is stimulated 
following transactivation by the tat protein. In HIV-infected cells the HIV-LTR 
initially produces basal rates of early mRNA, due to the binding of host transcription 
factors to the LTR. However, one of the early mRNAs produced is that for tat, and 
as levels of this protein increase, transcription from the LTR is stimulated by a 
rro/u-activation mechanism. In cells transfected with genes driven by the HIV-LTR 
this frany-activation can be mediated by co-transfection with a plasmid containing the 
tat gene under the control of a constitutive eukaryotic promoter (e.g Rosen et al., 
1986a). The tat protein is a 86 amino acid protein encoded by a mRNA produced by 
double splicing of the full length RNA (Muesing et al., 1985). It acts by binding at 
the Transactivation Region or TAR sequence, located at the transcription start site, 
(bases +  1 - +  79). The TAR sequence forms a stem loop structure essential for tat 
induction of the HIV-LTR (Muesing, 1987).
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The inducible transcription system described above met the requirements of the 
proposed experiments and was developed as an in vivo assay system to study the 
effect a3 has on cellular protein synthesis.
7.3 Construction of reporter plasmids containing the S4 gene
The S4 gene(s) was first subcloned into a plasmid containing the HIV-LTR. 
The plasmid used, HXBH2, was obtained from C.Chapman (Chester Beatty Labs, 
London). It contained the HIV-LTR (550 bp) including the TAR sequence cloned 
into the polylinker o f pUC18. The S4 gene was readily inserted downstream of the 
promoter as illustrated in figure 28. Clones containing the S4 inserts were identified 
by mini-plasmid preparation and restriction enzyme analysis and were termed HX-1 
and HX-3 (figure 29).
Reovirus mRNA is not normally polyadenylated. However, to ensure correct 
processing and transport of mRNA within the transfected cells a poly A signal was 
added to the 3' end of the S4 gene(s). For this a vector (pSPPA4) (obtained from 
K.Leppard, 1990) containing the SV40 small T antigen splice signals upstream of the 
adenovirus E lb  poly A signal (size 350 bp), present in the polylinker of the cloning 
vector Bluescribe (figure 30), was used. To do this the HIV-S4 insert(s) in the HX 
plasmid(s) was isolated and inserted upstream of the poly A signal in pSPPA4 as 
outlined in figure 30. Full length clones were detected by Kpnl/Hincll digestion 
and referred to as HPA-1 for S4-1 inserts and HPA-3 for S4-3 inserts (figure 31). 
The presence o f a T7 promoter in the final plasmid upstream of the S4 gene allowed 
in vitro transcription-translation analysis to be used to determine that full length o3 
was still produced, despite the addition of the promoter and poly A tail. Figure 32 
shows that the final plasmids, HPA-1 and HPA-3, generate mRNA that encodes full 
length o3.
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FIGURE 28: CONSTRUCTION OF HIV-LTR-S4 CONTAINING SUBCLONES:- 
HX-1 AND HX-3.
The plasmid HXBH2 containing the HIV-LTR (550bp) in the polylinker of pUC18, 
was digested with Hindlll/BamHl and the 5' phosphate group was removed as 
described in Methods. The S4 gene(s) was removed from the S4BS clones (section 
4) by HindllllBamHI digestion and the fragment(s) isolated from a 1 % agarose gel 
as described in Methods. The vector and insert were ligated and transformed into 
JM103. Plasmids containing the S4 gene(s) downstream of the HIV-LTR were 
screened for by mini-plasmid preparations and restriction enzyme analysis (figure 
29).
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FIGURE 29: IDENTIFICATION OF HX-I AND HX-3 SUBCLONES.
M = BRL 1 KB LADDER 
A = HX-1 
B =  HX-3
Plasmids HX-1 and HX-3 were analysed on 1 % agarose gels. Full length HX-1 
and HX-3 of 1.75 Kb were identified by ECoRl digestion. Hindlll/BamHl 
digestion released full length S4 genes and Hindlll/Pstl digestion distinguished 
between HX-1 and HX-3, releasing 0.48 Kb and 0.7 Kb pieces from HX-1 and a 
full length 1.2 Kb insert from HX-3.
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FIGURE 30: CONSTRUCTION OF HTV-LTR-S4-POLY A CONTAINING 
SUBCLONES: HPA-1 AND HPA-3.
The plasmid pSPPA4 was digested with E coRI/Smal and the 5' phosphate group 
was removed as described in Methods. Full length (1.75 Kb) inserts of HX-1 and 
HX-3 were isolated on 1 % agarose gels following EcoRl/Smal digestion. The 
vector and insert were ligated and transformed into JM103 as described in Methods. 
Plasmids containing the S4 gene(s) upstream of the poly A signal were identified by 
mini-plasmid preparations and restriction enzyme analysis (figure 31).
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FIGURE 31: IDENTIFICATION OF HPA-1 AND HPA-3
M = BRL 1KB LADDER 
Al =  HPA-3 (undigested)
A2 =  HPA-3 
B1 =  HPA-1 
B2 =  HPA-1
HPA-1 and HPA-3 inserts were analysed on 1 % agarose gels. Full length inserts 
were identified by KpnI/HincII digestion, which also distinguished between the two 
genes.
For HPA-1 two insert containing bands were released, one of 1.43 Kb and one of
0.7 Kb. For HPA-3, three insert containing bands of 0.98 Kb, 0.4 Kb and 0.7 Kb 
were released.
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FIGURE 32: ANALYSIS OF PROTEIN PRODUCTS PRODUCED FROM HPA- 
1 AND HPA-3 .
A =  8-actin from T7-6-ACT (section 4.4)
B =  o3 type 1 from original S4-1BS (section 4.3)
C = o3 type 1 from HPA-1 
D =  <r3 type 3 from original S4-3BS (section 4.3)
E =  a3 type 3 from HPA-3
F =  Marker: pulse labelled reovirus type 3 infected cell lysate
The relevant DNA was linearised by either BamHI (S4-1 and S4-3 BS clones), XBal 
(HPA-1 and HPA-3) or HindiII (T7-ACT) digestion. mRNA was synthesised in 
vitro using T7 RNA polymerase as described in Methods and in section 4.4. In 
vitro translation analysis, in reticulocyte lysates, was carried out as described in 
Methods. The protein products were analysed on a 10 % polyacrylamide gel, run 
for 3 hours at 40 mA. The position of full length o3 is indicated on the right side 
of the figure.
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7.3.1 Insertion of HPA-1 and HPA-3 into a plasmid containing the CAT 
reporter gene
A plasmid with the CAT gene under the control of the cytomegalovirus 
immediate early promoter (CMV) was used to link the S4 gene(s) and CAT gene 
onto the same plasmid. CMV-CAT is based on the pSV2-CAT plasmid range 
developed by Gorman et al. (1982). The ideal restriction enzyme site for insertion 
of the HPA gene(s) into pCMV-CAT had to meet several requirements:
1. It had to be unique in pCMV-CAT
2. It had not to interfere with CAT gene expression
3. It had not to interfere with the plasmid origin of replication
4. It had not to interfere with the plasmid ampicillin resistance.
The only restriction enzyme site which met these requirements was BamHI, 
located within the SV40 splicing signal region. The HPA gene(s) were ligated into 
the plasmid as outlined in figure 33. 200 colonies of the resulting transformation 
were picked and were screened for S4 DNA by hybridisation using a nick translated 
S4-DNA probe, prepared as described in Methods. Figure 34 shows the results of a 
typical screening procedure to identify S4-3 containing colonies. Several of the 
colonies hybridising with the S4 probe were picked and further screened for inserts 
by mini-plasmid preparations and restriction enzyme analysis. Figure 35 shows the 
restriction enzyme analysis used to identify S4-1 and S4-3 inserts. These plasmids 
were termed CMV-1 and CMV-3 respectively.
7.4 Analysis of CAT activity from reporter gene constructs
To do this, plasmid DNA was first transfected into cells using either 
electroporation or calcium phosphate transfection. Following incubation at 37°C for 
48 hours cells were extracted and reporter gene expression assayed as described in
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FIGURE 33: CONSTRUCTION OF PLASMIDS CONTAINING THE CAT 
REPORTER GENE LINKED TO THE S4 GENE.
pCMV-CAT was digested with BamHI, and treated with Klenow 1 polymerase to 
produce blunt ends prior to removal of the 5' phosphate group as described in 
Methods.
The HPA insert(s) (2.1 Kb) was isolated on a 1 % agarose gel following 
ECoRliXBal digestion and treatment with Klenow 1 polymerase to produce blunt 
ends. Vector and insert were ligated and transformed into MC1061 and colonies 
containing CAT and S4 genes were identified by Grunstein hybridisation followed 
by mini-plasmid preparations and restriction enzyme analysis (figures 34 and 35).
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FIGURE 34: GRUNSTEIN HYBRIDISATION TO IDENTIFY S4 CONTAINING 
COLONIES.
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200 colonies were picked from the transformed plates (figure 33) were screened for 
the S4 gene using a nick translated S4 DNA probe prepared as described in 
Methods. The colonies were hybridised as described in Methods. HPA-3 was used 
for a positive control for the hybridisation (bottom row of photograph). 15 
potential positive colonies were picked and further screened for the S4 insert by 
mini-plasmid preparations and restriction enzyme analysis (figure 35).
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FIGURE 35: IDENTIFICATION OF S4 INSERTS IN CMV-CAT: CMV-1 AND 
CMV-3
A -  CMV-1 
B -  CMV-3 
C *  CMV-CAT 
M =  1 KB BRL LADDER
Potential CMV-1 and CMV-3 clones were analysed on a 1 % agarose gel. S4 
inserts were identified by Seal and H indi digestion, which determined the 
orientation of the inserts and distinguished between the two genes. The final 
orientations of the clones were different as is shown in figures A and B.
A. Orientation of CMV-1
H i n d i Sc a I
H i n d i
Seal
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B: Orientation of CMV-3
Methods. A plasmid containing the HIV-LTR driving CAT gene expression was 
used as a  positive control for induction of the HIV-LTR by tat. In this control 
transfection tat was expressed under the control of the SV40 early promoter (termed 
TAT). Reactions were carried out in triplicate as described in Methods.
7.4.1 Optimisation of electroporation voltage
To determine the optimum voltage for electroporation, L-cells were 
electroporated with 10 ng of CMV-CAT DNA at 250, 500, 750 or 1000 Volts. The 
survival of the cells was determined by observing cell monolayers over the 
incubation period. When the cells were electroporated at 500 Volts there was 
approximately 35 % cell mortality. When the voltage was increased to more than 
750 Volts the cell mortality was 70 % or greater. The relative CAT activity at each 
voltage value was assayed and maximum CAT activity was found in cells 
electroporated at 500 Volts (data not shown).
7.4.2. CAT activity in L<ells
To analyse CAT activity from reporter gene constructs the cells were 
electroporated at 500 Volts with a total of 20 /xg of DNA (10 ng of CAT-S4 
containing DNA and 10 ng of TAT or Bluescribe to keep the DNA input constant). 
Figure 36 shows that there is no difference in the relative CAT activities in the 
clones containing S4-3 in the presence or absence of TAT. This indicated that the 
insertion of S4 DNA into CMV-CAT did not disrupt CAT gene expression. In the 
control experiment, using co-transfection of HIV-CAT and TAT DNA, the expected 
increase in CAT activity was not seen. This suggested that the promoter might be 
non-functional in L-cells.
Rosen et al. (1986b) and Newstein et al. (1990) reported that the HIV-LTR 
system was non-functional in certain cell lines, particularly those of non-primate
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FIGURE 36: CAT ACTIVITY FROM CMV-CAT-S4 CONTAINING PLASMIDS
IN L-CELLS.
L-cells were transfected with 10 ng of CMV-CAT or CMV-3 and 10 ng of TAT or 
Bluescribe DNA, as a negative control for TAT activity. The plasmid, HIV-CAT, 
was used as a  positive control for TAT induction of the HIV-LTR. CAT activity is 
expressed in cpm taken at the 120 minute time point of the reaction.
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origin. To investigate this in our system, a comparative study of HIV-LTR/TAT 
activity in L-cells and HeLa cells, a cell line where the HIV promoter is known to 
function (Cullen, 1986; Sun & Baltimore, 1989), was undertaken. For these 
experiments and all following experiments, cells were transfected using the calcium 
phosphate technique as it was found to produce more consistent results than 
electroporation. Figure 37 shows that TAT induction of HIV promoter activity was 
20 fold in HeLa cells, whereas there was again no significant induction of CAT 
activity in L-cells, suggesting that they lack factors, possibly transcription factors, 
necessary for the HIV promoter to function.
7.4.3 Optimisation of TAT induction in HeLa cells
Several workers (Hauber and Cullen, 1989; Fenrick et a l., 1989) have 
reported that the level of TAT induction of the HIV-LTR is affected by the ratios of 
HIV-LTR DNA : TAT DNA used for transfection. To investigate this, HeLa cells 
were transfected with 10 /xg HIV-CAT and increasing amounts of TAT DNA from 
0.5 /xg to 15 /xg. Figure 38 shows that TAT induction reaches an optimum level at 
10 /xg of HIV-CAT and 4 /xg of TAT DNA, resulting in greater than 50 fold 
stimulation of CAT activity.
7.4.4 The effect of a3 on CAT gene expression in HeLa cells
To analyse the effect of o3 on CAT gene expression, HeLa cells were co­
transfected at the optimal HIV-LTR : TAT ratios obtained in the previous section. 
The CAT activity from CMV-1 and CMV-3 in the presence and absence of TAT was 
studied. Figure 39 shows that there was no significant difference in the expression 
from various CAT constructs suggesting o3 had no effect on CAT gene expression 
or alternatively that o3 was not being efficiently expressed.
1 4 1
FIGURE 37: COMPARISON OF TAT INDUCTION OF THE HIV-LTR IN  HeLa 
CELLS AND L-CELLS
A = L-cells 
B = HeLa cells
L-cells and HeLa cells were transfected with 10 ng of HIV-CAT and 10 /zg of TAT 
DNA. The results show the progressive increase in CAT activity (cpm) throughout 
the reaction. There was no significant stimulation of CAT activity in L-cells. By 
contrast, in HeLa cells there was a 20 fold increase in CAT activity in the presence 
of TAT.
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FIGURE 38: OPTIMISATION OF TAT INDUCTION IN HeLa CELLS.
HeLa cells were co-transfected with 10 ng of HIV-CAT and 0 - 10 /xg of TAT 
DNA as described in Methods. The cells were harvested and extracts prepared for 
assaying CAT activity as described in Methods. The results are expressed as the 
fold stimulation of CAT activity over samples where no TAT was added.
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HeLa cells were co-transfected with 10 ng CMV-1, CMV-3 or CMV-CAT and 4 ng 
of TAT DNA. The cells were harvested and extracts prepared to assay CAT 
activity as described in Methods. The results were expressed as the CAT activity 
(cpm) at 120 minutes into the reaction.
FIGURE 39: CAT ACTIVITY FROM CMV-CAT-S4 CONTAINING PLASMIDS
IN HeLa CELLS.
14 4

7.5 Detection of o3 in transfected cells
To confirm if o3 was being expressed in the experiments described in section 
7.3, polyclonal antibody against reovirus type 3 was raised in a New Zealand white 
rabbit as described in Methods. This would allow for detection of o3 in transfected 
cells by immunoprécipitation or immunofluorescence.
Before the serum was used to detect a3 expression in transfected cells its 
activity against type 3 and type 1 infected cells was investigated. Figure 40 shows 
that the serum was active against type 3 and type 1 virus.
To confirm that o3 was being produced during the reactions discussed in 
section 7.3.5, plates of CMV-1 and CMV-3 (section 7.2.2) transfected cells were 
labelled with 35S-met 48 hours post transfection and extracts were 
immunoprecipitated as described in Methods. However no o3 was detected in these 
samples, suggesting that o3 was only being made at very low levels by the CMV-1 
and CMV-3 CAT reporter plasmids.
The original HPA-1 and HPA-3 clones (section 7.2.1) from which the CMV 
constructs were derived had been shown to translate o3 in vitro (figure 32). These 
clones were transfected into HeLa cells in the presence or absence of optimal TAT 
concentrations and their ability to synthesise o3 in vivo was studied by 
immunoprécipitation and immunofluorescence. Again no o3 was detected. Two 
questions therefore arose:
1. Was the S4 gene functional in vivo?
2. Was the HIV promoter functional?
14 5
A =  Reovirus type 1 infected cells +  hyperimmune serum (phase/fluorescence)
B =  Reovirus type 3 infected cells +  hyperimmune serum (phase/fluorescence)
C =  Reovirus type 3 infected cells +  hyperimmune serum (fluorescence viewed 
under high magnification)
Monolayers of L-cells were infected with 0.1 pfu/cell or 0.5 pfu/cell of reovirus 
type 3 or reovirus type 1. Control cells were mock-infected. 18 hours post 
infection the cells were fixed and treated with polyclonal antibody to reovirus type 3 
as described in Methods.
It is also clearly evident from these photographs that reovirus grows solely in the 
cytoplasm of the cells.
FIGURE 40: DETECTION OF REOVIRUS TYPE 3 INFECTED CELLS BY
IMMUNOFLUORESCENCE.
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One possible reason for the lack of detection of o3 expression in the HPA-1, 
HPA-3 and CMV-1 and CMV-3 plasmids was that not enough o3 was being 
expressed to be detected or to have any effect on CAT gene expression.
COS-1 cells are a transformed monkey cell line expressing the SV40 T 
antigen, and they are therefore able to replicate introduced plasmids containing the 
SV40 origin of replication (Gluzman, 1981). Banjeri (1981) observed that the 
expression o f B-globin in transfected cells was enhanced in the presence of the SV40 
enhancer element.
To ascertain if the S4 gene was functionally expressed in vivo it was inserted 
into the polylinker region of pEXP6 (obtained from K.Leppard, 1990). This vector 
has the SV40 origin, promoter and SV40 poly A tail flanking either end of the 
standard polylinker. The S4 gene from the initial S4-pAT153 clone (figure 12, 
chapter 4) was inserted downstream of the SV40 promoter (figure 41), generating 
two individual subclones which were termed SV40-1 (containing S4-1) and SV40-3 
(containing S4-3) (figure 42). These constructs were transfected into COS-1 cells, to 
allow for replication of the plasmid and o3 synthesis was analysed by 
immunoprecipitation (figure 43). Figure 43 shows that both S4-1 and S4-3 genes 
were functional in vivo when expressed from the SV40 promoter. A strong o3 band 
was precipitated from SV40-3 transfected cells but only a very faint signal was 
produced from SV40-1 transfected cells.
To investigate if the reason for lack of detection of expression from the HIV- 
84 containing plasmids was due to insufficient o3 being expressed, the SV40 origin 
was inserted into the HIV-S4 containing plasmids. The SV40 origin was available in 
a plasmid termed pSVEl (obtained from K.Leppard, 1990) and could be isolated as 
a 350 bp piece. There was no suitable enzyme site available in CMV-1 or CMV-3 
for insertion of the SV40 origin. Therefore it was inserted downstream of the poly 
A signal in the HPA clones at the Sail site, a unique site located in the polylinker
7.5.1 Development of a o3 expressing system
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The plasmid pEXP6 contained the SV40 origin, early promoter and poly adénylation 
signals flanking either end of the M 13 polylinker. This was digested with Hindlll 
(immediately downstream of the promoter) and BamHl. The 5' phosphate group 
was removed as described in Methods. The S4 gene was released from pAT153 by 
Hindlll/BamHI (figure 12) and the insert isolated from a 1 % agarose gel as 
described in Methods. The vector and insert mixture were ligated and transformed 
into MC1061. Colonies containing the plasmid were screened for by mini-plasmid 
preparations and restriction enzyme analysis (figure 42).
FIGURE 41: CONSTRUCTION OF PLASMIDS CONTAINING THE SV40
PROMOTER TO DRIVE S4 GENE EXPRESSION.
KEY
1 \ \~ 1  SV40 PROMOTER
POLY A SIGNAL
148
BamHI
Hindlll
Hindlll/BamHI 
digestion
LIGATE
TRANSFORM
Hindlll BamHI
SV40-1
M -  1 Kb BRL ladder 
A =  SV40-1 
B =  SV40-3
SV40-1 and SV40-3 subclones were analysed on 1 % agarose gels. Full length 
inserts were identified by Hindlll/Pstl digestion as described in Methods.
SV40-1 results in 2 bands released from the S4 insert, one of 0.48 Kb and another 
of 0.7 Kb. SV40-3 results in the release of full length S4 gene.
FIGURE 42: IDENTIFICATION OF SV40-S4 CONTAINING PLASMIDS.
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FIGURE 43: DETECTION OF o3 IN TRANSFECTED COS-1 CELLS BY
IMMUNOPRECIPITATION.
A =  SV40-1 +  Hyperimmune serum 
B = SV40-1 +  Preimmune serum 
C =  SV40-3 +  Preimmune serum 
D =  SV40-3 +  Hyperimmune serum 
E = HPA-1 +  TAT +  Hyperimmune serum 
F =  HPA-1 +  TAT +  Preimmune serum 
G =  HPA-3 +  TAT +  Hyperimmune serum 
H = HPA-3 +  TAT +  Preimmune serum
I =  Pulse labelled reovirus type 3 infected cell lysate +  Hyperimmune serum 
J = Pulse labelled reovirus type 3 infected cell lysate +  Preimmune serum 
K = Pulse labelled reovirus type 3 infected cell lysate
COS-1 cells were transfected with 10 ng of the relevant DNA and labelled 48 
hours post transfection with -^S-met, harvested and immunoprecipitated as 
described in Methods. As a positive control pulse labelled reovirus type 3 infected 
cells were immunoprecipitated. The precipitated proteins were fractionated on a 10 
% polyacrylamide gel, electrophoresed for 3 hours at 40 mA and fluorographed.
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(figure 44). These subclones were identified by mini-plasmid preparations and 
restriction enzyme analysis and were termed HIV-1 and HIV-3 (figure 45).
To obtain maximum expression from these constructs they were expressed in 
COS-1 cells. COS-1 cells were first optimised for TAT induction of the HIV-LTR, 
in case the optimal level differed from that found for HeLa cells. Figure 46(a) 
shows that optimal activity was a 10:1 ratio of HIV:TAT DNA and that induction of 
the HIV-LTR in COS-1 cells was greater than in HeLa cells (compare with figure 
38). The relative CAT activity produced was also greater in COS-1 cells than in 
HeLa cells (figure 46(b)).
The HIV constructs and optimal TAT concentrations were co-transfected into 
COS-1 cells and o3 expression analysed 48 hours post transfection by 
immunofluorescence as described in Methods. Figure 47 shows that type 3 o3 was 
detected in cells co-transfected with HIV-3 and TAT and to a lesser extent in cells 
transfected with HIV-3 in the absence of TAT. By contrast type 1 o3 was not 
detected by immunofluorescence.
7.5.2 Summary
Expression of o3 was detected in transfected cells by inserting the SV40 origin 
of replication into the initial HPA plasmids produced in section 7.2. The SV40 
origin increases the copy number of the plasmid in the cell hence producing more 
protein. However o3 was also detected in cells transfected in the absence o f TAT. 
A recent report by Proudfoot et al. (1990) has shown that transcription from the 
HIV-LTR in plasmids containing the SV40 origin of replication occurs without TAT 
induction, suggesting that expression from the HIV-LTR can be activated by plasmid 
replication. This may be the reason for the observations obtained in these 
experiments.
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The SV40 origin (350 bp) was isolated from plasmid pSVEl by E  coRl/Hindlll 
digestion and treated with Klenow 1 polymerase to produce blunt ends. The vector 
HPA-1 or HPA-3 was digested with Sail, treated with Klenow 1 polymerase and the 
5' phosphate group removed as described in Methods. The SV40 origin insert was 
isolated from a 1.5 % agarose gel as described in Methods. Vector and insert were 
ligated and transformed into MC1061. Colonies containing the insert were analysed 
by mini-plasmid preparations and restriction enzyme analysis (figure 45). These 
were termed HTV-1 and HIV-3.
FIGURE 44: ADDITION OF THE SV40 ORIGIN OF REPLICATION TO HIV-
S4-POLY A CONSTRUCTS.
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HIV-1 and HIV-3 subclones were analysed on 1.5 % agarose gels. Full length 
subclones were identified by Hindi 11 digestion. Those samples containing the insert 
released a fragment of 1.85 Kb (tracks E and I) and those with no insert released a 
fragment of 1.55 Kb.
FIGURE 45: IDENTIFICATION OF HIV-1 AND HIV-3 SUBCLONES
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FIGURE 46a: OPTIMISATION OF TAT INDUCTION OF THE HIV-LTR IN 
COS-1 CELLS.
COS-1 cells were transfected with 10 ng of HIV-CAT and 0 - 1 0  ng of TAT. 
The cells were harvested and CAT activity monitored as described in Methods. The 
results were expressed as the relative increase in CAT activity over HIV-CAT 
activity in the absence of TAT, which is taken as 1.
FIGURE 46b: COMPARISON OF EXPRESSION FROM THE HIV-LTR IN 
HeLa AND COS-1 CELLS.
The activity from the HIV-LTR expressed in COS-1 cells and HeLa cells was 
compared in parallel reactions.
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FIGURE 47: DETECTION OF <r3 EXPRESSION IN TRANSFECTED CELLS 
BY IMMUNOFLUORESCENCE
A =  HIV-3 +  TAT (Phase/fluorescence)
B «  HIV-3 +  TAT (Fluorescence)
C *  HIV-3 - TAT (Fluorescence)
D =  HIV-1 + TAT (Fluorescence)
COS-1 cells were transfected with the relevant DNA and the cells were fixed and 
prepared for immunofluorescence as described in Methods. a i  type 3 was detected 
by immunofluorescence in cells transfected with HTV-3 in the presence or absence 
of TAT. It was also detected in cells transfected with SV40-3. However a i  type 1 
was not detected from the HIV-1 or SV40-1 constructs.
Magnification x 100
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The fact that ®3 type 1 was not detected suggested that either it is not as 
efficiently expressed as ®3 type 3 or that the reovirus type 3 polyclonal antibody 
used in these experiments was not active against this protein. In the following 
experiments the latter was assumed to be true.
7.6 The effect of ®3 on CAT gene expression in COS-1 cells
COS-1 cells were co-transfected with HIV-1 or HIV-3 DNA and CMV-CAT in 
the presence or absence of TAT DNA. To ensure that all the cells expressing CAT 
also expressed ®3, a DNA ratio of 10 Mg of S4 DNA to 1 Mg o f reporter gene DNA 
was used. To analyse ®3 expression, cells were also prepared for 
immunofluorescence. Figure 48 shows that there was no significant difference in 
CAT activity in any of the samples despite ®3 type 3 being detected by 
immunofluorescence.
7.6.1 Summary
Despite ®3 from type 3 virus being expressed in COS-1 cells, the protein had 
no effect on CAT gene expression in this system. There could be several reasons for 
this. First ®3 may not inhibit host protein synthesis on its own but may require some 
other viral factors. Another possibility is that insufficient o3 was being produced to 
have any effect on CAT gene expression.
7.7. CMV-CAT gene expression in reovirus infected cells
To ascertain if the reason for the lack of inhibition of CAT gene expression 
produced by ®3 was due to it requiring other viral factors, the effect of type 1, type 
2 and type 3 virus on CAT gene expression was studied.
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FIGURE 48: THE EFFECT OF o3 ON CAT GENE EXPRESSION IN COS-1 
CELLS
COS-1 cells were co-transfected with 10 ng of H1V-S4 containing DNA, 1 ng of 
CMV-CAT and 1 ng of TAT. HPA-3 was used as a negative control. The cells 
were harvested and cell extracts analysed for CAT gene expression as described in 
Methods.
The results are expressed as the CAT activity at the 120 minute time point o f the 
reaction.
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These experiments involved infecting the cells with 5 pfu/cell of type 1, type 2 
or type 3 virus. Control cells were mock-infected. The cells were infected 8 hours 
prior to transfection of CMV-CAT DNA to allow viral protein synthesis to begin. 
One set of samples was pulse labelled to ensure viral protein synthesis was 
occurring. The transfected cells were harvested and CAT activity was analysed as 
previously described. The results are shown in figure 49. Under the conditions of 
the experiment infection of L-cells with reovirus type 1, 2 or 3 did not cause 
inhibition of CAT protein synthesis. Viral protein synthesis was occurring in each 
of the sets of transfected cells as is shown in figure 50.
7.7.1 Summary
The results from this experiment suggest that the CAT gene may not, after all, 
be a suitable reporter plasmid for studying the mechanism of host shut-off by 
reovirus.
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FIGURE 49: THE EFFECT OF REOVIRUS TYPE 1, TYPE 2 AND TYPE 3 ON 
CAT GENE EXPRESSION.
L-cells were infected with 5 pfu/cell of reovirus type 1, 2 or 3 eight hours prior to 
transfection with 10 ng of CMV-CAT. Mock infected cells were used as a control. 
The cells were harvested at 24 hours post transfection and CAT activity assayed as 
described in Methods. The results were expressed as the total increase in CAT 
activity from time point 0 to the end of the reaction.
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FIGURE 50: VIRAL PROTEIN SYNTHESIS IN CELLS TRANSFECTED WITH 
CMV-CAT
In a parallel set of reactions to those described in figure 49 the cells were pulse 
labelled with ^5S-met as described in Methods. The proteins were fractionated on a 
5-11 % gradient polyacrylamide gel to allow for complete resolution of the viral 
proteins.
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8.1 Introduction
The results obtained in the previous chapter suggested that <r3 had no effect 
on CA T gene expression. To investigate if this phenomenon was true for other 
reporter genes the effect of ct3 on the E.Coli LacZ reporter gene system, which 
encodes the enzyme 8-galactosidase (6-gal), was examined. This gene system 
was initially used in studies of bacterial gene regulation (Casadaban e t al., 1980) 
as enzyme activity can be simply measured by a spectrophotometric assay. Hall 
et al. (1983) produced a system in which the LacZ gene was fused to the early 
promoter of SV40, which facilitated its use in transient expression systems to 
measure 6-gal activity in transfected mammalian cells. This system has been 
successfully used as a reporter gene in a variety of mammalian systems, for 
example; it was used as a marker in the study of rous sarcoma virus (RSV) 
expression and replication (Norton and Coffin, 1985).
8.2 The effect of o3 on 6-gal gene expression
The basic rationale of the experiments looking at the effect o f  o3 on 8-gal 
activity follows that used in assaying CAT activity, that is, a DNA ratio of 10 /xg 
of <r3 expressing DNA: 1 ng of reporter gene DNA : 1 ng o f TAT DNA was 
used. The control for the level of TAT induction of the HIV-LTR was a plasmid 
containing the LacZ gene under the control of the HIV promoter. The reporter 
plasmid, pCHllO (obtained from A.Easton, 1990), containing the LacZ gene 
under the control of the early SV40 promoter was used as a positive control.
8.2.1 Results
Figure 51 shows that in cells expressing type 3 o3 a 5-7 fold increase in 8- 
gal activity was obtained, rather than the decrease expected if 8-gal was acting as 
a reporter gene for the inhibition of host cell protein synthesis by type 3 o3. In
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FIGURE 51: THE EFFECT OF *3 ON B-GALACTOSIDASE ACTIVITY.
COS-1 cells were co-transfected with either 10 ng of SV40-S4 constructs (illustrated 
in figure 41, chapter 7) or 10 ng of HIV-1 or HIV-3 (illustrated in figure 44, 
chapter 7) and 1 ng o f  TAT or Bluescribe. In all cases 1 ng  of pCHllO LacZ 
reporter gene was co-transfected as described in Methods. The cells were harvested 
48 hours post transfection and extracts were assayed for B-gal activity as described 
in Methods. The results are expressed as the stimulation of B-gal activity over the 
activity found in cells co-transfected with HPA-3 (containing the HIV-LTR, S4 and 
Poly A  tail) / pCHllO control which was taken as 1.
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contrast there was no alteration in 8-gal expression in cells co-transfected with 
DNA able to express type 1 <r3.
8.3 The effect of o3 on CAT gene expression from different CAT 
reporter genes
8.3.1 Introduction
It was surprising to find that <j3 had different effects on the two reporter 
gene systems. A major difference between the two reporter systems was that 
expression of the LacZ  gene was under the control of the SV40 promoter 
whereas CAT gene expression was under the control of the immediate early 
promoter of CMV. To investigate whether the effect of o3 on reporter gene 
expression was promoter dependent, a variety of plasmids with the CAT gene 
under the control o f the following constitutive promoters were examined:
1. Thymidine Kinase (TK) promoter of HSV
2. CMV promoter
3. Rous sarcoma virus (RSV) promoter
4. SV40 early promoter
The control plasmid in this experiment was the original pEXP6 plasmid 
from which the SV40-1 and SV40-3 plasmids had been derived (figure 42). 
COS-1 cells were co-transfected with 10 /tg SV40-1, SV40-3 or pEXP6 and 1 ng 
of the relevant CAT plasmid.
8.3.2 Results
The results from this experiment are shown in figure 52. For each of the 
CAT reporter plasmids used there is little difference in the CAT activity 
produced from cells transfected with control DNA and SV40-1 DNA. However, 
for cells transfected with SV40-3, there is a marked stimulation in CAT activity
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FIGURE 52: THE EFFECT OF a3 ON REPORTER GENE EXPRESSION.
COS-1 cells were CO-transfected with 10 /xg of SV40-1 (column A), SV40-3 
(column B) or pEXP6 (column C) and 1 /xg of the various CAT plasmids in which 
CAT expression was under the control of the following promoters:
TK-CAT: Thymidine kinase promoter from HSV 
CMV-CAT: Immediate early promoter from cytomegalovirus 
RSV-CAT: Long terminal repeat of rous sarcoma virus 
PSV2CAT: SV40 early promoter
CAT activity from the cell extracts was analysed as described in Methods. The 
results are expressed as the difference in CAT activity compared to that found in 
cells transfected with pEXP6 and the relevant CAT plasmid as a control, which is 
taken as 1.
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in all but CMV-CAT transfected cells. The increase is greatest in pSV^CAT 
transfected cells (4 fold). Comparison of the relative CAT activity from each 
promoter is shown in figure 53. The relative CAT activity from the CMV-CAT 
promoter is at least 10 times greater than that from the other promoters.
When the effect of o3 on SV40-LocZ (pCHllO) and SV40-CAT 
(PSV2CAT) was compared the amount of stimulation of expression of both 
reporter genes produced by type 3 o3 was comparable (figure 54).
8.4 Summary
The results presented in this chapter show that type 3 o3 stimulated reporter 
gene expression but type 1 o3 had no effect on either 8-gal or CAT gene 
expression. This stimulation appears to be promoter specific. Type 3 o3 had no 
effect on CAT gene expression when it was under the control of the CMV 
promoter. However, when CAT gene expression was driven by SV40 or RSV 
promoters type 3 o3 caused a significant stimulation of expression. When the 
relative CAT activity from the various promoters was compared, the activity 
from the CMV promoter was found to be at least 10 times greater than that of the 
other promoters. One possible explanation for the failure of o3 to stimulate 
CMV-CAT gene expression is that the CAT activity produced from the CMV 
promoter was too great for a3 synthesised from either SV40 or HIV promoters to 
have any effect on it.
1 6 6
FIGURE 53: RELATIVE CAT ACTIVITY FROM VARIOUS CAT
PROMOTERS
The CAT activity (cpm) o f the different promoters described in figure 52 were 
compared. The results are expressed as the relative CAT activity at the 90 minute 
time point of the reaction.
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FIGURE 54: THE EFFECT OF a3 ON LACL AND CAT GENE EXPRESSION
COS-1 cells were co-transfected with 10 ng of SV40-1 (column A), SV40-3 
(column B) or pEXP6 (column C) and with 1 ng of either pSV2CAT or 1 ng 
pS \2 Lacz- Reporter gene expression was assayed as described in Methods. The 
results are expressed as the stimulation o f  reporter gene expression over that found 
in cells co-transfected with pEXP6 and the relevant reporter gene as a control, 
which is taken as 1.
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CHAPTER 9
THE CONSTRUCTION OF S4 HYBRIDS AND THEIR EFFECT ON 
REPORTER GENE EXPRESSION
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9.1 Introduction
The work discussed in the previous chapters presented evidence to suggest 
that the effect of the two o3 proteins on reporter gene expression differed. 
Considering the high homologies of the two proteins (Atwater et al., 1986) it 
was also surprising to note that type 1 o3 was not detected by 
immunofluorescence (figure 47, chapter 7), and in only very small amounts by 
immunoprécipitation (figure 43, chapter 7). Previous evidence based on in vitro 
translation assays suggested that type 1 o3 was translated with the same 
efficiency as o3 type 3 (figure 32, chapter 7). It therefore seemed reasonable to 
assume that type 1 o3 was not recognised by the type 3 polyclonal serum used in 
the immunofluorescence and immunoprécipitation studies. In light of the 
findings in chapter 8, that is, the apparent stimulation of reporter gene expression 
by type 3 o3 but not by that from type 1 o3, polyclonal serum against type 1 
reovirus was raised to check that our hypothesis for the failure to detect high 
level expression of type 1 <r3 following its transfection into cells was correct. 
During the time that this sera was being raised, hybrids between the two S4 
genes were constructed in an attempt to localise the region o f o3 responsible for 
the differential effects the two proteins have on reporter gene expression.
9.2 Construction of S4 hybrids
These were constructed between the HPA-1 and HPA-3 clones (illustrated 
in figure 31, chapter 7). To do this simply required unique restriction enzyme 
sites at corresponding positions in the two genes and in the terminal additions 
generated during cDNA manipulation. Kpnl and Styl were chosen. KpnJ cuts 
both clones uniquely at the 5' end of the HIV-LTR and Styl cuts both S4 genes at 
nucleotide 824 and does not have a second site in either HPA-1 or HPA-3. The
170
cloning strategy used is outlined in figure SS. This strategy dictated that 
complete digestion of each plasmid DNA was essential, to ensure that the vector 
containing fragments used (B and D figure 55) did not contain any full length S4 
gene sequences. Two hybrid clones were isolated: one containing the S' portion 
of S4-1 (HIV-LTR -S4-1 (824 bp)) and the 3' portion of S4-3 (Rec-1), the other 
containing the 5' portion of S4-3 and the 3' portion of S4-1 (Rec-3). Due to the 
high homology of the S4 genes a range of digests were required to identify the 
recombinants (figure 56 and 57). These were Pst I, Hindi, Aval and Pvull, each 
of which cut either once or twice at different positions within the two S4 genes 
and once or not at all within the vector sequence (figures 56 and 57). This 
allowed for identification of the hybrids by comparison with the parent plasmid. 
For example, the parent plasmid of Rec-1 is HPA-3 and the insert is from HPA- 
1. HPA-1 and HPA-3 can be readily identified by Pstl digestion as S4-1 
contains an internal Pstl site at nucleotide 489 (figure 57(a)) which is absent in 
S4-3. Therefore Rec-1 would be expected to have the same restriction enzyme 
profile as wild type HPA-1 and not its parent plasmid HPA-3. The same 
argument applies for analysis with Hindi. S4-3 contains an internal Hindi site 
at nucleotide 438 which is absent from S4-1 (figure 56(a)). On the other hand 
Pvull digestion of Rec-1 would be expected to give the same restriction enzyme 
profile as the parent plasmid HPA-3, as HPA-1 contains a Pvull site at 
nucleotide 848 (i.e. at the 3' end downstream of the Styl junction) which is 
absent in HPA-3 (figure 57(a)). Finally, Aval cuts at two different positions in 
HPA-1 and HPA-3, therefore two unique restriction enzyme profiles would be 
expected for the hybrids (figure 57(a)). When the restriction enzyme profiles of 
the hybrids were analysed on 1 % agarose gels (figure 56(b) and 57(b)) all of the 
above predictions were met.
These constructs were generated prior to the discovery o f  the requirement 
of the SV40 origin in the plasmid to achieve detectable levels o f  a3 expression.
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FIGURE 55: CONSTRUCTION OF S4 HYBRIDS: REC-1 AND REC-3
HPA-1 and HPA-3 (illustrated in figure 30, chapter 7) were digested with KpnI/Styl 
to generate two fragments: a 1.37 Kb insert, containing the HIV-LTR and relevant 
part of the S4 gene (bases 0-824), and a 3.28 kB fragment containing the rest of the 
vector:
A = HPA-1 KpnI/Styl 
B =  Remaining HPA-1 vector 
C =  HPA-3 KpnI/Styl 
D = Remaining HPA-3 vector
The 4 fragments were isolated from a 1 % agarose gel and the 5' phosphate groups 
of B and D removed by treatment with CIP as described in Methods.
A was then ligated with D and B with C. The ligation(s) mix was transformed into 
MC1061. Colonies containing the hybrids were identified by mini-plasmid 
preparations and restriction enzyme analysis.
KEY
HPA-1 containing the HIV-LTR. S4-1 and poly A  signal 
HPA-3 containing the HIV-LTR, S4-3 and poly A  signal
17 2
LIGATE C  WITH B
i
TRANSFORM
/ \
Kpn1 Styl Kpn1 Styl
Rec-1
FIGURE 56a: PREDICTION OF RESTRICTION ENZYME DIGESTS FOR S4 
HYBRIDS I.
As discussed in the text the enzymes Aval, H indi, PvuII and PstI were chosen to 
identify the hybrids. The positions where these enzymes cut in HPA-1 and HPA-3 
are shown in this figure (Aval and Hindi) and in figure 57a (PvuII and PstI).
Note: HPA clones contain 5' HIV-LTR-S4-Poly A 3 ', and the only variables in 
these digests come from the S4 gene.
The predicted restriction enzyme profile of the hybrids, when compared to the wild 
type HPA-1 and HPA-3 are as follows:
Aval: Digests S4-3 at nucleotide 764 and S4-1 at nucleotide 848, i.e. on either side 
of the Sty I  site used to generate the hybrids , therefore Rec-1 and Rec-3 would be 
expected to have two different restriction enzyme profiles when cut with the 
enzyme.
Hindi: Digests S4-3 at nucleotide 438 and 857 and S4-1 at nucleotide 857. 
Therefore Rec-1 would be expected to have the same restriction enzyme profile as 
HPA-1 and Rec-3 the same profile as HPA-3.
FIGURE 56b: IDENTIFICATION OF S4 HYBRIDS (I).
Hybrids Rec-1 and Rec-3 were identified by digestion with Aval, H in d i and 
analysed on 1 % agarose gels. The restriction enzyme profiles agreed with those 
predicted in figure 56a:
Aval: Two unique restriction enzyme profiles (track C is not fully digested).
Hindi: Rec-1 has the same profile as HPA-1 and Rec-3 as HPA-3.
A *  HPA-1 
B = Rec-1 
C «  HPA-3 
D -  Rec-3
M = lkb BRL ladder marker
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FIGURE 57a: PREDICTION OF RESTRICTION ENZYME DIGESTS FOR S4 
HYBRIDS (n)
The positions where PvuII and Pstl cut in HPA-1 and HPA-3 shown in the figure. 
PvuII: Digests S4-1 at nucleotide 838 and S4-3 does not have a PvuII site. 
Therefore Rec-1 would be expected to have the same restriction enzyme profiles as 
HPA-3 and Rec-3 the same profile as HPA-1.
Pstl: Digests S4-1 at position 489 and S4-3 does not have a Pstl site, therefore 
Rec-1 would be expected to have the same restriction enzyme profile as HPA-1 and 
Rec-3 the same profile as HPA-3.
FIGURE 57b: IDENTIFICATION OF S4 HYBRIDS 0D
Hybrids Rec-1 and Rec-3 were further identified by digestion with Pstl and PvuII 
and analysed on 1 % agarose gels. The restriction enzyme profiles agreed with 
those predicted in figure 57a.
PvuII: Rec-1 has the same restriction enzyme profile as HPA-3 and Rec-3 as HPA- 
1. It should be noted that these are only partially digested by the enzyme, however 
the main band differentiating the serotypes (1 kb) can be clearly seen. When this 
was reanalysed all the correct bands were present (data no shown).
Pstl: Rec-1 has the same restriction enzyme profile as HPA-1 and Rec-3 as HPA-3.
A = HPA-1 
B «  Rec-1 
C = HPA-3 
D = Rec-3
M = lkb BRL ladder marker
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APvu11 Pst1
The SV40 origin was therefore inserted into the Sail site present in the polylinker 
of Rec-1 and Rec-3 exactly as described for the construction of HIV-1 and HIV-3 
clones from HPA-1 and HPA-3 (figure 30). The resulting clones were termed 
HY-1 (derived from Rec-1) and HY-3 (derived from Rec-3) and were identified 
by Hindlll and PstI digestion as shown in figure 58.
9.3 The effect of a i hybrid expression on reporter gene expression
Figure 59 shows that expression of hybrid o3 from HY-1 resulted in a  5-7 
fold increase in 8-gal activity, similar to that produced by parental type 3 o3. By 
contrast cells expressing the hybrid o3 from HY-3 gave no stimulation in fi-gal 
activity, similar to the situation observed for parental type 1 ai. Since HY-1 
contains the 5' 800 bases of S4-1 and the 3‘ 400 bases of S4-3 these results 
suggested that the 3' end of S4-3 contains the domain responsible for stimulation 
of reporter gene expression.
When a i expression from the hybrids was analysed by immunofluorescence 
using type 3 polyclonal serum, a i  expression was detected in cells transfected 
with HY-1 but not in those transfected with HY-3 (figure 60). The fact that 
expression of parental type 1 a i could not be detected by fluorescence but that 
from HY-1 (containing the 5’ 800 bases of S4-1 and 3’ 300 bases of S4-3) was, 
suggested that the 3’ end of the S4-3 gene contained the region required for 
immunological recognition of the a3 protein
9.4 Analysis of type I a3 expression.
To ascertain if the lack of detection of type 1 a i by reovirus type 3 
antibody was indeed due to the serum not recognising the protein, polyclonal 
serum was raised against reovirus type 1 as described in Methods. The serum 
was initially checked for activity by immunofluorescence of mouse L-cells
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FIGURE 58: IDENTIFICATION OF HYBRIDS CONTAINING THE SV40
ORIGIN
A =  Rec-3 
B =  Rec-1 
C -  Hy-1 
D -  Hy-3
The S4 hybrid(s) was digested with Sail and Klenow filled. A small DNA fragment 
containing the SV40 origin was released from pSVEl by ECoRl/Hindlll digestion 
and the ends of the fragment Klenow filled. The fragment was ligated into the 
vectors containing the hybrid S4 genes and transformed into MC1061 as illustrated 
in figure 44. Antibiotic resistant colonies containing the SV40 origin were screened 
by mini-plasmid preparations and restriction analysis. PstI digestion released the 
expected 700 bp insert. Hindlll digestion released a 350 bp insert which was due to 
the regeneration of the Hindlll site by ligation of Hindlll/Sall blunt ends. The 
diagram beneath the photograph represents the full length inserts and positions 
where the enzymes cut. The enzymes used did not digest the rest o f the vector.
Regeneration of Hindlll
Vector digested with 
Sail 
G
CAGCT
GTCGA
CAGCT
Insert digested with 
Hindlll and ECoRI 
AGCTT G 
A CTTAA
AGCTT
TCGAA
S
GTCGAAGCTT
CAGCTTCGAA
Regeneration of Hirdlll site
176

FIGURE 59: THE EFFECT OF o3 ON B-GAL GENE EXPRESSION
COS-1 cells were co-transfected with 10 ng of plasmid containing the S4 gene, 1 ng 
of TAT and 1 /xg of pCHl 10. Reporter gene activity was analysed as described in 
Methods. The results are expressed as the fold increase in B-gal activity compared 
to the control sample (HPA-3) which is taken as 1. The various S4 containing 
plasmids are shown below the graph.
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HIV-1 HIV-3 C O N  HY-1 HY-3 
+/- T A T  +  -  + -  +  -  +
HIV-1
FIGURE 60: DETECTION OF <r3 EXPRESSION IN CELLS TRANSFECTED 
WITH HY-1 AND HY-3 WITH TYPE 3 ANTIBODY.
A = HY-1 +  TAT (phase)
B -  HY-1 +  TAT (fluorescence)
C =  HY-3 +  TAT (phase)
D = HY-3 +  TAT (fluorescence)
Subconfluent monolayers of COS-1 cells in 12 well tissue culture dishes were co­
transfected with 5 pg of the relevant S4 containing DNA and 0.5 pg of TAT. 48 
hours post transfection the cells were fixed and prepared for immunofluorescence as 
described in Methods.
magnification xlOO
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infected at a low m.o.i with reovirus type 1 or 3 as previously described. As 
expected the serum was active against both type 1 and type 3 reovirus (figure 
61).
In order to analyse o3 expression using the polyclonal sera raised against 
type 1 virus, COS-1 cells were transfected with 5 /xg of HIV-1, HIV-3, HY-1 or 
HY-3 in the presence of 0.5 /xg of TAT and were prepared for 
immunofluorescence as described in Methods. Positive fluorescence was 
obtained from cells transfected with HIV-3. However, o3 expression was not 
detected in HIV-1 transfected cells (figure 62). In view of the high homology of 
the two proteins it was not surprising that the type 1 serum was cross reactive 
with type 3 o3 as was initially expected. However, it was surprising that no 
detectable type 1 o3 expression was seen using this homologous sera. Positive 
fluorescence was also obtained in cells transfected with HY-1 (figure 62(c)), but 
no detectable o3 expression was detected in HY-3 transfected cells as had 
previously been found using type 3 serum (figure 60).
These results and those using SV40 driven o3 expression (section 7.5.1) 
suggested that lack of detection of type 1 o3 was either due to some problem in 
synthesis of the protein, which seemed unlikely from the in vitro translation data, 
or alternatively that the type 1 protein was unstable in comparison to that from 
type 3 in transfected cells.
9.5 Analysis of o3 stability
To analyse the stability of o3 in transfected cells pulse chase experiments 
were carried out. The rationale was that if o3 was stable the intensity of o3 
immunoprecipitated from pulse and chase samples would be the same. If on the 
other hand the protein was not stable the chased samples would be expected to 
give less protein than the pulsed samples. To do this experiment duplicate six 
well dishes of subconfluent monolayers of COS-1 cells were transfected with 10
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FIGURE 61 : ACTIVITY O F  REOVIRUS T Y P E  1 P O L Y C L O N A L  S E R U M  A GAINST 
REOV1RUS TYPE 1 A N D  TYPE 3
A  L-cells Infected with reovirus type 1 (m o  i 0.1)
B: L-ceHe Infected wflh reovlrue type 3  (m.o.l 0.1)
Subconfluent monolayer» of L-cella were Infected with reovirue type 1 or type 3 
at an m.o.i of 0.1 and were prepared for Immunofluorescence as described in 
method*. The cells were viewed under pheee/fluorescence
Magnification x100
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FIGURE 62: DETECTION OF o3 EXPRESSION WITH REOVIRUS TYPE 1 
POLYCLONAL SERUM
A = HIV-1 +  TAT (phase/fluorescence) 
B = HIV-3 +  TAT (phase/fluorescence) 
C =  HY-1 +  TAT (phase/fluorescence) 
D = HY-3 +  TAT (phase/fluorescence)
Subconfluent monolayers of COS-1 cells in 12 well tissue culture dishes were co­
transfected with 5 ng of the relevant S4 containing DNA and 0.5 ng of TAT. 48 
hours post transfection the cells were fixed and prepared for immunofluorescence as 
described in Methods.
magnification x 100
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ng of HIV-1, HIV-3, HY-1 or HY-3 and 1 ng of TAT or with 10 /zg of SV40-1 
or SV40-3. 48 hours post transfection the cells were starved of methionine for 1 
hour and then pulse labelled for 6 hours as described in Methods. After this 
pulse labelling period, one well of each sample was harvested and the other 
chased by overlaying the cells with 1 ml of 100 x met-containing media for a 
further 6 hours. 1 /tl aliquots of the cell extracts were TCA precipitated and 
equal amounts of labelled protein immunoprecipitated using type 1 serum as 
described in Methods.
9.5.1 Results
The immunoprecipitated proteins were analysed on 10 % polyacrylamide 
gels as described in Methods. Figure 63(a) shows that only very small amounts 
of type 1 o3 (tracks A and B) were immunoprecipitated in comparison to those 
from type 3 a3 (tracks C and D). In the chase samples (track B) even less type 1 
<t3 is detected than in the pulse labelled samples suggesting that type 1 o3 is 
indeed unstable. It is also evident that the lower band associated with pulse 
labelled type 3 o3 expression (track C) is not present in the chase track (track D). 
This suggests that this shorter protein product is a protein which is fully 
processed during the chase period. In contrast to type 3 o3, cells transfected 
with the S4 gene from type 1 virus do not appear to express this smaller protein. 
When protein expression from the hybrids was examined (figure 63(b)) it was 
evident that the protein synthesised from HY-1 (containing amino acids 1-264 of 
<r3 type 1 and amino acids 265-365 of o3 type 3) was as stable as that from the 
plasmid containing the parental type 3 S4 gene. However, the protein expressed 
by HY-3 (containing amino acids 1-264 of o3 type 3 and amino acids 265-365 of 
a3 type 1) had a stability comparable to that of type 1 o3 (figure 63(b), tracks E 
and F). These results suggest that the 3' end of S4-3 confers stability to o3. It is 
also evident that the lower band associated with pulse labelled type 3 o3
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FIGURE 63: ANALYSIS OF a3 STABILITY
A
A -  SV40-1 pulse 
B =  SV40-1 chase 
C = SV40-3 pulse 
D =  SV40-3 chase 
E *  HIV-1 pulse 
F =  HIV-1 chase 
G =  Type 3 pulse 
H = Type 3 chase
B
A =  HIV-3 pulse 
B = HIV-3 chase 
C =  HY-1 pulse 
D -  HY-1 chase 
E «  HY-3 pulse 
F -  HY-3 chase 
G =  Type 3 pulse 
H =  Type 3 chase
Duplicate subconfluent monolayers of COS-1 cells in six well dishes were 
transfected with 10 ng of the relevant DNA and 1 ng of TAT if required. 48 hours 
post transfection the cells were starved of methionine for 1 hour followed by a 6 
hour pulse with ^S-m et. One set of samples was harvested and the other chased 
for a further 6 hours with lOOx methionine as described in the text and in Methods. 
The cells were subjected to freeze thawing and sonication as described in Methods 
and the cell debris was removed by microfugation. 1 p i aliquots of the supernatants 
were TCA precipitated and equal amounts of labelled protein were 
immunoprecipitated with reovirus type 1 polyclonal serum. The proteins were 
analysed on 10 % polyacrylamide gels.
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expression (track A) is not synthesised in cells transfected with HY-1 DNA but it 
is synthesised in cells transfected with HY-3 DNA. This suggests that the lower 
band present in the <r3 tracks from the type 3 S4 gene is produced by the 5' end 
of the S4 gene of type 3.
9.6 Summary
Hybrids between S4-1 and S4-3 were constructed containing the 5 ' 800 
bases of one serotype and the 3* 400 bases of the other serotype. The SV40 
origin of replication was added to these plasmids to allow for replication of 
plasmid DNA in transfected cells. HY-1, containing the 3' 400 bases of S4-3, 
produced a marked stimulation of B-gal expression in co-transfected cells, 
comparable to that given by wild type S4-3. These results suggested that the 
domain for this activity may lie in the 3' end of the S4-3 gene. Type 3 and type 
1 polyclonal antibodies detected o3 by immunofluorescence in HY-1 but not HY- 
3 transfected cells.
When the stability of a3 was investigated it was found that type 1 a3 is 
much less stable than type 3 o3 and that the 3' domain of S4-3 is responsible for 
this stability. These results suggest that the ability o f HY-1 to stimulate reporter 
gene expression is due to an increase in the stability of the protein. The 
significance of these results and a possible mechanism by which it may operate 
will be discussed in chapter 10.
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10.1 The effect of o3 on eukaryotic gene expression in in  vitro and in
vivo assay systems
The aim of the work presented in this thesis was to gain a greater insight 
into the role of reovirus in controlling host cell protein synthesis, a function of 
the S4 gene of the virus (Sharpe & Fields, 1982). Initial work confirmed the 
findings o f Munemitsu and Samuel (1984), namely that type 3 reovirus does 
indeed inhibit host protein synthesis with greater efficiency than reovirus type 1. 
To further investigate this intracellular pathogenic property of the virus, in vitro 
and in vivo assay systems were designed in an attempt to model the effect of the 
S4 gene on host cell protein synthesis. The basic reagents for both these assay 
systems were full length cDNA clones of the S4 gene from serotypes 1 and 3 of 
the virus (S4-1 and S4-3) cloned into the versatile Bluescribe vector (discussed in 
chapter 4).
Two in vitro translation assay systems were developed. The first was based 
on the rabbit reticulocyte lysate system and the second made use of S-10 cell 
extracts prepared from infected and uninfected L-cells. The o3 produced in 
these systems had no effect on either o3 or B-actin translation in the reticulocyte 
lysate system, or on endogenous mRNA translation in the S-10 cell extract 
system. One possible reason for the lack of effect of a3 in both cases may have 
been that insufficient a3 was synthesised to have any effect on translation. In the 
case of the reticulocyte lysate system, discussed in chapter S, this could possibly 
have been overcome by adding exogenous ct3, prepared from infected cells as 
described by Huisman and Joklik (1976), to the system.. Another and possibly 
more likely explanation for the lack of effect of <r3 in vitro may be that it 
requires several other viral and/or cellular proteins to cause a full inhibitory 
effect. Indeed, the ability of reovirus type 3 ol to inhibit cellular DNA synthesis
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has recently been shown to require other viral proteins (Fajorado & Shatkin, 
1990).
The in vitro assay system was developed in an attempt to provide a quick 
assay in which to test hybrids between S4-1 and S4-3 and thereby domain map 
the region of S4-3 responsible for inhibition of host protein synthesis, prior to 
studying the effect of the protein in vivo. However the results obtained in this 
piece o f work did not provide any evidence to suggest that <r3 has any direct 
effect on host cell protein synthesis in an in vitro situation.
To develop an in vivo assay system o3 could be expressed from either a 
constitutive promoter or an inducible promoter, the latter being favoured to allow 
for the possibility that o3 was toxic to the cells. One obvious way to study the 
effect of o3 on host protein synthesis in vivo would have been to transfect cells 
with a  DNA construct from which o3 would be expressed and about 48 hours 
post transfection to label the cells with 35S-met. Then, to determine if <r3 did 
indeed inhibit host protein synthesis, the extent of 33S-met incorporation into 
protein by TCA precipitation could have been measured . However the 
transfection efficiency is rarely greater than 10 % and therefore it would be 
difficult to measure the extent of inhibition of host protein synthesis in cells 
expressing o3 compared to the background of total cell protein synthesis. 
Indeed, Lemay and Shatkin (1986) studied the effect of o3 in an assay system 
similar to this and observed that no direct effect on host protein synthesis could 
be related to o3 expression. To overcome this problem we developed a system 
involving the use of reporter genes, as a marker for eukaryotic protein synthesis. 
For these assays o3 synthesis was under the control of the tat inducible HIV-LTR 
to allow for analysis of reporter gene expression in the presence or absence of o3 
expression. However, as discussed in chapter 7, in order to produce a detectable 
level of o3 in transfected cells the SV40 origin of replication had to be added to 
the plasmids and transfection carried out in COS cells which express the T-
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antigen of SV40 and consequently amplify by replication any plasmid containing 
the SV40 origin. This change also increased the amount of HIV-LTR activity 
such that <r3 was detected in both the presence and absence of co-transfection 
with TAT. This suggested that the use of the inducible HIV-LTR/TAT system 
proposed by Sun and Baltimore (1989), is not as generally applicable as they 
initially suggested. Using polyclonal antibody against reovirus type 3 to detect 
o3 expression in transfected cells, type 3 o3 was readily detected by both 
immunofluorescence and immunoprécipitation. Type 1 o3 was however not 
detected by immunofluorescence and only a very faint signal was detected by 
immunoprécipitation (figure 43 chapter 7). Restriction enzyme analysis and in 
vitro transcription-translation analysis showed that the a3 from the type 1 virus 
was synthesised, and hence it was initially assumed that the lack of detection of 
type 1 o3 was due to a failure of the protein to be recognised by the antibodies 
raised against type 3 virus.
The effect of o3 on two different reporter genes ( used as markers for host 
cell protein synthesis), CAT and B-gal, was examined. o3 expressed from Type 
3 caused a 5-7 fold increase in B-gal gene expression and in CAT gene 
expression when such expression was under the control of the herpes simplex TK 
promoter, the LTR of rous sarcoma virus or the early promoter of SV40. 
However, when CAT expression was under the control of the immediate early 
promoter of CMV then type 3 o3 had no effect on its expression. One reason for 
this may be that the CMV promoter was the strongest used in these assays and 
consequently the levels of CAT produced may have been too high for o3 
produced from either the SV40 or HIV-LTR (in the presence of the SV40 origin 
of replication) promoters to have any effect on it. In contrast to these findings 
the o3 of type 1 had no effect on reporter gene expression irrespective of which 
promoter it was being expressed from.
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The results of the in vivo experiments therefore suggest that type 3 <r3 
causes a stimulation of non-viral mRNA translation whilst that from type 1 o3 
does not. However, it must be remembered that when studied in isolation the 
effects produced by o3 may not be a true reflection of what occurs in infected 
cells. It is possible that the S4 gene product controls the level of inhibition of 
protein synthesis but requires other proteins from either type 1 or type 3 to 
complex with it to cause a full inhibitory effect. In fact Lee et at. (1981) showed 
that o3 is complexed to p ic  in vivo by using monoclonal antibodies to <x3. 
Conversely, the effects observed in this work may be related to the way the virus 
controls host protein synthesis and/or how it controls its own protein synthesis at 
the expense of cellular protein synthesis.
10.2. Current hypotheses for reovirus control of cellular protein 
synthesis.
As discussed in the Introduction there have been various proposals as to 
how reovirus controls host cell protein synthesis. Skup et al. (1981) initially 
hypothesised that control of host cell protein synthesis by reovirus occurred by a 
switch from cap dependent to cap independent translation at late times in viral 
infection. However this mechanism has been controversial for many years and 
recent evidence suggests that it may not be the mechanism of control. Using S- 
10 cell extracts prepared from uninfected and type 3 infected L-cells Lemieux et 
al. (1984) showed that capped reovirus and L-cell mRNA were both translated 
with greater efficiency in uninfected extracts than in infected extracts. By 
comparison uncapped reovirus mRNA was translated with greater efficiency in 
infected cell extracts. However, the theory that all uncapped mRNA would be 
translated with greater efficiency in the infected extracts did not hold true in the 
case of uncapped poliovirus mRNA, which was not translated efficiently in the 
virus infected extracts. As a consequence of these observations Lemieux et al.
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(1984) proposed that a viral factor may be involved in promoting the efficient 
translation of viral mRNA late in infection. Indeed Lemieux el al. (1987) 
showed that o3 purified from infected cells, according to the protocol described 
by Huisman and Joldik (1976), stimulated the translation o f late viral mRNA. 
Further contradiction to this mechanism has recently been reported by Feduchi et 
al. (1988) who demonstrated that co-infection of cells with poliovirus shuts-off 
reovirus protein synthesis. Our results based on in vitro and in vivo assay 
systems did not provide any support for Millward's hypothesis.
The results presented in this work suggest that o3 causes an increase in 
protein synthesis. Other workers have also found cr3 to have similar effects on 
both viral and non-viral mRNAs. Lemieux et al. (1987) showed that ct3 
stimulated the translation of late viral mRNA. Work by Giantini and Shatkin 
(1989) also demonstrated that co-transfection of cells with a cDNA copy of the 
S4 gene of type 3 virus and a reporter gene resulted in a 10 fold stimulation in 
the reporter gene expression. In this case <r3 expression was driven by the RSV 
promoter and the reporter gene used was RSV-CAT, with transfections being 
carried out in COS-7 cells. To investigate the level at which this stimulation 
occurred and to see if this effect was due to intracellular competition between the 
co-expressing vectors, steady state CAT mRNA levels were examined by 
Northern blot analysis. This showed that there was only slight intracellular 
competition between the vectors and that stimulation of RSV-CAT by S4-3 
occurred largely at the post transcriptional level.
This phenomenon of stimulation of non-viral mRNA translation has also 
been shown to be a function of the VAI RNA of adenovirus (previously 
discussed in the Introduction). Svensson St Akusj&rvi (1984) demonstrated that 
VAI stimulates the translation of both early and late viral mRNA. To investigate 
the effect of VAI on non-viral mRNAs Svensson and Akusjarvi (1985) studied 
the levels of CAT gene expression in cells expressing VAI. They found a 5-6
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fold stimulation of CAT protein synthesis, suggesting that adenovirus VAI 
mediates a translational stimulation which is not restricted to viral mRNAs 
(Svensson & Akusjarvi, 1985). The mechanism of control of translation by VAI 
has been discussed in detail in section 1.4. Briefly, ds RNA is produced during 
adenovirus replication. This activates a kinase, DAI, which in turn 
phosphorylates the alpha subunit of eukaryotic initiation factor 2 (eIF-2a) 
thereby blocking the recycling and dephosphorylation of eIF-2 required for 
continuation of initiation of protein synthesis. VAI is produced in large amounts 
at late times in infection and complexes with DAI, blocking the activation of the 
kinase and thus allowing recycling of eIF-2 and the translation of late viral 
mRNAs (Katze et al., 1987; Galabru el al., 1989). Akusjarvi et al. (1987) have 
proposed that a similar mechanism operates in cells transfected with plasmid 
DNA, that is, dsRNA may be produced by base pairing of complementary 
plasmid transcripts which may then activate DAI and cause a decrease in protein 
synthesis in the transfected cells. VAI counteracts this response and restores 
translational activity resulting in an apparent stimulation o f reporter gene 
expression.
10.3 A possible mechanism for a3 action
The results obtained by Sveenson and Akusj&rvi (1985) bear a close 
resemblance to the results obtained with <r3 both by ourselves and others. It is 
conceivable that o3, in isolation from other viral factors, may control protein 
synthesis by a mechanism similar to adenovirus. Another important property of 
o3 is that it has an affinity for dsRNA (Huisman & Joklik, 1976). In the 
transfected cells DAI may be activated by dsRNA or other RNA structures 
produced during the transcription and processing of the reporter gene mRNA 
which is foreign to the cell. The effect of type 3 o3 produced following co­
transfection of cells may involve association with these RNA structures thus
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preventing DAI activation and allowing protein synthesis to continue. This may 
also be related to the events occurring in infected cells. At late times in viral 
infection, when inhibition of host protein synthesis is evident in type 3 infected 
cells, ct3 may prevent the activation of DAI by binding to dsRNA structures 
produced during viral replication, thus allowing the translation of late viral 
mRNAs which, being the dominant mRNA in the cells, out-compete the host 
mRNA for the ribosomes. Therefore in the transfected cells, in the absence of 
other viral proteins, reporter gene expression may be stimulated by o3 in the 
same way as it stimulates the synthesis of late viral protein synthesis.
In recent years there has been other evidence to support the hypothesis that 
o3 acts as an antagonist to DAI. Bischoff and Samuel (1989) studied the 
activation of human Pi/eIF-2o protein kinase (DAI) by SI and S4 reovirus 
mRNA to gain a further insight into the mechanism of Interferon action which is 
induced by viral infection (section 1.2.4). They observed that reovirus SI 
mRNA was a potent activator of DAI where as reovirus S4 mRNA was a very 
poor activator. Kitajeski et al. (1986) had previously shown other RNAs such as 
VAI, tRNA and 5S ribosomal RNA to be poor activators .
As mentioned in the Introduction there is a translational discrepancy 
between the S class mRNAs. S4 mRNA is translated 10 times more efficiently 
than SI mRNA. To further investigate the mechanism by which this may occur, 
Samuel and colleagues (1990) investigated the effect of 2 aminopurine on the 
translation efficiency of SI and S4 mRNA. 2 aminopurine (2AP) is a potent 
inhibitor of DAI and acts in a similar way to VAI (Kaufman & Murtha, 1987). 
They showed that 2AP treatment of cells transfected with S I or S4 cDNA 
increased the translation of SI mRNA, possibly by inhibiting the activation of 
DAI, but failed to have any effect on the translation of S4 mRNA. This may 
have been because o3 had already inhibited the activation of DAI. Imani and 
Jacobs (1988) have also suggested that o3 may be an antagonist o f  DAI.
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The results described in the previous paragraph were all obtained using the 
S4 gene of type 1 reovirus. Our results showed distinct differences between the 
ability of the o3 proteins of the two serotypes to stimulate translation: o3 from 
type 3 stimulated reporter gene expression whereas that from type 1 did not cause 
any stimulation. These findings could, in turn, be related to apparent differences 
the two genes exhibit on host cell protein synthesis. In an attempt to begin the 
localisation of the region(s) of S4 responsible for these differences, hybrids 
between the two S4 genes were constructed. One of the hybrids, Hy-1, 
contained the first 800 bp of S4-1 joined to the 3' terminal 400 bp of S4-3 whilst 
the other, Hy-3, was the converse i.e: the 5' end of type 3 joined to the 3 ' end of 
type 1. Co-transfection experiments showed that Hy-1 stimulated B-gal gene 
expression to the same extent as wild type S4-3 and that Hy-3 had no effect on 
reporter gene expression, similar to that of wild type S4-1. This result initially 
suggested that the domain of the type 3 gene causing stimulation of reporter gene 
expression lay in the 3' terminal third of the S4-3 gene.
As discussed in chapter 9 type 1 o3 was found to be much less stable in 
transfected cells than that from type 3. Analysis of the stability of the proteins 
synthesised from the hybrids indicated that the 3' end of S4-3 conferred stability 
on the o3 of type 1 and also increased its ability to stimulate reporter gene 
expression, suggesting that these two properties of the protein are closely related.
In the region of S4 (824-1196 bp) where the difference in the properties of 
the two genes appears to lie there are 27 base changes between two viruses, 7 of 
which result in 6 amino acid changes. The amino acid changes are scattered 
throughout the domain with the exception of 2 changes at amino acids 300 and 
301.
The non-homologous amino acid positions of the domain are listed below.
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Amino Acid
Position Tyl Ty3 Tyl Ty3
300 Asp Glu GAT GAG
301 Ser Ala TCA GTC
325 Asp Asn GAC AAT
345 Ser Pro TCA CCA
348 Thr He ACC ATC
353 Asp Asn GAT AAT
As mentioned earlier an important property of o3 is that it binds to dsRNA. 
Schiff et al. (1988) investigated the structural basis of this binding activity. <r3 
was functionally dissected by proteolytic cleavage with S.aureus V8 protease, 
which generated two major fragments of 24K and 16K. The carboxy terminal 
fragment was found to contain the dsRNA- binding domain. We have shown 
that the carboxy terminus of type 3 protein is responsible for both stability in 
transfected cells and its ability to stimulate reporter gene expression. One 
explanation for the differences in the two a3s with respect to their ability to 
stimulate reporter gene expression may be that the type 3 protein is more stable, 
allowing it to bind to more dsRNA structures, thus causing the proposed effects 
discussed in section 10.3. The observations made with hybrid S4 genes i.e. the 
ability of HY-1 (containing the 3' end of S4-3) to stimulate reporter gene 
expression provides evidence to support the argument that a3 regulates protein 
synthesis by its ability to bind dsRNA.
<r3 is the most abundant protein in the infected cells and it is mostly found 
complexed with file, both constituents of the viral outer capsid shell. Huisman 
and Joldik (1976) showed that only free <r3 was able to bind to double stranded 
RNA structures. The ability of the virus to stimulate late viral mRNA protein
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synthesis may be related to the amount of free o3 present in the cell throughout 
the infection cycle.
10.4 Future Experiments
Further work is required to confirm the proposed mechanism of S4 control 
of host protein synthesis. Firstly, the effect of a3 on reporter gene expression 
could be examined in the presence of other viral proteins, for example, file, to 
see i f  this still causes stimulation of reporter gene expression. Secondly the 
levels of DAI in the transfected cell extracts could be assayed to see if they are 
different in cells transfected in the presence or absence of the reporter gene.
10.5 Concluding remarks
The results presented in this thesis have provided evidence to support the 
idea that the reovirus protein o3 controls protein synthesis by antagonising DAI 
activation, thus allowing the expression of late viral proteins at the expense of 
cellular protein synthesis, resulting in an apparent inhibition of host cell protein 
synthesis. There is a difference in the ability of type 1 and type 3 reovirus to do 
this. These results suggest that o3 from type 3 is stable when expressed on its 
own in transient assay systems, and is capable of binding to dsRNA structures, 
resulting in the inhibition of DAI activation which in turn stimulates reporter 
gene expression and late viral protein synthesis. In contrast to type 3, type 1 
reovirus does not inhibit host cell protein synthesis and its <x3 protein does not 
stimulate reporter gene expression. We have shown that type 1 o3 is unstable 
when expressed on its own in transient assays. It may be that this protein is only 
stable when it is complexed with file  on the outer capsid shell. Only free o3 
binds to dsRNA and hence o3 type 1, being unstable, cannot bind to it and thus 
may not activate DAI kinase activity. Type 1 reovirus does not grow as quickly
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as type 3 in tissue culture, which may in part be due to the inability of its a3 
protein to  promote late viral protein synthesis at the expense of cellular protein 
synthesis. Further work will hopefully clarify the mechanism by which reovirus 
controls protein synthesis.
196

ACS, G., KLETT, H., SCHONBERG, M., CHRISTMAN, J., LEVIN, D.H. 
& SILVERSTEIN, J.C., (1971). Mechanism of reovirus dsRNA synthesis in 
vitro and in vivo. Journal o f  Virology 18, 684-689.
ADENSICK, N. St DARNELL, J.E., (1972). Biogenesis and characterisation 
of histone messenger RNA in HeLa cells. Journal o f Molecular Biology 67, 
397-406.
AHMED, R. & FIELDS, B.N., (1981). Reassortment of genome segments 
between reovirus defective interfering particles and infectious virus: construction 
of temperature sensitive and attenuated viruses by rescue of mutations from 
defective interfering particles. Virology 111, 351-363.
AHMED, R. St FIELDS, B.N., (1982). Role of the S4 gene in establishment 
of persistent reovirus infection in L-cells. Cell 28, 605-608.
AHMED, R. & GRAHAM, A.F., (1977). Persistent infections in L-cells with 
temperature-sensitive mutants of reovirus. Journal o f  Virology 23, 250-262.
AKUSJARVI, G., MATHEWS, M.B., ANDERSON, P., VENNSTR6MM, B. 
& PETTERSSON, U., (1980). Structure of genes for virus-associated RNAI 
and RNAII of adenovirus type 2. Proceedings o f the National Academy o f  
Sciences (USA) T7, 2424-2430.
AKUSJARVI, G., SVENSSON, C. St NYGARD, O., (1987). A mechanism 
by which adenovirus virus-associated RNAI controls translation in a transient 
expression assay. Molecular and Cellular Biology 7, 549-551.
198
AN, G ., HIDAKA, K. St SIMINOVITCH, L.t (1982). Expression of bacterial 
ß-galactosidase in animal cells. Molecular and Cellular Biology 2, 1628-1632.
ANDERSON, K.P. St FENNIE, E.H., (1987). Adenovirus Early Region 1A 
modulation of Interferon antiviral activity. Journal o f Virology 61, 787-795.
ATWATER, J.A., MUNEMITSU, S.M. St SAMUEL, C.E., (1986).
Biosynthesis of reovirus-specified polypeptides. Molecular cDNA cloning and 
nucleotide sequence of the reovirus serotype 1 Lang strain s4 mRNA which 
encodes the major capsid surface glycoprotein o3. Biochemical and Biophysical 
Research Communications 136, 183-192.
ATWATER, J.A., MUNEMITSU, S.M. St SAMUEL, C.E., (1987).
Biosynthesis of reovirus-specified polypeptides. Efficiency of expression of 
cDNAs of the reovirus SI and S4 genes in transfected animal cells differs at the 
level of translation. Virology 150, 350-357.
BABICH, A., FELDMAN, L.T., NEVINS, J.R., DARNELL, J.E., JR., St 
WEINBERGER, C ., (1983). Effect o f  Adenovirus on metabolism of specific 
host mRNAs; transport control and specific translational discrimination. 
Molecular and Cellular Biology 3, 1212-1221.
BABLANIAN, R. St RUSSELL, W .C., (1974). Adenovirus polypeptide 
synthesis in the presence of non-replicating poliovirus. Journal o f General 
Virology 24, 261-279.
BALL, A. St WHITE, C.N., (1976). Order of transcription of genes of 
vesicular stomatitis virus. Proceedings o f the National Academy o f Sciences 
(USA) 73, 442-446.
199
BANERJI, J ., RUSCONI, S. St SCAFFNER, W., (1981). Expression of a 8- 
globin gene is enhanced by remote SV40 DNA sequences. Cell 27, 299-308.
BEATO, M., (1989). Gene regulation by steroid hormones. Cell 56, 335-344.
BEAUDET, A.L. St CASKEY, C.T., (1971). Mammalian peptide chain 
termination, II. Codon specificity and GTPase activity of release factor. 
Proceedings o f the National Academy o f Sciences (USA) 68, 619-624.
BELLAMY, A.R. Sc JOKLIK, W.K., (1967). Studies on the A-rich RNA of 
reovirus. Proceedings o f the National Academy o f Sciences (USA) 58, 1389- 
1395.
BERGER, I., HAUBER, J., HAUBER, R., GEIGER, R. St CULLEN, B.R., 
(1988). Secreted placental alkaline phosphatase. A powerful new quantitative 
indicator of gene expression in eukaryotic cells. Gene 66, 1-10.
BERNSTEIN, H.D., SONENBERG, N. St BALTIMORE, D., (1985). 
Poliovirus mutant does not selectively inhibit host cell protein synthesis. 
Molecular and Cellular Biology 5, 2913-2932.
BISCHOFF, J.R. St SAMUEL, C.E., (1989). Mechanism of interferon action. 
Activation of the human Pl/eIF-2a protein kinase by individual reovirus s-class 
mRNAs. Virology 172, 106-115.
BONNEAU, A. St SONENBERG, N., (1987). Proteolysis of the p200 
component of the cap-binding protein complex is not sufficient for complete
2 0 0
inhibition of host cell protein synthesis after poliovirus infection. Journal o f 
Virology 61, 986-991.
BORSA, J., COPPS, T.P, SARGENT, M.D., LONG, D.G. Sc CHAPMAN,
J.D ., (1973a). New intermediate subviral particles in the in vitro uncoating of 
reovirus virions by chymotrypsin. Journal o f Virology 11, 552-564.
BORSA, J., MORASH, B.D., COPPS, T.P., LIEVAART, P.A. Sc SZEKELY, 
J.G ., (1979). Two modes of entry of reovirus particles ink; »--cells. Journal 
o f  General Virology 45, 161-170.
BORSA, J., SARGENT, M.D, COPPS, T.P. Sc CHAPMAN, J.D., (1973b). 
Specific monovalent cation effects on modification of reovirus infectivity by 
chymotrypsin digestion in vitro. Journal o f  Virology 11, 1017-1019.
BRENDLER, T ., GODEFROY-COLBURN, T ., CARLILL, R.D. Sc THACH, 
R.E, (1981a). The role of mRNA competition in regulating translation. 
Development of a quantitative in vitro assay. Journal o f  Biochemistry 256, 
11747-11754.
BRENDLER, T., GODEFROY-COLBURN, T ., YU, S.Sc THACH, R.E 
(1981b). The role of mRNA competition in regulating translation. Comparison 
of in vitro and in vivo results. Journal o f Biochemistry 256, 11755 11761.
CANNING, W.M. Sc FIELDS, B.N., (1983). Ammonium chloride prevents 
lytic growth of reovirus and helps to establish persistent infection in mouse L- 
cclls. Science 219, 987-988.
20 1
CASADABAN, M.J. Sc COHEN, S.N., (1980). Analysis of gene control 
signals by DNA fusion and cloning in Escherichia Coli. Journal o f Molecular 
Biology 138, 179-207.
CECH, T.R., (1983). RNA splicing: Three themes with variations. Cell 34, 
713-716.
CHANG, C.T. Sc ZWEERINK, H.J., (1971). Fate of parental reovirus in 
infected cells. Virology 46, 544-555.
CHOI, A.H.C Sc LEE, P.W.K., (1988). Does the B-adrenergic receptor 
function as a reovirus receptor? Virology 163, 191-197.
CLARKE, P.A., SHARP, N.A. Sc CLEMENS M .J., (1990). Translational 
control by Epstein-Barr virus small RNA EBER-1. European Journal o f 
Biochemistry 193, 635-641.
CO, M.S., GAULTON, G.N. FIELDS, B.N. Sc GREENE, M.I., (1985a). 
Isolation and biochemical characterisation of the mammalian reovirus type 3 cell 
surface receptor. Proceedings o f the National Academy o f Sciences (USA) 82, 
1494-1498.
CO, M S., GAULTON, G.N. TOMINAGA, A., HOMCY, C.J., FIELDS, 
B.N. Sc GREENE, M.I., (1985b). Structural similarities between the 
mammalian beta-adrenergic and reovirus type 3 receptors. Proceedings o f the 
National Academy o f Sciences (USA) 82, 5315-5318.
COX, D.C. Sc SHAW, i.E . (1974). Inhibition of cellular DNA synthesis after 
reovirus infection. Journal o f Virology 13, 760 765.
2 0 2
CULLEN, B.R., (1986). Trans-activation of human immunodeficiency virus 
occurs via a bimodal mechanism. Cell 46, 973-982.
DALES, S., (1973). Early events in cell-animal interactions. Bacteriological 
Reviews 37, 103-145.
DASSO, M.C. St JACKSON, R.J., (1989). On the fidelity of mRNA 
translation in the nuclease-treated rabbit reticulocyte lysate system. Nucleic 
Acids Research 17, 3129-3144.
DE STEFANO, J., OLMSTED, E., PANNIERS, R. St LUCAS-LENARD, J., 
(1990). The a  subunit of eukaryotic initiation factor 2 is phosphorylated in 
Mengovirus-infected mouse L-cells. Journal o f  Virology 64, 4445-4453.
DETJEN, B.M., WALDEN, W.E. St THACH, R.E., (1982). Translational 
specificity in reovirus-infected mouse fibroblasts. Journal o f  Biochemistry 257, 
9855-9860.
DEVANEY, M.A., VIKRAM, N., LLOYD, R.E., EHRENFELD, E. St 
GRUBMAN, M.J., (1988). Leader protein of Foot-and Mouth Disease Virus is 
required for cleavage of the p220 component of the Cap-Binding Protein 
Complex. Journal o f  Virology 62, 4407-4409.
DRAYNA, D. & FIELDS, B.N., (1982). Activation and characterisation of the 
reovirus transcriptase: Genetic analysis. Journal o f Virology 41, 110-118.
203
DRETZEN, G., BELLARD, M., SASSONE-CORSI, P. Sc CHAMBON, P. 
(1981). A reliable method for the recovery of DNA fragments from agarose 
and acrylamide gels. Analytical Biochemistry 112, 295-298.
DUNIGAN, D.D. Sc LUCAS-LENARD, J ., (1983). Two transcription 
products of the vesicular stomatitis virus genome may control L-cell protein 
synthesis. Journal o f  Virology 45, 618-626.
DUNIGAN, D.D., BAIRD, S. Sc LUCAS-LENARD, J. (1986). Lack of 
correlation between the accumulation of plus-strand leader RNA and the 
inhibition of protein and RNA synthesis in vesicular stomatitis virus infected 
mouse L-cells. Virology 150, 231-246.
EASTMAN, A., (1987). An improvement to the novel rapid assay for 
chloramphenicol acetyltransferase gene expression. BioTechniques 5, 701-732.
EDERY, I., PETRYSHYN, R. Sc SONENBERG, N., (1989). Activation of 
double-stranded RNA-dependent kinase (dsl) by the TAR region of HIV-1 
mRNA. A novel translational control mechanism. Cell 56, 303-312.
EHRENFELD, E. Sc LUND, H., (1977). Untranslated vesicular stomatitis 
virus messenger RNA after poliovirus infection. Virology 80, 297-308.
ENSMINGER, W.D. Sc TAMM, I., (1969a). Cellular DNA and protein 
synthesis in reovirus infected cells. Virology 39, 357-359.
ENSMINGER, W.D. Sc TAMM, I., (1969b). The step in cellular DNA 
synthesis blocked by reovirus infection. Virology 39, 935-938.
204
ERNST, S.H. Sc SHATKIN, A.J., (1985). Reovirus hemagglutinin mRNA 
codes for two polypeptides in overlapping reading frames. Proceedings o f  the 
National Academy o f  Sciences (USA) 82, 48-52.
ETCHISON, D. & FOUT, S., (1985). Human Rhinovirus 14 infection of 
HeLa cells results in the proteolytic cleavage of the p220 cap-binding complex 
subunit and inactivates globin mRNA translation in vitro. Journal o f Virology 
54, 634-638
ETCHISON, D., MILBURN, S.C., EDERRY, I., SONENBERG, N. Sc 
HERSHEY, J.W.B., (1982). Inhibition of HeLa cell protein synthesis 
following poliovirus infection correlates with the proteolysis of a 220,000-dalton 
polypeptide associated with eucaryotic initiation factor 3 and a binding protein 
complex. Journal o f  Biochemistry 257, 14806-14810.
FAJARDO, E. Sc SHATKIN. A.J., (1990). Expression of the two reovirus SI 
gene products in transfected mammalian cells. Virology 178, 223-231.
FARRELL, P.J., BALKOW, K., HUNT, T., JACKSON, R.J. Sc TRACHSEL, 
H., (1977). Phosphorylation of initiation factor eIF-2 and the control of 
reticulocyte protein synthesis. Cell 11, 187-190.
FEDUCHI, E., ESTEBAN, M. Sc CARRASCO, L., (1989). Reovirus type 3 
synthesises proteins in interferon-treated HeLa cells without reversing the 
antiviral state. Virology 164, 420-426.
FENRICK, R., MALIM, M.H., HAUBER, J., LE, S., MAIZEL, J. Sc 
CULLEN, B.R., (1989). Functional analysis of the Tat trans activator of 
human immunodeficiency virus type 2. Journal o f  Virology 63, 5006-5012.
205
FERNANDEZ-MUNOZ, R. & DARNELL, J.E., (1976). Structural difference 
between the 5' terminus of viral and cellular mRNA in Poliovirus-infected cells. 
Possible basis for the inhibition of host protein synthesis. Journal o f  Virology 
126, 719-726.
FIELDS, B.N. & JOKLIK, W.K., (1969). Isolation and preliminary genetic 
and biochemical characterisation of temperature-sensitive mutants of reovirus. 
Virology 37, 335-342.
FIELDS, B.N., (1971). Temperature-sensitive mutants of reovirus type 3 
features of genetic recombination. Virology 46, 142-148.
FIELDS, B.N., (1982). Molecular basis of reovirus virulence. Brief Review. 
Archives o f Virology 71, 95-107.
FRESCO, L.D., KURILLA, M.G. & KEENE, J.D., (1987). Rapid inhibition 
of processing and assembly of small nuclear ribonucleoproteins after infection 
with vesicluar stomatitis virus. Molecular and Cellular Biology 7, 1148-1155.
FURUICHI, Y. & SHATKIN, A.J., (1976). Differential synthesis of blocked 
and unblocked 5' - termini in reovirus mRNA: Effect of pyrophosphate and 
pyrophosphatase. Proceedings o f the National Academy o f Sciences (USA) 73, 
3448-3452.
FURUICHI, Y., LaFIANDRA, A. & SHATKIN, A.J., (1977). 5’ terminal 
structure and messenger RNA stability. Nature 266, 235-219.
206
FURUICHI, Y.t MORGAN, M., MUTHUKRISHNAN, S. Sc SHATKIN, 
A.J., (1975a). Reovirus messenger RNA contains a methylated blocked 5' 
terminal structure. mVGCS'lppp^'XjmpCpC. Proceedings o f the National 
Academy o f Sciences (USA) 72, 362-366.
FURUICHI, Y., MUTHUKRISHNAN,S. Sc SHATKIN, A.J., (1975b). 5’- 
terminal M7G(5')ppp(5')GMp in vivo. Identification in reovirus genome RNA. 
Proceedings o f the National Academy o f Sciences (USA) 75, 742-745.
FURUICHI, Y., MUTHUKRISHNAN,S., TOMASZ, J. Sc SHATKIN, A.J., 
(1976). Mechanism of formation of reovirus mRNA 5' terminal blocked and 
methylated seqeunce M7GpppGMpC. Journal o f  Biochemistry 251, 5043-5053.
GAILLARD, R.K. Sc JOKLIK, W.K., (1985). The relative translation 
efficiencies of reovirus messenger RNAs. Virology 147, 336-348.
GALABRU, J., KATZE, M.G.,ROBERT, N. Sc HOVANESSIAN, A.G., 
(1989). The binding of double-stranded RNA and adenovirus VAI RNA in the 
interferon-induced protein kinase. European Journal o f  Biochemistry 178, 581- 
589.
GAULTON, G.N Sc GREENE, M.I., (1989). Inhibition of cellular DNA 
synthesis by reovirus occurs through a receptor-linked signalling pathway that is 
mimicked by antiidiotypic antireceptor antibody. Journal o f Experimental 
Medicine 169, 197-211.
GIANTINI, M. Sc SAHTKIN, A.J., (1989). Stimulation of chloramphenicol 
acetyltransferase mRNA translation by reovirus capsid polypeptide <j3 in 
cotransfected COS cells. Journal o f Virology 63, 2415-2421.
207
GIANTINI, M. Sl SHATKIN, A.J., (1987). Reovirus major capsid protein 
expressed in Escherichia coli. Gene 56, 153-160.
GIANTINI, M., SEUGER, L.S., FURUICHI, Y. St SHATKIN, A.J., (1984). 
Reovirus type 3 genome segment S4. Nucleotide sequence of the gene encoding 
a major virion surface protein. Journal o f Virology 52, 984-987.
GLUZMAN, Y., (1981). SV40-transformed simian cells support the replication 
of early SV40 mutants. Cell 23, 175-182.
GOMATOS, P.J. & TAMM, I., (1963). Synthesis in reovirus infected L-cells. 
Biochemical and Biophysical Acta 72, 651-653.
GORMAN, C.M., MERLINO, G.T., WILLINGHAM, M.C., PASTAN, I. & 
HOWARD, B.H., (1982a). The rous sarcoma virus long terminal repeat is a 
strong promoter when introduced into a variety of eukaryotic cells by DNA 
mediated transfection. Proceedings o f the National Academy o f Sciences (USA) 
79, 6777-6781.
GORMAN, C.M ., MOFFAT, L.F. St HOWARD, B.H., (1982b).
Recombinant genomes which express chloramphenicol acetyltransferase in 
mammalian cells. Molecular and Cellular Biology 2,1044-1051.
GRABOWSKI, P.J., PADGETT, R.A. St SHARP, P.A., (1984). Messenger 
RNA splicing in vitro: An excised intervening sequence and a potential 
intermediate. Cell 37, 415-427.
208
/GREEN, M.R., MANIATIS, T., MELTON, D.A., (1983). Human 8-Globin 
pre-mRNA synthesised in vitro is accurately spliced in Xenopus Oocyte nuclei. 
Cell 32, 681-694.
GRUNSTEIN, M. St HOG NESS, D.S., (1975). Colony hybridisation: A 
method for the isolation of cloned DNAs that contain a specific gene. 
Proceedings o f the National Academy o f Sciences (USA) 72, 3961-3964.
GUNNERY, S., RICE, A.P., ROBERTSON, H.D. St MATHEWS, M.B., 
(1990). Tat-responsive region RNA of human immunodeficiency virus 1 can 
prevent activation of the double-stranded-RNA-activated protein kinase. 
Proceedings o f the National Academy o f Sciences (USA) 87, 8687-8691.
GUPTA, S.L., (1979). Specific protein phosphorylation in interferon-treated 
uninfected and vims infected mouse L929 cells: Enhancement by double- 
stranded RNA. Journal o f  Virology 29, 301-310.
HALL, C.V., JACOB, P.E., RINGOLD, G.M. St LEE, F., (1983). 
Expression and regulation of Escherichia coli Lac Z gene fusions in mammalian 
cells. Journal o f  Molecular and Applied Genetics 2, 101-109.
HAND, R. St TAMM, I., (1974). Initiation of DNA replication in mammalian 
cells and its inhibition by reovirus infection. Journal o f  Molecular Biology 
82,175-183.
HAND, R., ENSM1NGER, W.D. St TAMM, I., (1971). Cellular DNA 
replication in infections with cytocidal RNA viruses. Virology, 44 527-536.
209
HAUBER, J. St CULLEN, B.R., (1989). Mutational analysis of the conserved 
basic domain of human immunodeficiency virus tat protein. Journal o f Virology 
62, 673-679.
HAYES, E.C., LEE, P.W.K., MILLER, S.E. St JOKLIK, W.K. (1981). The 
interaction of a series of hybridoma IgGs with reovirus particles. Virology 108, 
147-152.
HERZ, C., STAVANZER, E. St KRUG, R.M., (1981). Influenza virus, an 
RNA virus, synthesises its messenger RNA in the nucleus. Cell 26, 391-400.
HEWLETT, M.J., ROSE, J.K. St BALTIMORE, D., (1976). 5*-Terminal 
structure of poliovirus polyribosmal RNA is pUp. Proceedings o f the National 
Academy o f Sciences (USA) 73, 327-330.
HRDY, D.B., RUBIN, D.H. St FIELDS, B.N., (1982). Molecular basis of 
reovirus neurovirulence: Role of the M2 gene in avirulence. Proceedings o f the 
National Academy o f Sciences (USA) 79, 1298-1302.
HUISMANS, H. St JOKLIK, W.K., (1976). Reovirus coded polypeptides in 
infected cells: Isolation of two native monometric polypeptides with affinity for 
single-stranded and double-stranded RNA respectively. Virology 70, 411-424.
HUNT, T., VANDERHOFF.G., LONDON, I.M., (1972). Control of globin 
synthesis: The role of Heme. Journal o f Molecular Biology 66, 471-481.
1MAN1, F. & BETRAM, L.J., (1988). Inhibitory activity for the interferon- 
induced protein kinase is associated with the reovirus serotype 1 o3 protein. 
Proceedings o f the National Academy o f Sciences (USA) 85, 7887-7891.
2 1 0
INGLIS, S.C., (1982). Inhibition of host protein synthesis and degradation of 
cellular mRNAs during infection by influenza and herpes simplex virus. 
Molecular and Cellular Biology 2  1644-1648.
JACOBS, B.L. & SAMUEL, C .E ., (1985). Biosynthesis of reovirus-specified 
polypeptides. The reovirus si mRNA encodes two primary translation products. 
Virology 143, 63-74.
JEN, G. & THACH, R.E., (1982). Inhibition of host translation in 
encephalomyocarditis virus-infected L cells: a novel mechanism. Journal o f  
Virology 43, 250-261.
JOKLIK, W.K., (1972). Studies on the effect of chymotrypsin on reovirus. 
Virology 49, 700-715.
JOKLIK, W.K., (1974). Reproduction of reoviridae. In Comprehensive 
Virology 2, 297-334. Plenum Press, New York.
JOKLIK, W.K., (1981). Structure an function of the reovirus genome. 
Microbiological Reviews 45, 483-501.
KATZE, M.G. & KRUG, R.M ., (1984). Metabolism and expression of RNA 
polymerase II transcripts in influenza virus-infected cells. Molecular and 
Cellular Biology 4, 2198-2206.
KATZE, M .G., DeCORATO, D., SAFER, B., GALABRU, J. & 
HOVANESSIAN, A.G., (1987). Adenovirus VAI RNA complexes with the
211
68,000 Mr protein kinase to regulate its autophosphorylation and activity. The 
EMBO Journal 6, 689-697.
KATZE, M .G., DETJEN, B.M., SAFER, B. Sc KRUG, R.M., (1986). 
Translational control by influenza virus. Suppression of the kinase that 
phosphorylâtes the alpha subunit of initiation factor eIF-2 and selective 
translation of influenza viral mRNAs. Molecular and Cellular Biology 6, 1741- 
1750.
KAUFMAN, R.J. Sc MURTHA, P., (1987). Translational control mediated by 
eukaryotic initiation factor-2 is restricted to specific mRNAs in transfected cells. 
Molecular and Cellular Biology 7, 1568-1571.
KILHAM, L. Sc MARGOLIS, G., (1969). Hydrocephalus in hamsters, ferrets, 
rats and mice following inoculations with reovirus type 1. II. Pathological 
studies. Laboratory Investigations 21, 189-198.
KITAJEWSKI, J., SCHNEIDER, R.J., SAFER, B., MUNEMITSU, S.M., 
SAMUEL, C.E., THIMMAPPAYA, B. Sc SHENK, T ., (1986). Adenovirus 
VAI RNA antagonises the antiviral action of interferon by preventing activation 
of the interferon-induced eIF-2o kinase. Cell 45, 195-200.
KOZAK, M., (1981). Possible role of flanking nucleotides in recognition of the 
AUG initiator codon by eukaryotic ribosomes. Nucleic Acids Research 9, 5233- 
5252.
KOZAK, M., (1983). Comparison of initiation of protein synthesis in 
procaryotes, eucaryotes and organelles. Microbiological Reviews, 47, 1-45.
212
KOZAK, M., (1989). The scanning model for translation: An update. Journal 
o f Cell Biology 108,229-241.
KRAMER, A., KELLER, W., APPEL, B. Sc LUHRMAN, R., (1984). The 5* 
terminus of the RNA moiety of U1 small nuclear ribonucleoprotein particles is 
required for the splicing of messenger RNA precursors.. Cell 38, 299-307.
KRÄUSSLICH, H.G., NICKLIN, M.J.H., TOYODA, H., ETCHISON, D. Sc 
WIMMER E., (1987). Poliovirus proteinase 2A induces cleavage of eukaryotic 
initiation factor 4F polypeptide p220. Journal o f  Virology 61, 2711-2718.
KUDO, H. Sc GRAHAM, A.F., (1965). Synthesis of reovirus ribonucleic acid 
in L-cells. Journal o f Bacteriology 99, 936-945.
KURTZ, D.T. Sc NICODEMUS, C.F., (1981). Cloning if <*2U globulin 
cDNA using a high efficiency technique for the cloning of trace messenger 
RNAs. Gene 13, 145-152.
KWONG, A.D. & FRENKEL, N., (1987). Herpes simplex virus infected cells 
contain a function(s) that destabilise both host and viral mRNAs. Proceedings 
o f the National Academy o f Sciences (USA) 84, 1926-1930.
KWONG, A.D.& FRENKEL, N., (1989). The Herpes simplex virus virion 
host shutoff function. Journal o f  Virology 63,4834-4839.
KWONG, A.D., KRUPER, J.A. Sc FRENKEL, N., (1988). Herpes simplex 
virus virion host shutoff function. Journal o f Virology 62, 912-921.
213
LAEMMILI, (1970). Cleavage o f the structural proteins during the assembly of 
the head of the bacteriophage T4. Nature 111, 680-683.
LAURENT, A .G., KRUST, B., GALABRU, J ., SVAB, J, St 
HOVANESS1AN, A.G., (1983). Monoclonal antibodies to an interferon- 
induced Mr 68,0000 protein and their use for the detection of double-stranded 
RNA-dependent protein kinase in human cells. Proceedings o f the National 
Academy o f Sciences (USA) 82, 4341-4345.
LAZAROWITZ, S.G., COMPANS, R.W. St CHOPPIN, P.W., (1971). 
Influenza virus structural and non structural proteins in infected cells and their 
plasma membranes. Virology 46, 830-843.
LEE, F., HALL, C.V., R1NGOLD, G.M., DOBSON, D.E., LUH, J. St 
JACOB, P.E., (1984). Functional analysis of the steroid hormone control 
region of mouse mammary tumor virus. Nucleic Acids Research 12, 4191- 
4206.
LEE, K.A.W St SONENBERG, N., (1982). Inactivation of cap-binding 
proteins accompanies the shut-off of host proteins synthesis by poliovirus. 
Proceedings o f  the National Academy o f Sciences (USA) 79, 3447-3451.
LEE, K.A.W ., EDERRY, I., HANECAK, R., WIMMER, E. St 
SONENBERG, N., (1985). Poliovirus protease 3C(P3-7c) does not cleave 
p220 of the eukaryotic mRNA cap-binding protein complex. Journal o f  
Virology 55, 489-493.
LEE, P.W.K., HAYES, E.C and JOKLIK, W.K., (1981). Protein ol is the 
reovirus cell attachment protein. Virology 108, 156-
214
LEE, T.G., TOMITA, J., HOVANESSIAN, A.G. Sc KATZE, M.G., (1990). 
Purification and partial characterisation of a cellular inhibitor of the interferon- 
induced protein kinase of Mr 68,000 from influenza virus-infected cells. 
Proceedings o f the National Academy o f  Sciences (USA) 87, 6208-6212.
LEMAY, G. Sc MILLWARD, S., (1987). Expression of the cloned S4 gene of 
reovirus serotype 3 in transfromed eucaryotic cells: Enrichment of the viral 
protein in the crude initiation fraction. Virus Research 6, 133-140.
LEMIEUX, R., LEMAY, G. Sc MILLWARD, S., (1987). The viral protein 
sigma 3 participates in translation of late viral mRNA in reovirus-infected L- 
cells. Journal o f Virology 61, 2472-2479.
LEMIEUX, R., ZARBL, H. Sc MILLWARD, S., (1984). mRNA 
discrimination in extracts from uninfected and reovirus-infected L-cells. 
Journal o f  Virology 51, 215-222.
LEVIN, D.H. Sc SAMUEL, C.E., (1980). Biosynthesis of reovirus-specified 
polypeptides. Purification and characterisation of the small-sized class mRNAs 
of reovirus type 3. Coding assignments and translational efficiencies. Virology 
106, 1-13.
LEVIN, D.H., MENDELSOHN, N., SCHONBERG, M., KLETT, H., 
SILVERSTEIN, S. Sc KAPULER, A M., (1970). Properties of RNA 
transcriptase in reovirus subviral particles. Proceedings o f the National 
Academy o f Sciences (USA) 66, 890-897.
215
LLOYD, R.E., JENSE, H .G., Sc EHRENFELD, E., (1987). Restriction of 
translation of capped mRNA in vitro as a model for poliovirus-induced 
inhibition of host cell protein synthesis. Relationship to p220 cleavage. Journal 
o f Virology 61, 2480-2488.
LODISH, H.F. & PORTER, M., (1980). Translational control of protein 
synthesis after infection by vesicular stomatitis virus. Journal o f  Virology 36, 
719-733.
LODISH, H.F. & PORTER, M., (1981). Vesicular stomatitis virus mRNA and 
inhibition of translation of cellular mRNA - Is there a P function in vesicular 
stomatitis virus. Journal o f  Virology 16, 1351-1356.
LOH, P.C. & SOERGEL, M ., (1965). Growth characteristics of reovirus type 
2. Actinomycin D and the synthesis of viral RNA. Proceedings o f the National 
Academy o f Sciences (USA) 54, 857-863.
LUFTIG, R.B., KILHAM, S.S., HAY, A .J., ZWEERINK, H.J. & JOKLIK, 
W.K., (1972). An ultrastructural study of virions and cores of reovirus type 3. 
Virology AS, 170-181.
LUTSCH, G., BENNDORF, R., WESTERMAN, P., BOMMER, U. 8c 
BIELKA, H., (1986). Structure and location of initiation factor eIF-3 within 
native small ribosomal subunits from eukaryotes. European Journal o f Cell 
Biology 40, 257-265
MARAN, A. Sc MATHEWS, M.B., (1988). Characterisation of the double- 
stranded RNA implicated in the inhibition of protein synthesis in cells infected
216
with a mutant adenovirus defective for VA RNAj. Journal o f  Virology 164, 
106-113.
MARGOLIS, G., KILHAM, L. Sc GONATOS, N.K., (1971). Reovirus type 3 
encephalitis: Observations of virus-cell interactions in neuronal tissues. 
Laboratory Investigations, 24, 101-109.
MARVALDI, J ., SEKELLICK, M.J., MARCUS, P.I. Sc LUCAS-LENARD, 
J., (1978). Inhibition of mouse L-cell protein synthesis by Ultraviolet-irradiated 
Vesicular Stomatitis Virus requires viral transcription. Virology 84, 127-133.
MARVALDI, J.L., LUCAS-LENARD, J., SEKELLICK, M.J. Sc MARCUS, 
P.I., (1977). Cell killing by viruses. Cell killing and protein synthesis 
inhibition by vesicular stomatitis virus require the same gene functions. 
Virology 79, 267-280.
Mc CRAE, M.A. Sc McCORQUODALE, J.G ., (1982). Molecular biology of 
rotaviruses. IV. Molecular cloning of the bovine rotavirus genome. Journal o f 
Virology 44, 1076-1079.
MCALLISTER, P.E. Sc WAGNER, R.R., (1976). Differential inhibition of 
host protein synthesis in L-cells infected with RNA- temperature-sensitive 
mutants of vesicular stomatitis virus. Journal o f  Virology 18, 550-558.
McCRAE, M.A. Sc JOKLIK, W.K., (1978). The nature of the polypeptide 
encoded by each of the 10 double-stranded RNA segments of reovirus type 3. 
Virology 89, 578-593.
217
McCRAE, M.A. St WOODLAND, H .R., (1981). Stability of non- 
polyadenylated viral mRNAs injected into frog oocytes. European Journal o f 
Biochemistry 114, 467-470.
McCRAE, M.A. Double-stranded RNA viruses. In Virology: a practical 
approach. IRL Press 1985. 151-167.
McGOWAN, J.J. St WAGNER, R.R., (1981). Inhibition of cellular DNA 
synthesis by vesicular stomatitis virus Journal o f  Virology 38, 356-
McGOWAN, J.J., EMERSIN, S.U. St WAGENR, R.R., (1982). The plus- 
strand leader RNA of VSV inhibits DNA-dependent transcription of adenovirus 
and SV40 genes in a soluble whole-cell extract. Cell 28, 325-333.
MOLDAVE, K., (1985). Eukaryotic Protein Synthesis. Annual Reviews in 
Biochemistry 54, 1109-1149.
MORGAN, E.M. & ZWEERINK, H .J., (1975). Characterisation of 
transcriptase and replicase particles isolated from reovirus infected cells. 
Journal o f  Virology 68, 455-466.
MUESING, M.A., SMITH, D.H. St CAPON, D.J., (1987). Regulation 
mRNA accumulation by a human immunodeficiency virus trans-activator 
protein. Cell 48, 691-701.
MUESING, M.A., SMITH, D.H., CABRADILLA, C.D., BENTON, C.V., 
LASKY, L.A. & CAPON, D.J., (1985). Nucleic acid structure and expression 
of human AIDS/lymphadenopathy retrovirus. Nature 313, 450-458.
218
MUNEMITSU, S.S. St SAMUEL, C .E., (1984). Biosynthesis of reovirus- 
specified polypeptides. Multiplication rate but not yield of reovirus serotypes 1 
and 3 correlates with the level of virus-mediated inhibition of cellular protein 
synthesis. Virology 136, 133-143.
MUNROE, D. St JACOBSON, A., (1990). mRNA poly (A) tail, a 3* enhancer 
of translational initiation. Molecular and Cellular Biology 10, 3441-344S.
MUNROE, D. & JACOBSON, A., (1990). mRNA poly (A) tail, a 3' enhancer 
of translational initiation. Molecular and Cellular Biology 10, 3441-3445.
MUSTOE, T.A., RAMIG.R.F., SHARPE, A.H. St FIELDS, B.N., (1978). 
Genetics of reovirus. Identification of the ds RNA segments encoding the 
polypeptides of the u and a size classes. Virology 89, 594-604.
NAGAI, J., TANAKA, M. St NAKASHIMA, K., (1984). Conformation and 
template activity of human reovirus genome RNA. Journal o f Biochemistry 95, 
679-684.
NEUMANN, J.R ., MORENCY, C.A. & RUSSIAN, K.O., (1987). A novel 
rapid assay for chloramphenicol acetyltransferase gene expression. 
BioTechniques 5 , 444-447.
NEWSTEIN, M., STANBRIDGE.E.J., CASEY, G. Sl SHANK, P.R. (1990). 
Human chromosome 12 encodes a species-specific factor which increases human 
immunodeficiency virus Type 1 /^/-mediated irons activation in rodent cells. 
Journal o f Virology 64, 4565-4567.
219
NISHIOKA, Y. St SILVERSTEIN, S .t (1977). Degradation of cellular mRNA 
during infection by herpes simplex virus. Proceedings o f the National Academy 
o f Sciences (USA)  74, 2370-2374.
NOMOTO, A., LEE, Y.F. St WIMMER, E., (1976). The 5' end of poliovirus 
mRNA is not capped with m7G(5’)ppp(5')Np. Proceedings o f the National 
Academy o f Sciences (USA) 73, 375-380.
NONOYAMA, M ., MILLWARD, S. Si GRAHAM, A.F., (1974). Control of 
transcription of the reovirus genome. Nucleic Acids Research 1, 373-385.
NORTON, P.A. Si COFFIN, J.M ., (1985). Bacterial 6-galactosidase as a 
marker of Rous Sarcoma Virus gene expression and replication. Molecular and 
Cellular Biology 5, 281-290.
NUSS, D.L., OPPERMANN, H. St KOCH, G., (1975). Selective blockage of 
initiation of host protein synthesis in RNA-virus-infected cells. Proceedings o f  
the National Academy o f Sciences (USA) 72, 1258-1262.
NYGARD, O. & NILSSON, L., (1990). Translational dynamics. Interactions 
between the translational factors, tRNA and ribosomes during eukaryotic 
synthesis. European Journal o f Biochemistry 191, 1-17.
O'MALLEY, R.P., DUNCAN, R .F., HERSHEY, J.W.B. & MATHEWS, 
M.B., (1989). Modification of protein synthesis initiation factors and the shut­
off of host protein synthesis in adenovirus infected cells. Virology 169, 112- 
118.
220
O’MALLEY, R.P., MARIANO, T.M, SIEKIERKA, J. Sc MATHEWS, M B.,
(1986). A mechanism for the control of protein synthesis by adenovirus VA 
RNA1. Cell 44, 391-400.
OCHOA, S., (1983). Regulation of Protein Synthesis initiation in eukaryotes. 
Archives o f Biochemistry and Biophysics 223, 325-349.
OFFIT, P.A., CLARK, H.K., KORNSTEIN, M.J. Sc PLOTKIN, S.A., 
(1984). A murine model for oral infection with a primate rotavirus (Simian 
SAI 1). Journal o f Virology 51, 233-236.
PACHA, R.F. & CONDIT, R.C., (1985). Characterisation of a temperature- 
sensitive mutant of vaccinia virus reveals a novel function that prevents virus- 
induced breakdown of RNA. Journal o f  Virology 56, 395-403.
PAUL, R.W., CHOI, A.H.C. Sc LEE, P.W.K., (1989). The o-anomeric form 
of sialic acid is the minimal receptor determinant recognised by reovirus. 
Virology 172, 382-385.
PELHAM, R.B. Sc JACKSON, R.J., (1976). An efficient mRNA-dependent 
translation system from reticulocyte lysates. European Journal o f  Biochemistry 
67, 247-256.
PENMAN, S., SCHERRER, K., BECKER. Y. & DARNELL, J.E., (1963). 
Polyribosomes in normal and poliovirus-infected HeLa cells and their 
relationship to messenger RNA. Proceedings o f the National Academy o f  
Sciences (USA) 49, 654-662.
221
PESTKA, S., LANGER, J.A., ZOON, K. Sc SAMUEL, C.E., (1987). 
Interferons and their actions. Annual Reviews in Biochemistry 56, 727-777.
PROUD, C.G., (1986). Guanine nucleotides, protein phosphorylation and the 
control of translation. Trends in Biochemical Sciences 11, 73-77.
PROUDFOOT, N.J. Sc MONKS, J. (1990). Activation of the HIV promoter by 
DNA replication. AIDS meeting Exceter, September 1990. Abstract 10.
RACANIELLO, U.R. Sc BALTIMORE, D., (1981). Molecular cloning of 
poliovirus cDNA and determination of the complete sequence of the viral 
genome. Proceddings o f the National Academy o f Sciences (USA) 78, 4887- 
4891.
RALPH, S.J., HARVEY, J.D. Sc BELLAMY, A.R., (1980). Subunit structure 
of the reovirus spike. Journal o f  Virology 36, 894-896.
RAMIG, R.F., CROSS, R.K. Sc FIELDS, B.N., (1977). Genome RNAs and 
polypeptides of reovirus serotypes 1, 2 and 3. Journal o f  Virology 27, 726-733.
RAMIG, R.F., MUSTOE, T.A., SHARPE, A.H. Sc FIELDS, B.N., (1978). 
A genetic map of reovirus. II. Assignment of the double-stranded RNA- 
negative mutant groups C, D and E to gene segments. Virology 85, 531-544.
RAY, B.K., BRENDLER, T.G., ADYA, S., DANIELS-McQUENN, S., 
MILLER, J.K., HERSHEY, J.W.B., GRIFO, J.A., MERRICK, W.C. Sc 
THACH, R.E., (1983). Role of mRNA competition in regulating translation . 
Further characterisation of mRNA discriminatory initiation factors. Proceedings 
o f the National Academy o f Sciences (USA) 80, 603-697.
222
RAYCHAUDHURI, P., STRINGER, E.A., VALENZUELA, D.M., 
MAITRA, U., (1984). Ribosomal antiassociation activity in Rabbit 
Reticulocyte Lysates. Journal o f  Biochemistry 259, 11939-11935.
READ, G.S. & FRENKEL N., (1983). Herpes simplex virus mutants defective 
in the virion-associated shut off of host polypeptide synthesis and exhibiting 
abnormal synthesis of a (immediate early) viral polypeptides. Journal o f 
Virology 46, 498-512.
REICHEL, P.A., MERRICK, W.C., SIEKIERKA, J. & MATHEWS, M.B., 
(1985). Regulation of a protein synthesis initiation factor by adenovirus virus- 
associated RNA1. Nature 313, 196-200.
RHIM, J.S., SMITH, K.O. & MELNICK.J.L., (1961). Complete and coreless 
forms of reovirus (ECHO 10). ratio of number of virus particles to infection 
units in the one step growth cycle. Virology 15, 428-435.
RHOADS, R.E., (1988). Cap recognition and the entry of mRNA into the 
protein synthesis initiation cycle. Trends in Biochemical Sciences 13, 52-55.
RICE, A.P. & ROBERTS, B.E., (1983). Vaccinia virus induces cellular mRNA 
degradation. Journal o f Virology 47, 529-539.
RICE, A.P., DUNCAN, R., HERSHEY, J.W.B. & KERR, I.M ., (1985a). 
Double-Stranded RNA-dependent protein kinase and 2-5A System are both 
activated in Interferon-treated, Encephalomyocarditis Virus-Infected HeLa 
Cells. Journal o f Virology 54, 894-898.
223
RICE, A.P., KERR, S.M., ROBERTS, W.K., BROWM, R.E. Sc KERR, I.M., 
(1985b). Novel 2',5'-oligoadenylated synthesised in interferon treated Vaccinia 
Virus infected cells. Journal o f  Virology 56, 1041-1044.
ROGERS, J. Sc WALL, R., (1980). A mechanism for RNA splicing. 
Proceedings o f the National Academy o f Sciences (USA) 77, 1877-1879.
ROIZMAN, B., BORMAN, G.S., KAMAU-ROUSTA, M., (1965). 
Macromolecular synthesis in cells infected with herpes simplex virus. Nature 
206, 1374-1375.
RONER, M.R., GAILLARD, R.K. Sc JOKLIK, W.K., (1989). Control of 
reovirus messenger RNA translation efficiency by the regions upstream of 
initiation codons. Virology 168, 292-301.
ROSE, J.K., TRACHSEL, H., LEONG, K. Sc BALTIMORE, D., (1978). 
Inhibition of translation by poliovirus. Inactivation of a specific initiation 
factor. Proceedings o f the National Academy o f Sciences (USA) 75, 2732-2736.
ROSEN, C.A., SODROSKI, J.G., CAMPBELL, K. Sc HASELTINE, W.A., 
(1986a). Construction of recombinant murine retroviruses that express the 
human T-cell leukemia virus type II and human T-cell lymphotropic virus type 
III trans activator genes. Journal o f Virology 57, 379-384.
ROSEN, C.A., SODROSKI, J.G., GOH, W.C., DAYTON, A.I., LIPPKE, J. 
& HASELTINE, W.A., (1986b). Post-transcriptional regulation accounts for 
the trans-activation of the human T-lymphotropic virus type III. Nature 319, 
555-559.
224
RUBIN, D.H. St FIELDS, B.N., (1980). Molecular basis of reovims 
virulence. Role of the M2 gene. Journal o f  Experimental Medicine 152, 853- 
868.
RUECKERT, R.R St WIMMER, E., (1984). Systemic nomenclature of 
picomavirus proteins. Journal o f Virology 50, 957-959.
RYCHLIK, W., DOMIER, L.L., GARDNER, P.R. St HELLMAN, G.M.,
(1987). Amino acid sequence of the mRNA cap-binding protein from human 
tissues. Proceedings o f the National Academy o f Sciences (USA) 84, 945-949.
SAFER, B., (1983). 2B or NOT 2B. Regulation of the catalytic utilisation of 
eIF-2. Cell 33,7-8.
SAHNI, G. St SAMUEL, C.E., (1986). Mechanism of Interferon Action. 
Expression of Vesicular Stomatitis Virus G Gene in transfected COS cells is 
inhibited by Interferon at the level of Protein Synthesis. Journal o f 
Biochemistry 261, 16764-16768.
SAKUMA, S. St WATANABE, Y., (1972). Reovirus replicase - directed 
synthesis of double stranded ribonucleic acid. Journal o f  Virology 10, 628-638.
SAMBROOK, J., FRITSCH, E.F St MANIATIS, T ., (1989). Molecular 
cloning a laboratory manual. Cold Spring Harbour Laboratory Press.
SAMUEL C.E., (1979a). Mechanism of interferon action. Kinetics of 
interferon action in mouse L29 cells: Phosphorylation of protein synthesis 
initiation factor eIF-2 and ribosome associated protein PI. Virology 83,281-285.
225
SAMUEL, C.E. St BRODY, M.S., (1990). Biosynthesis of reovirus-specified 
polypeptides. 2 aminopurine increases the efficiency of translation of reovirus 
si mRNA but not s4 mRNA in transfected cells. Virology 176, 106-113.
SAMUEL, C.E., (1979b). Mechanism of interferon. Phosphorylation of 
protein synthesis initiation factor eIF-2 in interferon-treated human cells by a 
ribosome associated protein kinase possessing site - specificity similar to the 
hemin regulated rabbit reticulocyte kinase. Proceedings o f the National Academy 
o f Sciences (USA) 76,600-604.
SAMUEL, C.E., DUNCAN, R., KNUTSON, G.S. St HERSHEY, J.W.B., 
(1984). Mechanism of Interferon Action. Increased phosphorylation of protein 
synthesis initiation factor eIF-2a in interferon treated Reovirus mouse L929 
fibroblasts in vitro and in vivo. Journal o f Biochemistry 259, 13451-13457.
SCHIFF, L.A. St FIELDS, B.N., (1989). Reoviruses. In Fields Virology 
Volume 2. Raven Press. 1307-1329.
SCHIFF, L.A., NIBERT, M .L., CO, M.S., BROWN, E.G. St FIELDS, B.N.,
(1988). Distinct binding sites for zinc and double-stranded RNA in the reovirus 
outer capsid protein o3. Molecular and Cellular Biology 8, 273-283.
SCHNEIDER, R J. & SHENK, (1987). Impact of virus infection on host cell 
protein synthesis. Annual Reviews in Biochemistry 56, 317-332.
SCHNEIDER, R.J., SAFER, B., MUNEMITSU, S.M., SAMUEL, C.E. St 
SHENK, T., (1985). Adenovirus VAI RNA prevents phosphorylation of the 
eukaryotic initiation factor 2 a  subunit subsequent to infection. Proceedings o f 
the National Academy o f Sciences (USA) 82, 4321-4325.
226
SCHNITZLEIN, W.M., O’BANION M.K., POIROT, M.K. St REICHMANN, 
M.E., (1983). Effect of intracellular vesicular stomatitis virus mRNA 
concentration on the inhibition of host cell protein synthesis. Journal o f 
Virology 45, 206-214.
SCHONBERG, M., SILVERSTEIN, S.C., LEVIN, D.H. Sc ACS, G., (1971). 
Asynchronous synthesis of the complementary strands of the reovirus genome. 
Proceedings o f the National Academy o f Sciences (USA) 68, 505-508.
SHARP, P.A., (1981). Speculations on RNA Splicing. Cell 23, 643-646.
SHARPE, A.H. & FIELDS, B.N., (1981). Reovirus inhibition of cellular 
DNA synthesis. Role of the SI gene. Journal o f Virology 38, 389-392.
SHARPE, A.H. & FIELDS, B.N., (1982). Reovirus inhibition of cellular 
RNA and protein synthesis. Role of the S4 gene. Virology 122, 381-391.
SHARPE, A.H. Sc FIELDS, B.N., (1985). Pathogenesis of viral infections. 
Basic concepts derived from the reovirus model. The New England Journal o f 
Medicine 312, 486-496.
SHARPE, A.H., RAMIG, R.F., MUSTOE, T.A. Sc FIELDS, B.N., (1978). 
A genetic mapof reovirus. I. Correlation of genome RNAs between serotypes 
1, 2 and 3. Virology 84, 63-74.
SHATKIN, A.J. Sc LaFIANDRA, A.J., (1972). Transcription by infectious 
subviral particles of reovirus. Journal o f  Virology 10, 698-706.
227
SHATKIN, A.J. St SIPE, J.D., (1968). RNA polymerase activity in purified 
reoviruses. Proceedings o f the National Academy o f Sciences (USA) 61, 1463- 
1469.
SHATKIN, A .J., (1985). mRNA Cap Binding Proteins. Essential Factors for 
Initiating Translation. Cell 40, 223-224.
SHATKIN, A .J., SIPE, J.D. St LOH, P ., (1968). Separation of ten reovirus 
genome segments by polyacrylamide gel electrophoresis. Journal o f Virology 2, 
986-991.
SIEKIERKA, J., MARIANO, T.M ., REICHEL, P.A. St MATHEWS, M.B., 
(1985). Translational control by adenovirus. Lack of virus-associated RNA1 
during adenovirus infection results in phosphorylation of initiation factor eIF-2 
and inhibition of protein synthesis. Proceedings o f the National Academy o f 
Sciences (USA) 82, 1959-1963.
SILVERSTEIN, S.C. & DALES, S., (1968). The penetration of reovirus RNA 
and initiation of its genetic function in L-strain fibroblasts. Journal o f  Cell 
Biology 36, 197-230.
SILVERSTEIN, S.C., ASTELL, C., LEVIN, D.H. , SCHONBERG, M. St 
ACS, G., (1972). The mechanism of uncoating and gene activation in vivo. 
Virology 47, 797-806.
SILVERSTEIN, S.C., CHRISTMAN, J.K. St ACS, G., (1976). The reovirus 
replicative cycle. Annual Reviews in Biochemistry 45, 375-408.
228
SKEHEL, J.J. & JOKLIK, W.K., (1969). Studies of the in vitro transcription 
of reovirus cores. Virology 39, 822-831.
SKEHEL, J.J., (1972). Polypeptide synthesis in influenza virus-infected cells. 
Virology 49, 23-36.
SKUP D. Sc MILLWARD, S., (1977). Highly efficient translation of 
messenger RNA in cell-free extracts prepared from L-cells. Nucleic Acids 
Research 4, 3581-3587.
SKUP, D. & MILLWARD, S., (1980a). Reovirus-induced modification of 
cap-dependent translation in infected L-cells. Proceedings o f the National 
Academy o f Sciences (USA) 77, 152-156.
SKUP, D. & MILLWARD, S., (1980b). mRNA capping enzymes are masked 
in reovirus progeny subviral particles. Journal o f  Virology 34, 490-496.
SKUP, D., ZARBL, H. Sc MILLWARD, S., (1981). Regulation of translation 
in L-cells infected with reovirus. Journal o f Molecular Biology 151, 35-55.
SODROSKI, J., ROSEN, C., WONG-STAAL, F. SALAHUDDIN, S.Z., 
POPOVIC, M., ARYA, S., GALLO, R.C. Sc HASELTINE, W.A., (1985). 
Trans-acting transcriptional regulation of human T-cell leukemia virus type III 
long terminal repeat. Nature 171-173.
SONENBERG, N., (1981). ATP/Mg2 +  dependent cross-linking of cap 
binding proteins to the 5' end of eukaryotic mRNA. Nucleic Acids Research 9, 
1643-1656.
229
SONENBERG, N., (1987). Regulation of translation by poliovirus. Advances 
in Virus Research 33, 175-204.
SONENBERG, N., GUERT1N, D. 8l LEE, K.A.W., (1982). Capped mRNAs 
with reduced secondary structure can function in extracts from poliovirus- 
infected cells. Molecular and Cellular Biology 2, 1633-1638.
SONENBERG, N., MORGAN, M.A., MERRICK, W.C. St SHATKIN A.J.,
(1978) . A polypeptide in eukaryotic initiation factors that crosslinks specifically 
to the 5 '-terminal cap in mRNA. Proceedings o f the National Academy o f 
Sciences (USA) 75, 4843-4837.
SONENBERG, N., RUPPRECHT, K.M., HECHT, S.M. St SHATKIN, A.J.,
(1979) . Eukaryotic mRNA cap binding protein. Purification by affinity 
chromatography on Sepharose-coupled m7GDP. Proceedings o f the National 
Academy o f Sciences (USA) 76, 4345-4348.
SONENBERG, N., SKUP, D., TRACHSEL, H. St MILLWARD, S., (1981). 
In vitro translation in reovirus- and poliovirus-infected cell extracts: Effects of 
anti-cap binding protein monoclonal antibody. Journal o f  Biochemistry 256, 
4138-4141.
SPANDIDOS, D.A. & GRAHAM, A.F., (1976). Non-permissive infection of 
L-cells by an avian reovirus. Restricted transcription of the viral genome. 
Journal o f Virology 19, 977-984.
STANNERS, C.P., FRANCOEUR, A.M. St LAM, T., (1977). Analysis of 
vesicular stomatitis virus mutant with attenuated cytopathogenicity: mutation in 
viral function, P, for inhibition of protein synthesis. Cell, I I ,  273-280.
230
STROM, T. & FRENKEL, N., (1987). Effects of Herpes Simplex Virus on 
mRNA stability. Journal o f Virology 61, 2198-2207.
STURZENBECKER, L.J., NIBERT, M., FURLONG, D. St FIELDS B.N., 
(1987). Intracellular digestion of reovirus particles requires a low pH and is an 
essential step in the viral infectious cycle. Journal o f Virology 61, 2351-2361.
SUN, X. & BALTIMORE, D., (1989). Human immunodeficiency virus tat- 
activated expression of poliovirus protein 2A inhibits mRNA translation. 
Proceedings o f the National Academy o f Sciences (USA) 86, 2143-2146.
SVENSSON, C. St AKUSJARVI, G., (1984). Adenovirus VA RNA1. A 
positive regulator o f mRNA translation. Molecular and Cellular Biology 4, 
736-742.
SVENSSON, C. Sl AKUSJARVI, G., (1985). Adenovirus VA RNA1 mediates 
a translational stimulation which is not restricted to the viral mRNAs. The 
EMBO Journal 4, 957-964.
TAHARA, S.M ., MORGAN, M.A., SHATKIN, A.J., (1983). Binding of 
Inosine-substituted mRNA to Reticulocyte Ribosomes and Eukaryotic Initiation 
Factors 4A and 4B requires ATP. Journal o f  Biochemistry 258, 11350-11353.
THIMMAPPAYA, B., WEINBERGER, C., SCHNEIDER, R.J. St SHENK, 
T ., (1982). Adenovirus VAI RNA is required for efficient translation of viral 
mRNAs at late times after infection. Cell 31, 543-551.
231
TRACHSEL, H., SONENBERG, N., SHATKIN, A.J., ROSE, J.K., LEONG,
K., BERGMANN, J.E ., GORDON, J. & BALTIMORE, D., (1980). 
Purification of a factor that restores translation of vesicular stomatitis virus 
mRNA in extracts from poliovirus-infected HeLa cells. Proceedings o f the 
National Academy o f Sciences (USA) 77, 770-774.
WAGNER, R., (1987). Rhabdovirus biology and infection: An overview. 9- 
16. In Rhabdoviridae. Edited by R.Wagner. Plenum Press, New York.
WALDEN, W.E., GODEFROY-COLBURN, T. & THACH, R.E (1981). The 
role of mRNA competition in regulating translation. Demonstration of 
competition in vivo. Journal o f  Biochemistry 256 11739-11746.
WEINER, H.L. & FIELDS, B.N., (1977). Neutralisation of reovirus: The 
gene responsible for the neutralisation antigen. Journal o f  Experimental 
Medicine 146, 1305-1310.
WEK, P.K. & WAGNER, R.R., (1979). Transcription of vesicular stomatitis 
virus is required to shut off cellular RNA synthesis. Journal o f Virology 30, 
410-413.
WHITAKER-DOWLING, P. & YOUNGER, J.S., (1984). Characterisation of 
a specific kinase inhibitory factor produced by Vaccinia Virus which inhibits the 
Interferon-Induced Protein Kinase. Virology 137, 171-181.
WYCKOFF, E.E., HERSHEY, J.W.B. & EHRENFELD, E., (1990). 
Eukaryotic initiation factor 3 is required for poliovirus 2A protease-induced 
cleavage of the p220 component of eukaryotic initiation factor 4F.
232
YEUNG, M.C., U M , D., DUNCAN, R., SHAHRABADI, M.S., 
CASHDOLLAR, L.W & LEE, P.W.K., (1989). The cell attachment proteins 
of type 1 and type 3 reovirus are differentially susceptible to trypsin and 
chymotrypsin. Virology 170, 62-70.
YOON, K., THIEDE, M.A. & RODAN, G.A., (1988). Alkaline phosphatase 
as a reporter enzyme. Gene 66, 11-17.
ZAP, M., EVANS, P. St LUCAS-LENARD, J ., (1990). The inhibition of 
mouse -cell 45 S ribosomal RNA processing is a highly uv-resistant property of 
vesicular stomatitis virus. Virology 177, 75-84.
ZARBL, H. & MILLWARD, S., (1983). The reovirus multiplication cycle. 
In The Reoviridae. Edited by W.K. JOKLIK. Plenum Press, New York.
ZARBL, H., HASTINGS, K.E.M. St MILLWARD, S. (1980a). Reovirus core 
particles synthesise capped oligonucleotides as a result of abortive transcription. 
Archives o f Biochemistry and Biophysics 202, 348-360.
ZARBL, H., SKUP.D. & MILLWARD, S., (1980b). Reovirus progeny 
subviral particles synthesise uncapped mRNA. Journal o f  Virology 34, 497-506.
ZEEVI, M., NEVINS, J.R., DARNELL, J.E., (1982). Newly formed mRNA 
lacking polyadenylic acid enters the cytoplasm and the polyribosomes but has a 
shorter half-life in the absence of polyadenylic acid. Molecular and Cellular 
Biology 2, 517-525.
ZWEERINK, H.J. & JOKLIK, W.K., (1970). Studies on the intracellular 
synthesis of reovirus-specified proteins. Virology 41, 501-518.
233
ZWEERINK, H.J., (1974). Multiple forms of ss -* ds RNA polymerase 
activity in reovirus-infected cells. Nature 247, 313-315.
ZWEERINK, H.J., ITO, Y. & MATSUHOSA, T. (1972). Synthesis of 
reovirus double-stranded RNA within virion-like particles. Virology 50, 349- 
358.
234

